Go to
JCI Insight
Citations to this article
Arturo Casadevall, Liise-anne Pirofski
Published March 13, 2020
Citation Information: J Clin Invest. 2020;130(4):1545-1548. https://doi.org/10.1172/JCI138003.
Citation Information: J Clin Invest. 2020;130(4):1545-1548. https://doi.org/10.1172/JCI138003.
Abstract
Authors
Arturo Casadevall, Liise-anne Pirofski
Total citations by year
Citation information
Citations to this article (547)
| Title and authors | Publication | Year |
|---|---|---|
|
Coagulation Profile of Convalescent Plasma Donors and Recipients
Pitkänen HH, Helin T, Khawaja T, Pietilä JP, Kajova M, Välimaa H, Vahlberg T, Ihalainen J, Vierikko A, Vapalahti O, Kantele A, Lassila R |
Clinical and Applied Thrombosis/Hemostasis | 2025 |
|
mGem: A quarter century with the Pirofski–Casadevall damage response framework—a dynamic construct for understanding microbial pathogenesis
Nosanchuk JD |
mBio | 2025 |
|
SARS-CoV-2 IgG Antibodies in COVID-19 Convalescent Plasma and Conventional Plasma Units
Sulaiman A, Sengsouk I, White JL, Marshall C, Fernandez RE, Redd AD, Eby Y, Casadevall A, Sullivan D, Gebo K, Shoham S, Laeyendecker O, Rai H, Bloch EM, Crowe EP, Tobian AA |
Transfusion | 2025 |
|
Genetic and Epigenetic Determinants of COVID-19 Susceptibility: A Systematic Review.
Gasmi A, Kassym L, Menzel A, Anzar W, Dadar M, Semenova Y, Arshad M, Bihunyak T, Meguid NA, Peana M, Bekbergenova Z, Bjørklund G |
Current medicinal chemistry | 2025 |
|
Therapeutic Approaches for COVID-19: A Review of Antiviral Treatments, Immunotherapies, and Emerging Interventions.
Alves MCS, da Silva RCC, de Leitão-Júnior SSP, de Balbino VQ |
Advances in therapy | 2025 |
|
COVID-19 Vaccination in Patients with Hematological Malignances
Franchini M, Maggi F, Focosi D |
Vaccines | 2025 |
|
After the Hurricane: Anti-COVID-19 Drugs Development, Molecular Mechanisms of Action and Future Perspectives
Khalifa HO, Al Ramahi YM |
International journal of molecular sciences | 2024 |
|
Safety and Efficacy of Convalescent Plasma Combined with Other Pharmaceutical Agents for Treatment of COVID-19 in Hospitalized Patients: A Systematic Review and Meta-Analysis.
Franchini M, Focosi D, Cruciani M, Joyner MJ, Pirofski LA, Senefeld JW, Shoham S, Sullivan DJ, Casadevall A |
2024 | |
|
From Detection to Protection: Antibodies and Their Crucial Role in Diagnosing and Combatting SARS-CoV-2.
Kumar A, Tripathi P, Kumar P, Shekhar R, Pathak R |
Human vaccines | 2024 |
|
Emerging Treatment Approaches for COVID-19 Infection: A Critical Review.
Bharadwaj A, Kaur R, Gupta S |
Current molecular medicine | 2024 |
|
Vaccine-Boosted CCP Decreases Virus Replication and Hastens Resolution of Infection Despite Transiently Enhancing Disease in SARS-CoV-2–Infected Hamsters
Carroll TD, Wong T, Morris MK, Di Germanio C, Ma ZM, Stone M, Ball E, Fritts L, Rustagi A, Simmons G, Busch M, Miller CJ |
The Journal of Infectious Diseases | 2024 |
|
Convalescent Plasma as Adjunctive Therapy for Hospitalized Patients with COVID-19: The Co-CLARITY Trial
Gauiran DT, Dumagay TE, Ang MA, Dungog CC, Climacosa FM, Maganito SC, Alfonso RN, Quero AK, Lucero JA, Cortez CF, Evasan AL, King RA, Heralde FM, Bonifacio LB, Castillo GJ Jr, Escasa IM, Santos MC, Malundo AF, Mondragon AV, Salamat SE, Veloso JD, Carnate JM Jr, Tagayuna PY, Lim JA, Alejandria MM, Mirasol MA |
2024 | |
|
In vitro antibody-mediated SARS-CoV-2 infection suppression through human ACE2 receptor blockade
Redd PS, Merting AD, Klement JD, Poschel DB, Yang D, Liu K |
Immunology Letters | 2024 |
|
Monoclonal IgY antibodies: advancements and limitations for immunodiagnosis and immunotherapy applications.
Tabll AA, Shahein YE, Omran MM, Hussein NA, El-Shershaby A, Petrovic A, Glasnovic M, Smolic R, Smolic M |
2024 | |
|
Preclinical and Clinical Investigations of Potential Drugs and Vaccines for COVID-19 Therapy: A Comprehensive Review With Recent Update.
Mia ME, Howlader M, Akter F, Hossain MM |
2024 | |
|
A program for real-time surveillance of SARS-CoV-2 genetics
Brochu HN, Song K, Zhang Q, Zeng Q, Shafi A, Robinson M, Humphrey J, Croy B, Peavy L, Perera M, Parker S, Pruitt J, Munroe J, Ghatti R, Urban TJ, Harris AB, Alfego D, Norvell B, Levandoski M, Krueger B, Williams JD, Boles D, Nye MB, Dale SE, Sapeta M, Petropoulos CJ, Meltzer J, Eisenberg M, Cohen O, Letovsky S, Iyer LK |
Scientific Reports | 2024 |
|
Impact of variable titer COVID-19 convalescent plasma and recipient SARS-CoV2-specific humoral immunity on survival in hospitalized patients.
Iasella CJ, Hannan SJ, Lyons EJ, Lieber SC, Das A, Dimitrov D, Li W, Saul M, Popescu I, Koshy R, Burke R, Lape B, Brown MJ, Chen X, Sembrat JC, Devonshire K, Kitsios GD, Konstantinidis I, Snyder ME, Chen BB, Merlo CA, Hager DN, Kiss JE, Yazer MH, Wells AH, Morris A, McVerry BJ, McMahon DK, Triulzi DJ, McDyer JF |
PloS one | 2024 |
|
WHO Is Recommending against the Use of COVID-19 Convalescent Plasma in Immunocompromised Patients?
Franchini M, Casadevall A, Joyner MJ, Focosi D |
2023 | |
|
Convalescent plasma (hyperimmune immunoglobulin) for COVID-19 management: An update
Chavda VP, Bezbaruah R, Dolia S, Shah N, Verma S, Savale S, Ray S |
2023 | |
|
Convalescent plasma for people with COVID‐19: a living systematic review
Iannizzi C, Chai KL, Piechotta V, Valk SJ, Kimber C, Monsef I, Wood EM, Lamikanra AA, Roberts DJ, McQuilten Z, So-Osman C, Jindal A, Cryns N, Estcourt LJ, Kreuzberger N, Skoetz N |
The Cochrane Database of Systematic Reviews | 2023 |
|
Hyperimmune immunoglobulin for people with COVID‐19
Kimber C, Valk SJ, Chai KL, Piechotta V, Iannizzi C, Monsef I, Wood EM, Lamikanra AA, Roberts DJ, McQuilten Z, So-Osman C, Estcourt LJ, Skoetz N |
The Cochrane Database of Systematic Reviews | 2023 |
|
COVID-19 Convalescent Plasma for the Treatment of Immunocompromised Patients: A Systematic Review and Meta-analysis
Senefeld JW, Franchini M, Mengoli C, Cruciani M, Zani M, Gorman EK, Focosi D, Casadevall A, Joyner MJ |
2023 | |
|
Effectiveness of COVID-19 Convalescent Plasma (CCP) During the Pandemic Era: A Literature Review
Kandula UR, Tuji TS, Gudeta DB, Bulbula KL, Mohammad AA, Wari KD, Abbas A |
Journal of blood medicine | 2023 |
|
An overview on the treatments and prevention against COVID-19.
Panahi Y, Gorabi AM, Talaei S, Beiraghdar F, Akbarzadeh A, Tarhriz V, Mellatyar H |
Virology Journal | 2023 |
|
Comprehensive evaluation of six interventions for hospitalized patients with COVID-19: A propensity score matching study.
Alshamrani AA, Assiri AM, Almohammed OA |
2023 | |
|
Assessment of the impact of pathogen reduction technologies on the neutralizing activity of COVID-19 convalescent plasma.
Hindawi S, Elgemmezi T, A. El-Kafrawy S, Samadani H, Tilmisani M, Assiri O, Raml M, I. Azhar E, Badawi M |
Transfusion and Apheresis Science | 2023 |
|
Early Treatment, Inflammation and Post-COVID Conditions
Gebo KA, Heath SL, Fukuta Y, Zhu X, Baksh S, Abraham AG, Habtehyimer F, Shade D, Ruff J, Ram M, Laeyendecker O, Fernandez RE, Patel EU, Baker OR, Shoham S, Cachay ER, Currier JS, Gerber JM, Meisenberg B, Forthal DN, Hammitt LL, Huaman MA, Levine A, Mosnaim GS, Patel B, Paxton JH, Raval JS, Sutcliffe CG, Anjan S, Gniadek T, Kassaye S, Blair JE, Lane K, McBee NA, Gawad AL, Das P, Klein SL, Pekosz A, Casadevall A, Bloch EM, Hanley D, Tobian AA, Sullivan DJ |
2023 | |
|
Mechanistic insight into the protective and pathogenic immune-responses against SARS-CoV-2
Purbey PK, Roy K, Gupta S, Paul MK |
Molecular Immunology | 2023 |
|
A systematic review on impact of SARS-CoV-2 infection.
Thirumugam G, Radhakrishnan Y, Ramamurthi S, Bhaskar JP, Krishnaswamy B |
Microbiological research | 2023 |
|
COVID-19 and Multiorgan Response: The Long-Term Impact.
Harky A, Ala'Aldeen A, SundasButt, Duric B, Roy S, Zeinah M |
Current Problems in Cardiology | 2023 |
|
Prior COVID-19 Immunization Does Not Cause IgA- or IgG-Dependent Enhancement of SARS-CoV-2 Infection.
Yaugel-Novoa M, Noailly B, Jospin F, Berger AE, Waeckel L, Botelho-Nevers E, Longet S, Bourlet T, Paul S |
Human vaccines | 2023 |
|
Diagnosis, treatment protocols, and outcomes of liver transplant recipients infected with COVID-19.
Hashem M, El-Kassas M |
World journal of clinical cases | 2023 |
|
Convalescent plasma for people with COVID‐19: a living systematic review
Iannizzi C, Chai KL, Piechotta V, Valk SJ, Kimber C, Monsef I, Wood EM, Lamikanra AA, Roberts DJ, McQuilten Z, So-Osman C, Jindal A, Cryns N, Estcourt LJ, Kreuzberger N, Skoetz N |
The Cochrane Database of Systematic Reviews | 2023 |
|
COVID-19 Serology Data Provide Guidance for Future Deployments of Convalescent Plasma
Sullivan D, Casadevall A |
mBio | 2023 |
|
COVID-19: Variants, Immunity, and Therapeutics for Non-Hospitalized Patients.
Lee CYS, Suzuki JB |
Biomedicines | 2023 |
|
Use of covid-19 convalescent plasma to treat patients admitted to hospital for covid-19 with or without underlying immunodeficiency: open label, randomised clinical trial
Lacombe K, Hueso T, Porcher R, Mekinian A, Chiarabini T, Georgin-Lavialle S, Ader F, Saison J, Martin-Blondel G, De Castro N, Bonnet F, Cazanave C, Francois A, Morel P, Hermine O, Pourcher V, Michel M, Lescure X, Soussi N, Brun P, Pommeret F, Sellier P, Rousset S, Piroth L, Michot JM, Baron G, de Lamballerie X, Mariette X, Tharaux PL, Resche-Rigon M, Ravaud P, Simon T, Tiberghien P |
2023 | |
|
Blood‐derived product therapies for SARS‐CoV‐2 infection and long COVID
Wu J, Yang H, Yu D, Yang X |
2023 | |
|
Administration of vaccine-boosted COVID-19 convalescent plasma to SARS-CoV-2 infected hamsters decreases virus replication in lungs and hastens resolution of the infection despite transiently enhancing disease and lung pathology.
Carroll TD, Wong T, Morris MK, Di Germanio C, Ma ZM, Stone M, Ball E, Fritts L, Rustagi A, Simmons G, Busch M, Miller CJ |
bioRxiv : the preprint server for biology | 2023 |
|
Early antibody treatment, inflammation, and risk of post-COVID conditions
Gebo KA, Heath SL, Fukuta Y, Zhu X, Baksh S, Abraham AG, Habtehyimer F, Shade D, Ruff J, Ram M, Laeyendecker O, Fernandez RE, Patel EU, Baker OR, Shoham S, Cachay ER, Currier JS, Gerber JM, Meisenberg B, Forthal DN, Hammitt LL, Huaman MA, Levine A, Mosnaim GS, Patel B, Paxton JH, Raval JS, Sutcliffe CG, Anjan S, Gniadek T, Kassaye S, Blair JE, Lane K, McBee NA, Gawad AL, Das P, Klein SL, Pekosz A, Bloch EM, Hanley D, Casadevall A, Tobian AA, Sullivan DJ |
mBio | 2023 |
|
ComplexEye: a multi-lens array microscope for high-throughput embedded immune cell migration analysis.
Cibir Z, Hassel J, Sonneck J, Kowitz L, Beer A, Kraus A, Hallekamp G, Rosenkranz M, Raffelberg P, Olfen S, Smilowski K, Burkard R, Helfrich I, Tuz AA, Singh V, Ghosh S, Sickmann A, Klebl AK, Eickhoff JE, Klebl B, Seidl K, Chen J, Grabmaier A, Viga R, Gunzer M |
Nature Communications | 2023 |
|
Anti-SARS-CoV-2 Antibody Testing: Role and Indications.
Mink S, Fraunberger P |
Journal of Clinical Medicine | 2023 |
|
The Impact of Pathogen Reduction on Total IgG and IgG Subclass Profiles of Convalescent Plasma
Wasiluk T, Sredzinska M, Rogowska A, Dzieniszewska M, Zebrowska A, Boczkowska-Radziwon B, Gagola K, Stasiak-Barmuta A, Picard-Maureau M, Radziwon P |
Transfusion Medicine and Hemotherapy | 2023 |
|
Cytokine, Anti-SARS-CoV-2 Antibody, and Neutralizing Antibody Levels in Conventional Blood Donors Who Have Recovered from COVID-19
Maličev E, Žiberna K, Jazbec K, Kolenc A, Mali P, Potokar UR, Rožman P |
Transfusion Medicine and Hemotherapy | 2023 |
|
Pharmacokinetics of High-titer Anti-SARS-CoV-2 Human Convalescent Plasma in High-risk Children
Oren Gordon, Mary K. Brosnan, Steve Yoon, Dawoon Jung, Kirsten Littlefield, Abhinaya Ganesan, Christopher A. Caputo, Maggie Li, William Morgenlander, Stephanie N. Henson, Alvaro A. Ordonez, Patricia De Jesus, Elizabeth W. Tucker, Nadine Peart Akindele, Zexu Ma, Jo Wilson, Camilo A. Ruiz-Bedoya, M. Elizabeth M. Younger, Evan M Bloch, Shmuel Shoham, David Sullivan, Aaron A.R. Tobian, Kenneth R. Cooke, Ben Larman, Jogarao Gobburu, Arturo Casadevall, Andrew Pekosz, Howard M Lederman, Sabra Klein, Sanjay K. Jain |
JCI Insight | 2022 |
|
Monoclonal antibody targeting the conserved region of the SARS-CoV-2 spike protein to overcome viral variants
Wan-Ling Wu, Chen-Yi Chiang, Szu-Chia Lai, Chia-Yi Yu, Yu-Ling Huang, Hung-Chun Liao, Ching-Len Liao, Hsin-Wei Chen, Shih-Jen Liu |
JCI Insight | 2022 |
|
Is Better Standardization of Therapeutic Antibody Quality in Emerging Diseases Epidemics Possible?
S Ravlić, A Hećimović, T Kurtović, J Jelečki, D Forčić, A Slović, I Kurolt, Ž Šafranko, T Mušlin, D Rnjak, O Jakšić, E Sorić, G Džepina, O Rode, K Šljivac, T Vuk, I Jukić, A Markotić, B Halassy |
Frontiers in immunology | 2022 |
|
Multi-center matched cohort study of convalescent plasma for hospitalized patients with COVID-19
Cindy Ke Zhou, Monica M Bennett, Carlos H Villa, Kendall Hammonds, Yun Lu, Jason Ettlinger, Elisa Priest, Robert Gottlieb, Steven Davis, Edward Mays, Tainya C Clarke, Azadeh Shoaibi, Hui-Lee Wong, Steven A Anderson, Ronan Kelly |
PloS one | 2022 |
|
Convalescent plasma therapy against the emerging SARS-CoV-2 variants: Delineation of the potentialities and risks
M Dhawan, Priyanka, M Parmar, S Angural, O Choudhary |
International journal of surgery (London, England) | 2022 |
|
Convalescent Plasma for Preventing Critical Illness in COVID-19: a Phase 2 Trial and Immune Profile
J Sturek, T Thomas, J Gorham, C Sheppard, A Raymond, K Guex, W Harrington, A Barros, G Madden, Y Alkabab, D Lu, Q Liu, M Poulter, A Mathers, A Thakur, D Schalk, E Kubicka, L Lum, S Heysell, U Neogi |
Microbiology spectrum | 2022 |
|
Therapeutic Strategies for COVID-19 Lung Disease in Children
E Gatti, M Piotto, M Lelii, M Pensabene, B Madini, L Cerrato, V Hassan, S Aliberti, S Bosis, P Marchisio, M Patria |
Frontiers in Pediatrics | 2022 |
|
Lessons learned from the use of convalescent plasma for the treatment of COVID-19 and specific considerations for immunocompromised patients
M Beraud, E Meyer, M Lozano, A Bah, R Vassallo, B Brown |
Transfusion and apheresis science : official journal of the World Apheresis Association : official journal of the European Society for Haemapheresis | 2022 |
|
Passive Immunotherapy Against SARS-CoV-2: From Plasma-Based Therapy to Single Potent Antibodies in the Race to Stay Ahead of the Variants
W Strohl, Z Ku, Z An, S Carroll, B Keyt, L Strohl |
BioDrugs | 2022 |
|
Early administration of COVID ‐19 convalescent plasma with high titer antibody content by live viral neutralization assay is associated with modest clinical efficacy
A Belov, Y Huang, C Villa, B Whitaker, R Forshee, S Anderson, A Eder, N Verdun, M Joyner, S Wright, R Carter, D Hung, M Homer, C Hoffman, M Lauer, P Marks |
American Journal of Hematology | 2022 |
|
Development of SARS-CoV2 humoral response including neutralizing antibodies is not sufficient to protect patients against fatal infection
Choteau M, Scohy A, Messe S, Luyckx M, Dechamps M, Montiel V, Yombi JC, Gruson D, Limaye N, Michiels T, Dumoutier L |
Scientific Reports | 2022 |
|
Convalescent plasma to deliver therapeutic antibodies against COVID-19.
Senefeld JW, Casadevall A, Joyner MJ |
Trends in Molecular Medicine | 2022 |
|
Immune-related therapeutics: an update on antiviral drugs and vaccines to tackle the COVID-19 pandemic.
Mir I, Aamir S, Shah SRH, Shahid M, Amin I, Afzal S, Nawaz A, Khan MU, Idrees M |
Osong Public Health and Research Perspectives | 2022 |
|
COVID‐19 vaccination in patients receiving allergen immunotherapy (AIT) or biologicals—EAACI recommendations
Jutel M, Torres MJ, Palomares O, Akdis CA, Eiwegger T, Untersmayr E, Barber D, Zemelka\u2010Wiacek M, Kosowska A, Palmer E, Vieths S, Mahler V, Canonica WG, Nadeau K, Shamji MH, Agache I |
Allergy | 2022 |
|
COVID-19: Clinical laboratory diagnosis and monitoring of novel coronavirus infected patients using molecular, serological and biochemical markers: A review
Rasool G, Riaz M, Abbas M, Fatima H, Qamar MM, Zafar F, Mahmood Z |
International journal of immunopathology and pharmacology | 2022 |
|
Efficacy of COVID-19 treatments among geriatric patients: a systematic review.
Senderovich H, Vinoraj D, Stever M, Waicus S |
Therapeutic advances in infectious disease | 2022 |
|
Non-neutralizing antibodies: Deleterious or propitious during SARS-CoV-2 infection?
Zanella I, Degli Antoni M, Marchese V, Castelli F, Quiros-Roldan E |
International Immunopharmacology | 2022 |
|
Development of an efficient reproducible cell-cell transmission assay for rapid quantification of SARS-CoV-2 spike interaction with hACE2
Ssenyange G, Kerfoot M, Zhao M, Farhadian S, Chen S, Peng L, Ren P, Dela Cruz CS, Gupta S, Sutton RE |
2022 | |
|
Convalescent plasma – An insight into a novel treatment of covid-19 ICU patients
Chowdhry M, Hussain M, Singh P, Lekshmi M, Agrawal S, Kanwar M, Chawla R, Kantroo V, Bali R, Bansal A, Chawla A, Modi N, Mishra M, Khan Z |
Transfusion and Apheresis Science | 2022 |
|
Detection of neutralizing antibodies against multiple SARS-CoV-2 strains in dried blood spots using cell-free PCR
Danh K, Karp DG, Singhal M, Tankasala A, Gebhart D, de Jesus Cortez F, Tandel D, Robinson PV, Seftel D, Stone M, Simmons G, Bagri A, Schreiber MA, Buser A, Holbro A, Battegay M, Morris MK, Hanson C, Mills JR, Granger D, Theel ES, Stubbs JR, Corash LM, Tsai CT |
Nature Communications | 2022 |
|
A review of mass spectrometry‐based analyses to understand COVID‐19 convalescent plasma mechanisms of action
Baros\u2010Steyl SS, Al Heialy S, Semreen AH, Semreen MH, Blackburn JM, Soares NC |
PROTEOMICS | 2022 |
|
Analysis of 52 240 source plasma donors of convalescent COVID‐19 plasma: Sex, ethnicity, and age association with initial antibody levels and rate of dissipation
Schmidt AE, Vogel P, Chastain CA, Barnes T, Roth NJ, Simon TL |
Journal of Clinical Apheresis | 2022 |
|
COVID-19 Convalescent Plasma and Clinical Trials: Understanding Conflicting Outcomes
Focosi D, Franchini M, Pirofski LA, Burnouf T, Paneth N, Joyner MJ, Casadevall A |
Clinical microbiology reviews | 2022 |
|
Role of the humoral immune response during COVID-19: guilty or not guilty?
Yaugel-Novoa M, Bourlet T, Paul S |
Mucosal Immunology | 2022 |
|
Clinical Practice Guidelines From the Association for the Advancement of Blood and Biotherapies (AABB): COVID-19 Convalescent Plasma
Estcourt LJ, Cohn CS, Pagano MB, Iannizzi C, Kreuzberger N, Skoetz N, Allen ES, Bloch EM, Beaudoin G, Casadevall A, Devine DV, Foroutan F, Gniadek TJ, Goel R, Gorlin J, Grossman BJ, Joyner MJ, Metcalf RA, Raval JS, Rice TW, Shaz BH, Vassallo RR, Winters JL, Tobian AA |
Annals of internal medicine | 2022 |
|
Lack of efficacy of convalescent plasma in COVID‐19 patients with concomitant hematological malignancies: An Italian retrospective study
Lanza F, Monaco F, Ciceri F, Cairoli R, Sacchi MV, Guidetti A, Marchetti M, Massaia M, Arcaini L, Krampera M, Mohamed S, Gherlinzoni F, Mecucci C, Gentile M, Romano I, Venditti A, Ruggeri M, Ferrero D, Coviello E, Fabbri E, Corradini P, Passamonti F |
Hematological Oncology | 2022 |
|
A Review on Effectiveness of Plasma Therapy in Severe COVID-19 Patients
Kapil K, Muntode Gharde P |
Cureus | 2022 |
|
Inflammatory profile of convalescent plasma to treat COVID: Impact of amotosalen/UVA pathogen reduction technology
Cognasse F, Hamzeh-Cognasse H, Duchez AC, Shurko N, Eyraud MA, Arthaud CA, Prier A, Heestermans M, Hequet O, Bonneaudeau B, Rochette-Eribon S, Teyssier F, Barlet-Excoffier V, Chavarin P, Legrand D, Richard P, Morel P, Mooney N, Tiberghien P |
Frontiers in immunology | 2022 |
|
The transmembrane replacement H7N9-VLP vaccine displays high levels of protection in mice
Qin J, Hu B, Song Q, Wang R, Zhang X, Yu Y, Wang JH |
Frontiers in microbiology | 2022 |
|
Drugs for the prevention and treatment of COVID-19 and its complications: An update on what we learned in the past 2 years.
Remuzzi G, Schiaffino S, Santoro MG, FitzGerald GA, Melino G, Patrono C |
Frontiers in pharmacology | 2022 |
|
Efficacy and Safety of COVID-19 Convalescent Plasma in Hospitalized Patients-An Open-Label Phase II Clinical Trial.
Grubovic Rastvorceva RM, Useini S, Stevanovic M, Demiri I, Petkovic E, Franchini M, Focosi D |
2022 | |
|
Health literacy as a social vaccine in the COVID-19 pandemic.
Okan O, Messer M, Levin-Zamir D, Paakkari L, Sørensen K |
Health Promotion International | 2022 |
|
COVID-19 and Solid Organ Transplantation: Role of Anti-SARS-CoV-2 Monoclonal Antibodies.
Dhand A, Razonable RR |
Current Transplantation Reports | 2022 |
|
Leishmaniac Quest for Developing a Novel Vaccine Platform. Is a Roadmap for Its Advances Provided by the Mad Dash to Produce Vaccines for COVID-19?
Chang KP, Reynolds JM, Liu Y, He JJ |
Human vaccines | 2022 |
|
Capturing a Crucial 'Disorder-to-Order Transition' at the Heart of the Coronavirus Molecular Pathology-Triggered by Highly Persistent, Interchangeable Salt-Bridges.
Roy S, Ghosh P, Bandyopadhyay A, Basu S |
Human vaccines | 2022 |
|
Development of Improved High-Performance Liquid Chromatography Method for the Determination of Residual Caprylic Acid in Formulations of Human Immunoglobulins.
Štimac A, Kurtović T, Pavlović N, Halassy B |
Molecules (Basel, Switzerland) | 2022 |
|
Nanoplasmonic multiplex biosensing for COVID-19 vaccines.
Funari R, Fukuyama H, Shen AQ |
Biosensors & bioelectronics | 2022 |
|
Clinical progress of therapeutics and vaccines: Rising hope against COVID-19 treatment.
Bandaru R, Rout SR, Kamble OS, Samal SK, Gorain B, Sahebkar A, Ahmed FJ, Kesharwani P, Dandela R |
2022 | |
|
Early post-infection treatment of SARS-CoV-2 infected macaques with human convalescent plasma with high neutralizing activity had no antiviral effects but moderately reduced lung inflammation.
Van Rompay KKA, Olstad KJ, Sammak RL, Dutra J, Watanabe JK, Usachenko JL, Immareddy R, Roh JW, Verma A, Shaan Lakshmanappa Y, Schmidt BA, Di Germanio C, Rizvi N, Liu H, Ma ZM, Stone M, Simmons G, Dumont LJ, Allen AM, Lockwood S, Pollard RE, Ramiro de Assis R, Yee JL, Nham PB, Ardeshir A, Deere JD, Jain A, Felgner PL, Coffey LL, Iyer SS, Hartigan-O'Connor DJ, Busch MP, Reader JR |
PLoS pathogens | 2022 |
|
Biomarker based biosensors: An opportunity for diagnosis of COVID-19.
Khaksarinejad R, Arabpour Z, RezaKhani L, Parvizpour F, Rasmi Y |
Reviews in Medical Virology | 2022 |
|
Role of Therapeutic Plasmapheresis in SARS-CoV-2 Induced Cytokine Release Syndrome: A Retrospective Cohort Study on COVID-19 Patients.
Jamil Z, Khan AA, Yousuf H, Khalid K, Abbasi SM, Waheed Y |
International journal of general medicine | 2022 |
|
Robust anti-SARS-CoV2 single domain antibodies cross neutralize multiple viruses.
Singh S, Dahiya S, Singh YJ, Beeton K, Jain A, Sarkar R, Dubey A, Tehseen A, Sehrawat S |
iScience | 2022 |
|
Development of robust, indigenous ELISA for detection of IgG antibodies against CoV-2 N and S proteins: mass screening.
Srivastava AK, Gupta A, Chauhan D, Meena RC, Sugadev R, Eslavath MR, Gupta H, Karuna, Singh S, Singh Y, Tiwari RP, Kohli V, Varshney R, Ganju L |
Applied Microbiology and Biotechnology | 2022 |
|
Resultados del uso de plasma de pacientes convalecientes de COVID 19 en pacientes críticos.
Astola Hidalgo I, Fernández Rodríguez A, Martínez Revuelta E, Martínez Revuelta M, Ojea AM, Herrero Puente P, Escudero Augusto D |
Medicina Intensiva | 2022 |
|
The Omicron Variant of the Sars-Cov-2 Virus As the Dominant Agent of a New Risk of Disease amid the COVID-19 Pandemic.
Onishchenko GG, Sizikova TE, Lebedev VN, Borisevich SV |
Herald of the Russian Academy of Sciences | 2022 |
|
Single domain antibodies derived from ancient animals as broadly neutralizing agents for SARS-CoV-2 and other coronaviruses.
Lim HT, Kok BH, Lim CP, Abdul Majeed AB, Leow CY, Leow CH |
2022 | |
|
In Silico Evaluation of Natural Flavonoids as a Potential Inhibitor of Coronavirus Disease.
Kashyap P, Thakur M, Singh N, Shikha D, Kumar S, Baniwal P, Yadav YS, Sharma M, Sridhar K, Inbaraj BS |
Molecules (Basel, Switzerland) | 2022 |
|
Neutralizing COVID-19 Convalescent Plasma in Adults Hospitalized With COVID-19: A Blinded, Randomized, Placebo-Controlled Trial.
Self WH, Wheeler AP, Stewart TG, Schrager H, Mallada J, Thomas CB, Cataldo VD, O'Neal HR Jr, Shapiro NI, Higgins C, Ginde AA, Chauhan L, Johnson NJ, Henning DJ, Jaiswal SJ, Mammen MJ, Harris ES, Pannu SR, Laguio-Vila M, El Atrouni W, de Wit M, Hoda D, Cohn CS, McWilliams C, Shanholtz C, Jones AE, Raval JS, Mucha S, Ipe TS, Qiao X, Schrantz SJ, Shenoy A, Fremont RD, Brady EJ, Carnahan RH, Chappell JD, Crowe JE Jr, Denison MR, Gilchuk P, Stevens LJ, Sutton RE, Thomsen I, Yoder SM, Bistran-Hall AJ, Casey JD, Lindsell CJ, Wang L, Pulley JM, Rhoads JP, Bernard GR, Rice TW |
Chest | 2022 |
|
Application and Validation of SARS-CoV-2 RBD Neutralizing ELISA Assay.
Mousa ZS, Abdulamir AS |
Archives of Razi Institute | 2022 |
|
Structural Requirements and Plasticity of Receptor-Binding Domain in Human Coronavirus Spike.
Li Y, Zheng P, Liu T, Shi C, Wang B, Xu Y, Jin T |
Frontiers in Molecular Biosciences | 2022 |
|
Specific anti-SARS-CoV-2 S1 IgY-scFv is a promising tool for recognition of the virus.
Ge S, Wu R, Zhou T, Liu X, Zhu J, Zhang X |
AMB Express | 2022 |
|
COVID-19 convalescent plasma therapy through the lens of the third year of the pandemic.
|
Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases | 2022 |
|
Nucleocapsid-specific antibody function is associated with therapeutic benefits from COVID-19 convalescent plasma therapy
Herman JD, Wang C, Burke JS, Zur Y, Compere H, Kang J, Macvicar R, Taylor S, Shin S, Frank I, Siegel D, Tebas P, Choi GH, Shaw PA, Yoon H, Pirofski LA, Julg BD, Bar KJ, Lauffenburger D, Alter G |
Cell reports. Medicine | 2022 |
|
Convalescent plasma for COVID-19 in hospitalised patients: an open-label, randomised clinical trial.
Sekine L, Arns B, Fabro BR, Cipolatt MM, Machado RRG, Durigon EL, Parolo E, Pellegrini JAS, Viana MV, Schwarz P, Lisboa TC, Dora JMS, Portich JP, Paz AA, Silla L, Balsan AM, Schirmer FD, Franz JPM, da-Silveira LM, Breunig RC, Petersen V, Sosnoski M, Mesquita NF, Volpato FCZ, Sganzerla D, Falavigna M, Rosa RG, Zavascki AP |
European Respiratory Journal | 2022 |
|
The clinical outcomes of high neutralizing antibodies titer convalescent plasma therapy in early developed severe COVID-19 patients; a case-control study.
Nontawong N, Siripongboonsitti T, Tawinprai K, Boonpratoom M, Krailassiri N, Boonkhum C, Soonklang K, Poovorawan Y, Mahanonda N |
Annals of clinical microbiology and antimicrobials | 2022 |
|
Evaluation of a COVID-19 convalescent plasma program at a U.S. academic medical center
Root HB, Gilleskie M, Lu CH, Gilmore A, Evans M, Nelson BG, Johnson W, Gurney B, Kuruc J, Markmann AJ, Barzin AH, Wohl DA, Fischer WA, Park YA, Weiss S, Napravnik S, Baric R, de Silva AM, Lachiewicz AM, van Duin D, Margolis DM, Herce ME, Bartelt LA |
PloS one | 2022 |
|
Increased Levels of Autoantibodies against ROS-Modified Proteins in Depressed Individuals with Decrease in Antibodies against SARS-CoV-2 Antigen (S1-RBD).
Sherwani S, Raafat M, Rajendrasozhan S, Khan M, Saleem M, Husain Q, Khan S, Alam N, Khan MWA |
Current issues in molecular biology | 2022 |
|
Inflammatory markers and auto-Abs to type I IFNs in COVID-19 convalescent plasma cohort study
Cognasse F, Hamzeh-Cognasse H, Rosa M, Corseaux D, Bonneaudeau B, Pierre C, Huet J, Arthaud CA, Eyraud MA, Prier A, Duchez AC, Ebermeyer T, Heestermans M, Audoux-Caire E, Philippot Q, Le Voyer T, Hequet O, Fillet AM, Chavarin P, Legrand D, Richard P, Pirenne F, Gallian P, Casanova JL, Susen S, Morel P, Lacombe K, Bastard P, Tiberghien P |
EBioMedicine | 2022 |
|
'Convalescent Plasma'- An Effective Treatment Option to Prevent Emerging nCOVID-19- A Review.
Ashique S, Khatun T, Sahu G, Upadhyay A, Adhana A, Kumar S, Sandhu N, Kumar N |
Infectious disorders drug targets | 2022 |
|
Clinical outcomes of using plasma in COVID-19 convalescent critically ill patients
Astola Hidalgo I, Fernández Rodríguez A, Martínez Revuelta E, Martínez Revuelta M, Ojea AM, Herrero Puente P, Escudero Augusto D |
Medicina Intensiva | 2022 |
|
Currently available drugs for the treatment of Coronavirus-2
Anbarasan T, Sahu G, Goyal A |
2022 | |
|
Essentials of COVID-19 and treatment approaches
Pandey A, Yadav S |
2022 | |
|
Clinical, laboratory, and temporal predictors of neutralizing antibodies to SARS-CoV-2 among COVID-19 convalescent plasma donor candidates
Jim Boonyaratanakornkit, Chihiro Morishima, Stacy Selke, Danniel Zamora, Sarah A. McGuffin, Adrienne E. Shapiro, Victoria L. Campbell, Christopher L. McClurkan, Lichen Jing, Robin Gross, Janie Liang, Elena Postnikova, Steven Mazur, Vladimir V. Lukin, Anu Chaudhary, Marie K. Das, Susan L. Fink, Andrew Bryan, Alexander L. Greninger, Keith R. Jerome, Michael R. Holbrook, Terry B. Gernsheimer, Mark H. Wener, Anna Wald, David M. Koelle |
Journal of Clinical Investigation | 2021 |
|
A randomized double-blind controlled trial of convalescent plasma in adults with severe COVID-19
Max O'Donnell, Beatriz Grinsztejn, Matthew J Cummings, Jessica E. Justman, Matthew R Lamb, Christina Eckhardt, Neena M Philip, Ying Kuen Cheung, Vin Gupta, Esau João, Jose Pilotto, Maria Pia Diniz, Sandra Wagner Cardoso, Darryl Abrams, Kartik N. Rajagopalan, Sarah E. Borden, Allison Wolf, Leon Claude Sidi, Alexandre Vizzoni, Valdilea G. Veloso, Zachary C Bitan, Dawn Scotto, Benjamin Meyer, Samuel Jacobson, Alex Kantor, Nischay Mishra, Lokendra V Chauhan, Elizabeth F. Stone, Flavia Dei Zotti, Francesca La Carpia, Krystalyn E Hudson, Stephen Ferrara, Joseph Schwartz, Brie A Stotler, Wen-Hsuan W. Lin, Sandeep N. Wontakal, Beth Shaz, Thomas Briese, Eldad A Hod, Steven L. Spitalnik, Andrew Eisenberger, Walter I Lipkin |
Journal of Clinical Investigation | 2021 |
|
Results of the CAPSID randomized trial for high-dose convalescent plasma in severe COVID-19 patients
Sixten Körper, Manfred Weiss, Daniel Zickler, Thomas Wiesmann, Kai Zacharowski, Victor M. Corman, Beate Grüner, Lucas Ernst, Peter Spieth, Philipp M. Lepper, Martin Bentz, Sebastian Zinn, Gregor Paul, Johannes Kalbhenn, Matthias M. Dollinger, Peter Rosenberger, Thomas Kirschning, Thomas Thiele, Thomas Appl, Benjamin Mayer, Michael Schmidt, Christian Drosten, Hinnerk Wulf, Jan Kruse, Bettina Jungwirth, Erhard Seifried, Hubert Schrezenmeier |
Journal of Clinical Investigation | 2021 |
|
A MULTICENTER RANDOMIZED OPEN-LABEL CLINICAL TRIAL FOR CONVALESCENT PLASMA IN PATIENTS HOSPITALIZED WITH COVID-19 PNEUMONIA
Cristina Avendaño-Solá, Antonio Ramos-Martínez, Elena Muñez-Rubio, Belen Ruiz-Antorán, Rosa Malo, Ferran Torres, Ana Fernández-Cruz, Jorge Calderon-Parra, Concepcion Payares-Herrera, Alberto Díaz de Santiago, Irene Romera Martínez, Ilduara Pintos-Pascual, Jaime Lora-Tamayo, Mikel Mancheño-Losa, Maria Liz Paciello Coronel, AL Martinez-Gonzalez, Julia Vidán-Estévez, Maria José Nuñez-Orantos, Maria Isabel Saez-Serrano, Maria Lourdes Porras-Leal, Maria del Castillo Jarilla-Fernández, Paula Villares, Jaime Perez de Oteyza, Ascensión Ramos-Garrido, Lydia Blanco, Maria Elena Madrigal-Sánchez, Martín Rubio-Batllés, Ana Velasco-Iglesias, José Ramón Paño-Pardo, JA Moreno-Chulilla, Eduardo Muñiz-Diaz, Inmaculada Casas, Mayte Pérez-Olmeda, Javier García-Pérez, Jose Alcami, José Luis Bueno, Rafael F. Duarte |
Journal of Clinical Investigation | 2021 |
|
Treatment of Severe COVID-19 with Convalescent Plasma in Bronx, NYC
Hyun ah Yoon, Rachel Bartash, Inessa Gendlina, Johanna Rivera, Antonio Nakouzi, Robert H. Bortz III, Ariel S. Wirchnianski, Monika Paroder, Karen Fehn, Leana Serrano-Rahman, Rachelle Babb, Uzma N. Sarwar, Denise Haslwanter, Ethan Laudermilch, Catalina Florez, M. Eugenia Dieterle, Rohit K Jangra, J. Maximilian Fels, Karen Tong, Margarette C. Mariano, Olivia Vergnolle, George I. Georgiev, Natalia G. Herrera, Ryan J. Malonis, Jose A. Quiroz, Nicholas C. Morano, Gregory J. Krause, Joseph M. Sweeney, Kelsie Cowman, Stephanie A Allen, Jayabhargav Annam, Ariella Applebaum, Daniel Barboto, Ahmed Khokhar, Brianna J. Lally, Audrey Lee, Max Lee, Avinash Malaviya, Reise Sample, Xiuyi A Yang, Yang Li, Rafael E Ruiz, Raja Thota, Jason Barnhill, Doctor Y. Goldstein, Joan Uehlinger, Scott J. Garforth, Steven C. Almo, Jonathan R. Lai, Morayma Reyes Gil, Amy S. Fox, Kartik Chandran, Tao Wang, Johanna P Daily, Liise-anne Pirofski |
JCI Insight | 2021 |
|
Distinct antibody repertoires against endemic human coronaviruses in children and adults
Taushif Khan, Mahbuba Rahman, Fatima Al Ali, Susie S.Y. Huang, Manar Ata, Qian Zhang, Paul Bastard, Zhiyong Liu, Emmanuelle Jouanguy, Vivien Beziat, Aurélie Cobat, Gheyath Nasrallah, Hadi Yassine, Maria K. Smatti, Amira Saeed, Isabelle Vandernoot, Jean-Christophe Goffard, Guillaume Smits, Isabelle Migeotte, Filomeen Haerynck, Isabelle Meyts, Laurent Abel, Jean-Laurent Casanova, Mohammad R. Hasan, Nico Marr |
JCI Insight | 2021 |
|
IgV somatic mutation of human anti-SARS-CoV-2 monoclonal antibodies governs neutralization and breadth of reactivity
Mayara Garcia de Mattos Barbosa, Hui Liu, Daniel Huynh, Greg Shelley, Evan T. Keller, Brian T Emmer, Emily J. Sherman, David Ginsburg, Andrew A Kennedy, Andrew W. Tai, Christiane E. Wobus, Carmen Mirabelli, Thomas M. Lanigan, Milagros Samaniego, Wenzhao Meng, Aaron M. Rosenfeld, Eline T. Luning Prak, Jeffrey L. Platt, Marilia Cascalho |
JCI Insight | 2021 |
|
Case Report: Stepwise Anti-Inflammatory and Anti-SARS-CoV-2 Effects Following Convalescent Plasma Therapy With Full Clinical Recovery
A Zimmerli, M Monti, C Fenwick, I Eckerle, C Beigelman-Aubry, C Pellaton, K Jaton, D Dumas, GM Stamm, L Infanti, H Andreu-Ullrich, D Germann, M Mean, P Vollenweider, R Stadelmann, M Prella, D Comte, B Guery, D Gachoud, N Rufer |
Frontiers in immunology | 2021 |
|
Impact of serological and PCR testing requirements on the selection of COVID ‐19 convalescent plasma donors
JA Carter, AT Freedenberg, JL Romeiser, LR Talbot, NJ Browne, ME Cosgrove, ME Shevik, LM Generale, MG Rago, GA Caravella, T Ahmed, LJ Mamone, E BennettGuerrero |
Transfusion | 2021 |
|
High neutralizing potency of swine glyco‐humanized polyclonal antibodies against SARS‐CoV‐2
B Vanhove, O Duvaux, J Rousse, PJ Royer, G Evanno, C Ciron, E Lheriteau, L Vacher, N Gervois, R Oger, Y Jacques, S Conchon, A Salama, R Duchi, I Lagutina, A Perota, P Delahaut, M Ledure, M Paulus, RT So, CK Mok, R Bruzzone, M Bouillet, S Brouard, E Cozzi, C Galli, D Blanchard, JM Bach, JP Soulillou |
European Journal of Immunology | 2021 |
|
Inflammation, immunity and potential target therapy of SARS-COV-2: a total scale analysis review
SW Smail, M Saeed, T alkasalias, ZO Khudhur, DA Younus, MF Rajab, WH Abdulahad, HI Hussain, K Niaz, M Safdar |
Food and Chemical Toxicology | 2021 |
|
Detection of SARS‐CoV ‐2‐independent immunoregulatory activity of COVID ‐19 convalescent plasma
R Brox, S Achenbach, H Hackstein |
Transfusion | 2021 |
|
Statins in COVID-19 Therapy
J Olszewska-Parasiewicz, Ł Szarpak, S Rogula, A Gąsecka, U Szymańska, M Kwiatkowska, MJ Jaguszewski, R Sierpiński, A Zaczyński, W Wierzba, DA Kosior |
Life Sciences | 2021 |
|
COVID-19: Immunology, Immunopathogenesis and Potential Therapies
A Bhardwaj, L Sapra, C Saini, Z Azam, PK Mishra, B Verma, GC Mishra, RK Srivastava |
International Reviews of Immunology | 2021 |
|
Coronavirus Disease - COVID-19
N Rezaei |
2021 | |
|
Treatment of severe acute respiratory syndrome (SARS), Middle East respiratory syndrome (MERS), and coronavirus disease 2019 (COVID-19): a systematic review of in vitro , in vivo , and clinical trials
YJ Han, KH Lee, S Yoon, SW Nam, S Ryu, D Seong, JS Kim, JY Lee, JW Yang, JH Lee, A Koyanagi, SH Hong, E Dragioti, J Radua, L Smith, H Oh, RA Ghayda, A Kronbichler, M Effenberger, D Kresse, S Denicolò, W Kang, L Jacob, H Shin, JI Shin |
Theranostics | 2021 |
|
Hyperactivated RAGE in Comorbidities as a Risk Factor for Severe COVID-19—The Role of RAGE-RAS Crosstalk
S Chiappalupi, L Salvadori, R Donato, F Riuzzi, G Sorci |
Biomolecules | 2021 |
|
Convalescent Plasma for Infectious Diseases: Historical Framework and Use in COVID-19
JG Ripoll, N van Helmond, JW Senefeld, CC Wiggins, SA Klassen, SE Baker, KF Larson, BM Murphy, KJ Andersen, SK Ford, A Casadevall, MJ Joyner |
Clinical Microbiology Newsletter | 2021 |
|
A look-back at convalescent plasma to treat COVID-19
O Garraud, K Lacombe, P Tiberghien |
Transfusion and apheresis science : official journal of the World Apheresis Association : official journal of the European Society for Haemapheresis | 2021 |
|
Personalized therapy: can it tame the COVID-19 monster?
M Arish, F Naz |
Personalized Medicine | 2021 |
|
Convalescent plasma for adults with acute COVID-19 respiratory illness (CONCOR-1): study protocol for an international, multicentre, randomized, open-label trial
P Bégin, J Callum, NM Heddle, R Cook, MP Zeller, A Tinmouth, DA Fergusson, MM Cushing, MJ Glesby, M Chassé, DV Devine, N Robitalle, R Bazin, N Shehata, A Finzi, A McGeer, DC Scales, L Schwartz, AF Turgeon, R Zarychanski, N Daneman, R Carl, L Amorim, C Gabe, M Ellis, BS Sachais, KC Loftsgard, E Jamula, J Carruthers, J Duncan, K Lucier, N Li, Y Liu, C Armali, A Kron, D Modi, MC Auclair, S Cerro, M Avram, DM Arnold |
Trials | 2021 |
|
Convalescent plasma therapy in B-cell-depleted and B-cell sufficient patients with life-threatening COVID-19 – A case series
J Erber, JR Wiessner, C Huberle, J Schneider, H Mijočević, D von Bomhard, P Luppa, RM Schmid, S Rasch, T Lahmer |
Transfusion and apheresis science : official journal of the World Apheresis Association : official journal of the European Society for Haemapheresis | 2021 |
|
Recent advances in antibody‐based immunotherapy strategies for COVID‐19
A Esmaeilzadeh, S Rostami, PM Yeganeh, S Tahmasebi, M Ahmadi |
Journal of Cellular Biochemistry | 2021 |
|
Functional convalescent plasma antibodies and pre-infusion titers shape the early severe COVID-19 immune response
JD Herman, C Wang, C Loos, H Yoon, J Rivera, ME Dieterle, D Haslwanter, RK Jangra, RH Bortz, KJ Bar, B Julg, K Chandran, D Lauffenburger, L Pirofski, G Alter |
Nature Communications | 2021 |
|
The Journal of Clinical Investigation in the time of COVID-19
A Casadevall, S Jackson, GL Semenza, GF Tomaselli, RS Ahima |
Journal of Clinical Investigation | 2021 |
|
The pivotal roles of the host immune response in the fine-tuning the infection and the development of the vaccines for SARS-CoV-2
W Alturaiki, A Mubarak, AA Jurayyan, MG Hemida |
Human Vaccines & Immunotherapeutics | 2021 |
|
Convalescent Plasma Therapy for COVID-19: A Graphical Mosaic of the Worldwide Evidence
SA Klassen, JW Senefeld, KA Senese, PW Johnson, CC Wiggins, SE Baker, N van Helmond, KA Bruno, L Pirofski, S Shoham, BJ Grossman, JP Henderson, RS Wright, DL Fairweather, NS Paneth, RE Carter, A Casadevall, MJ Joyner |
Frontiers in Medicine | 2021 |
|
Use of convalescent plasma in COVID ‐19 patients with immunosuppression
JW Senefeld, SA Klassen, SK Ford, KA Senese, CC Wiggins, BC Bostrom, MA Thompson, SE Baker, WT Nicholson, PW Johnson, RE Carter, JP Henderson, WR Hartman, L Pirofski, RS Wright, DL Fairweather, KA Bruno, NS Paneth, A Casadevall, MJ Joyner |
Transfusion | 2021 |
|
The Effect of Convalescent Plasma Therapy on Mortality Among Patients With COVID-19: Systematic Review and Meta-analysis
SA Klassen, JW Senefeld, PW Johnson, RE Carter, CC Wiggins, S Shoham, BJ Grossman, JP Henderson, J Musser, E Salazar, WR Hartman, NM Bouvier, ST Liu, L Pirofski, SE Baker, N van Helmond, RS Wright, DL Fairweather, KA Bruno, Z Wang, NS Paneth, A Casadevall, MJ Joyner |
Mayo Clinic Proceedings | 2021 |
|
Convalescent Plasma for the Prevention and Treatment of COVID-19: A Systematic Review and Quantitative Analysis
HT Peng, SG Rhind, A Beckett |
2021 | |
|
Intravenous Immunoglobulins at the Crossroad of Autoimmunity and Viral Infections
C Perricone, P Triggianese, R Bursi, G Cafaro, E Bartoloni, MS Chimenti, R Gerli, R Perricone |
Microorganisms | 2021 |
|
Potent Molecular Feature-based Neutralizing Monoclonal Antibodies as Promising Therapeutics Against SARS-CoV-2 Infection
AJ Kombe, A Zahid, A Mohammed, R Shi, T Jin |
Frontiers in Molecular Biosciences | 2021 |
|
Rapid and Successful Implementation of a COVID-19 Convalescent Plasma Programme—The South African Experience
TN Glatt, C Hilton, C Nyoni, A Swarts, R Swanevelder, J Cowley, C Mmenu, T Moyo-Gwete, PL Moore, M Kutama, J Jaza, I Phayane, T Brits, J Koekemoer, U Jentsch, D Nelson, K van den Berg, M Vermeulen |
Viruses | 2021 |
|
Convalescent plasma or hyperimmune immunoglobulin for people with COVID-19: a living systematic review
V Piechotta, C Iannizzi, KL Chai, SJ Valk, C Kimber, E Dorando, I Monsef, EM Wood, AA Lamikanra, DJ Roberts, Z McQuilten, C So-Osman, LJ Estcourt, N Skoetz |
Cochrane Database of Systematic Reviews | 2021 |
|
Regulatory challenges of convalescent plasma collection during the evolving stages of COVID ‐19 pandemic in the United States
S Hassan, KA West, K ConryCantilena, VD Giorgi |
Transfusion | 2021 |
|
Kinetics of SARS-CoV-2 antibody responses pre-COVID-19 and post-COVID-19 convalescent plasma transfusion in patients with severe respiratory failure: an observational case–control study
MN Klein, EW Wang, P Zimand, H Beauchamp, C Donis, MD Ward, A Martinez-Hernandez, A Tabatabai, JW Baddley, EM Bloch, KE Mullins, MJ Fontaine |
Journal of clinical pathology | 2021 |
|
Effectiveness of convalescent plasma therapy in eight non-intubated coronavirus disease 2019 patients in Indonesia: a case series
TM Rahardjo, E Yogipranata, AH Naswan, FR Sari, F Budiono, H Permatasari, CH Chuntari |
Journal of medical case reports | 2021 |
|
Convalescent plasma bank facility location-allocation problem for COVID-19
VK Manupati, T Schoenherr, SM Wagner, B Soni, S Panigrahi, M Ramkumar |
Transportation Research Part E Logistics and Transportation Review | 2021 |
|
Convalescent Plasma Therapy in Critically Ill COVID-19 Patients: An Open Label Trial
F Khamis, ZA Arimi, HA Naamani, MA Bahrani, N Pandak, ZA Bolushi, SS Deenadayalan, AA Lawati, IA Salmi, I Al-Zakwani |
Oman Medical Journal | 2021 |
|
Effect of Convalescent Plasma on Organ Support–Free Days in Critically Ill Patients With COVID-19: A Randomized Clinical Trial
H Abdelhady, M Abdelrazik, Z Abdi, D Abdo, A Abdulle, L Abel, S Abouzeenni, G Abrahamson, Y Abusamra, L Adams, O Adebambo, D Ademokun, N Adhikari, D Affron, A Aggarwal, R Agno, H Ahmad, N Ahmad, S Ahmed, K Ainscough, J Ainsworth, G Airoldi, L Aitken, F Ajeneye, N Akhtar, O Akinwumiju, M Al-Bayati, M Albert, M Alderman, A Alegria, B Alexander, PD Alexander, J Alfonso, H Ali, S Ali, A Allameddine, S Allan, I Allard, B Allen, B Allen, J Allen, L Allen, L Allen, S Allibone, R Ambrosino, K Amenyah, M Ammoun, R Anand, SP Anand, K Andersen, C Anderson, K Anderson, T Anderson, M Andreae, S Andrews, G Andrikopoulos, A Anjum, M Anstey, M Antar, D Antcliffe, A Anthony, P Antoine, V Anumakonda, G Apostolides, L Aravindan, G Arbane, E Arbon, S Archer, N Aref, AM Arias, C Armali, J Armer-Ducker, M Armstrong, S Armstrong-Fisher, J Arnold, S Arnott, A Arroyo, V Arsenault, D Aryal, A Asghar, G Ashby, D Asher, B Ashford, S Ashgar, MA Ali, A Aspinwall, A Asquith, T Atallah, R Athay-Hunt, U Attanayaka, R Atugonza, M Aube, MC Auclair, K Austin, P Austin, S Awan, G Bacon, H Badhesha, K Bagavathy, D Baglole, C Bagnas, C Bagot, S Bagshaw, N Baig, S Bailey, K Baillie, W Bain, S Baines, A Baird, C Baker, E Baker, P Bakhtiari, D Bakthavatsalam, M Balaie, G Bali, S Balkee, A Ballinger, A Bamford, P Bamford, M Banerjee, L Banks, J Bannard-Smith, N Banning, B Bansal, R Banthorpe, I Barbash, A Barber, R Barber, M Barbosa, M Barillas, R Bariola, G Barker, N Barnes, M Barnett, N Barnett, R Baron, R Bart, J Bartholomew, S Bartley, D Barton, J Barwell, A Bashyal, K Basile, F Bass, C Bassford, P Bassi, B Bassis, I Bateman, M Bates, S Bates, D Batty, K Bauchmuller, P Baughan, L Baxter, C Baylem, L Bayliss, M Bayne, E Bays, R Bazin, G Beard, K Beard, R Beasley, L Beaudin, J Beaudoin, G Beaudoin-Bussières, S Beddows, C Bedford, D Beer, S Begum, J Beharry, XB Zhao, N Belec, G Bell, G Bell, J Bell, D Bellemare, F Benettaib, A Beninato, M Benlarbi, A Bennett, C Bennett, C Bennett-Mills, A Benoit, J Benstead, D Bentley, L Berg, C Bergin, C Berscheid, J Best-Lane, E Bevan, J Bewley, A Beyerl, S Bhagani, K Bhandal, S Biddie, J Biemans, K Bignell, S Bihari, M Bilodeau, C Bilton, MJ Binney, A Binnie, J Bion, C Birch, J Birch, K Birchall, I Birkinshaw, R Bisa, E Black, B Blackledge, S Blackmore, A Blackwell, L Blackwood, Y Bland, M Blanton, J Blaxland, D Blofield, M Blom, J Board, A Bociek, S Bodh, V Boisclair, S Bolton, W Bolton, H Bond, S Bonner, W Bonnert, L Boorman, C Booth, B Borgatta, C Borhani, N Borkent, R Borrell, Z Borrill, M Boshir, B Bouchard, MC Boulanger, D Boumahni, C Bourassa, M Bourne, R Bourne, D Boutin, M Boutin, D Bowen, J Bowen, H Bowler, G Bowyer, C Boyd, C Boyd, M Boyd, L Boyer, R Boyles, G Bozovic, D Brack, C Brackstone, R Bradburn, B Bradley, P Bradley, S Bradshaw, J Brailsford, S Brailsford, E Brant, A Brazier, P Bremmer, M Brend, V Brennan, S Brett, C Brewer, K Brickell, M Briggs, C Brightling, N Brillinger, L Brimfield, S Brisson, T Brittin, L Brochard, A Broderick, D Broggio, F Brohi, C Brookes, N Brooks, R Broom, M Browett, C Brown, E Brown, L Brown, M Brown, R Brown, W Brown, ME Brulotte, E Brunet, N Brunskill, K Bryan-Morris, J Buchan, A Buchanan, K Buckmire, J Budd, P Bugden, H Buhr, L Bullock, V Buonavoglia, A Buoy, D Burda, P Burgess, J Burkey, R Burnish, D Burns, K Burns, S Burns, A Busby, H Buscher, L Butler, S Butt, R Byrne, E Byworth, L Cabrelli, L Cabreros, T Cairns, M Caldwell, C Calfee, L Cambalova, S Cameron, A Campbell, D Campbell, H Campbell, K Campbell, L Campbell, R Campbell, J Campisi, S Campos, J Camsooksai, A Canabarro, E Carbonneau, N Cardenas, A Carlton, R Carnegie, E Carpenter, L Carpio, S Carr, FM Carrier, M Carrier, S Carrington, J Carr-Wilkinson, D Carter, M Carter, S Carter, S Carter-Graham, C Carveth-Marshall, S Casali, R Casey, S Cathcart, J Caulfield, A Cavayas, K Cawley, M Cecconi, J Centofanti, LC Warnapura, É Chamberland, E Chambers, S Champanerkar, C Chan, M Chan, P Chan, S Chand, V Chandler-Vizard, C Chang, T Channon, M Chapman, S Chapman, L Chapple, B Charles, R Charlewood, A Charlton, S Charlton, S Charlton, S Charnock, V Chauhan, R Chavez, M Cheadle, S Cherian, S Cherif, B Cheung, E Cheung, M Chhablani, K Chinn, V Chiroma, C Choquet, JY Chou, F Chowdhury, S Chukkambotla, J Chung, N Ciccone, R Cimaglia, E Cirstea, M Clark, R Clark, S Clark, W Clark, F Clarke, G Clarke, H Clarke, M Clarke, S Clarke, A Clarkson, A Claxton, I Clement, F Clemons, G Clermont, J Cleverdon, L Clifford, L Clifford, A Clinton, È Cloutier, M Cloutier, T Coates, M Cockrell, P Coghlan, C Colavecchia, C Cole, J Cole, J Cole, S Cole, J Coles, R Coles, D Collier, E Collins, É Collins, J Collins, M Collis, M Comery, K Connolly, J Connor, S Conran, P Conrod, C Conway, D Cook, T Cook, J Cooke, S Cooke, A Cooper, DJ Cooper, J Cooper, J Cooper, L Cooper, L Cooper, E Cooperwaite, E Corcoran, S Cormick, S Cornell, M Corriveau, C Corry, O Costerousse, A Cotton, A Coutts, R Cowburn, N Cowley, DA Cox, M Coyne, B Crane, L Crane, M Craner, TH Craven, A Crawford, S Crawshaw, B Creagh-Brown, R Creighton, O Cremer, N Crisp, M Croft, I Cron, D Crook, H Croot, M Crosby, S Cross, H Crumley, J Cudlipp, O Cuevas, D Cullen, M Cundall, D Curley, A Currie, A Curtis, B Curtis, R Cusack, B Cuthbertson, S Cutler, F DAragon, JD Rocha, A Daebis, P Daggett, R Daher, L Daigle, H Dakers-Black, J Daley, N Dallas, J Dalton, Z Daly, R Damhar, N Daneman, C Daniels, P Dark, K Darling, T Darling, S Darshana, A Das, J Daugherty, M Davey, M Davey, A David, N Davidson, A Davies, C Davies, E Davies, G Davies, J Davies, J Davies, L Davies, M Davies, M Davies, R Davies, A Davis, S Davison, J Dawe, L Dawe, LA Dawson, R Dawson, K de Courcy-Golder, D de Jong, AD la Rosa, AD Man, MD Neef, Bethan, T Dean, D Deans, J Dearden, A Deary, S Debigaré, W Dechert, R Dehulia, L del Sorbo, L Delaney, SD Toffalo, C Demetriou, C Denmade, R Derbyshire, P Desai, J Descôteaux-Dinelle, K Deshpande, M Detry, B Devine, D Devine, T Devine, B Dewitt, J Dhalliwal, A Dhesi, P Diamond, J Dice, S Digby, J Dijo, K Dimitrova, M Dineen, T Dinh, S Dixon-Mould, P Doble, J Dobson, R Doherty, R Dolman, C Donadee, K Donaldson, AM Dondrop, C Donegan, H Donkin, S Donlon, A Donnelly, P Donnison, R Doonan, P Doran, A Dornan, M Dougherty, J Douziech, K Dowling, P Downey, C Dragomir, C Drake, M Drebot, S Drews, N Drogman, M Drouin, J Druce, A Drummond, K Drury, H D'Silva, BD Plessis, E Duan, S Duberley, É Ducas, S Duff-Miller, E Duffy, H Duggan, Z Duke, M Duley, J Duncan, T Duncan, D Dunphy, M Duplaix, S Durgacharan, A Dushianthan, N Dussault, S Dyas, K East, C Eastgate, C Eaton, C Eaton-Howell, S Ebbinghaus, D Ebner, D Edmondson, A Edwards, T Edwards, E Effelaar, M Elhassan, C Elliott, T Elliott, AM Ellis, C Ellis, C Ellis, K Ellis, Y Ellis, C Ellsworth, E Elmahi, M Elmi, T Elsefi, A Eltayeb, S English, I Entino, S Epelman, S Ermann, A Escorcia, H Escreet, A Evans, D Evans, D Evans, M Evans, R Evans, T Eve, L Fagan, E Fagbodun, P Fairclough, J Falconer, K Falle, N Farahi, S Farnell-Ward, M Faulkner, K Feane, J Feely-Henderson, T Felton, G Fennessy, B Ferguson, N Ferguson, S Ferguson, S Ferguson, M Fernandez, JF Roman, G Fernando, X Ferndadez, C Ferringer, J Fesz, C Finch, J Finden, S Finn, A Finzi, D Fisher, E Fisher, MF Crisp, C Fitcher, S Fitzgibbon, E Fitzimmons, M Fitzpatrick, C Fitzpatrick-Creamer, C Flatters, S Fletcher, K Flynn, S Flynn, E Fonyonga, A Forbes, L Forbes, K Ford, S Ford, E Forster, K Foster, T Foster, T Foster, D Fottrell-Gould, A Foulds, D Founkaneli, MJ Fournier, R Fowler, C Fox, D Fox, E Fox, G Fox, Y Fozdar, C Francoeur, B Francois, J Frankcam, C Frankfurter, G Franklin, D Franks, C Franz, A Frater, M Free, I Freestone, C French, C Frey, L Friedrich, B Frise, M Frise, J Fryer, J Fullthorpe, C Furtado, R Gad, H Gagné, LP Gagné, J Galea, A Gallant, K Gallant, A Ganesan, S Ganguly, R Ganpat, C Gardiner-Hill, C Gardner, J Gardner, R Garney, H Garrard, W Garrard, P Garrett, M Garstka, M Garton, S Gates, D Gattas, K Gaudet, A Gaussen, J Gaylard, J Gazmen, A Geddis, M Gellamucho, L Gemmell, G Gendron-Lepage, W Geng, C George, M Germain, M Ghaffari, A Ghamraoui, A Ghattaoraya, A Ghosh, A Gibb, J Gilchrist, S Gilchrist, B Gill, M Gill, M Gillespie, K Gilmour, L Giorgi, S Girard, T Girard, D Gironne, K Gladas, K Glasby, L Glasgow, R Glazenburg, L Gledhill, S Gluck, W Goddard, G Godding, G Gogarty, P Gold, D Golden, EC Goligher, K Gomez, F Gommans, MG Pinto, T Gonzales, A Goodie, J Goodwin, S Goolam-Hossen, S Gopal, J Gorry, R Gould, J Goulet, A Gouveia, P Gowdy, G Goyette, B Graham, J Graham, L Graham, H Gray, I Gray, T Gray, MC Graza, P Grealish, I Grecu, G Green, J Green, T Green, D Greener, J Gregory, B Grice, A Griffith, A Griffiths, S Grimley, L Grimmer, S Grist, E Groenveld, J Gross, E Guitteaud, A Gupta, C Gupta, SG Rai, W Habeichi, SH Liboiron, B Hadebe, L Hadzik, G Haidar, S Haider, S Halden, A Haldeos, AS Hall, A Hall, E Hall, K Hall, RE Hall, S Halliday, DO Hamilton, V Hamlyn, N Hammond, S Hammond, E Hampson, I Hancock, K Hands, J Hanley, A Hanlon, T Hanna, S Hannan, T Hansen, H Hanson, J Hanson, H Hanwell, L Harden, C Hardy, R Harford, E Hargreaves, C Harland, S Harlow, F Harper, H Harper, M Harper, N Harper, K Harrington, C Harris, J Harris, N Harris, S Harrison, K Harrow, M Hartley, A Harvey, D Harvey, M Harward, M Hashmi, S Haskins, SB Hatch, S Haviland, J Hawes, C Hawkins, N Hawkins, T Hawkins, SK Hay, T Haydon, A Hayes, A Hayes, O Hc, W Headdon, G Healey, A Hebert, S Henderson, H Hennebury, L Hennen, K Hennessy, J Henning, CA Henry, CA Henry, J Henry, R Hera, M Herbert, S Heritier, K Heron, T Herrell, SB Hesson, S Hey, N Heydon, G Heywood-Beldon, J Hickey, A Hill, C Hill, H Hill, M Hill, M Hill, A Hilldrith, E Hillerby, E Hilton, M Hinde, C Hird, J Hoar, V Hodder, C Hodge, R Hodge, L Hodgkinson, C Hodgson, H Hodgson, K Hoiland, C Holbrook, A Holland, N Holland, S Holland, M Hollands, G Hollis, L Hollos, L Holloway, B Holmes, L Holt, T Home, LH del Hoyo, P Hooley, SJ Hoosdally, D Hope, P Hopkins, A Hormis, K Horne, D Horner, J Hornsby, N Horton-Turner, K Hoskin, L Hostler, P Hoszko, B Houghton, I Houghton, A Houston, BL Houston, K Howard, A Howarth, D Howarth, C Howcroft, D Howe, L Howie, R Howle, C Hrabi, K Hubka, A Hudson, C Hugelshofer, D Hughes, L Hughes, K Hugill, S Hullegie, J Hulme, S Hulse, L Humber, C Humphrey, L Hunold, B Hunt, A Hunter, I Hunter, SA Hurford, R Hurman, M Hussain, R Hussein, A Hutchinson, P Hutton, M Ibrahim, N Ijaz, C Ingall, R Innes, B Irving, P Irving, S Isaacs, G Isgro, A Isguzar, P Ishani, S Ismay, T Ison, A Issa, H Ivatt, C Ivel, A Jackson, D Jackson, J Jackson, K Jackson, S Jackson, S Jackson, S Jackson, N Jacob, R Jacob, A Jacques, TL Brown, V Jagannathan, S Jaggard, S Jain, C James, E Jamula, HJ Senya, P Janin, L Jappy, A Jarvis, L Jarvis, I Jawad, D Jayakumar, MJ Arachchige, Z Jeewa, E Jefferson, J Jeffrey, C Jenkins, S Jenkins, S Jenkins, S Jenkins, AR Jennings, R Jennings, S Jennings, J Jeriha, J Jeyachandran, D Jeyapalan, R Jha, S Jhanji, M Jimenez, M John, S John, M Johns, D Johnson, N Johnson, P Johnson, R Johnson, R Johnson, T Johnson, Z Johnson, B Johnston, L Johnston, A Jones, C Jones, D Jones, E Jones, H Jones, J Jones, J Jones, K Jones, G Jorritsma, A Jose, J Joseph, R Joshi, V Juhaz, K Kacinova, R Kahari, S Kalchko-Veyssal, K Kalchthaler, A Kaliappan, M Kalogirou, M Kamra, A Kandaswamy, S Kannan, V Kara, T Karachi, M Karakantza, M Karlikowski, V Kasipandian, S Kassir, A Katary, J Kaur, S Kaur, S Kavanagh, A Kayani, C Kaye, A Kazi, S Kaznica, S Kearley, L Keating, C Keatley, S Keeler, S Keen, A Keen, K Keen, K Kell, J Kellington, C Kelly, E Kelly, M Kelly, Z Kelly, O Kelsall, K Kemsley, S Kendrick, C Kennedy, K Kent, C Kerlin, G Kerr, M Kerr, S Kershaw, I Kerslake, M Kevern, I Khalid, C Khan, M Khan, M Khan, S Khan, M Khera, J Khorsandi, K Khwaja, E Kim, Y Kim, S Kimpton, A King, A King, T King, F Kinney, J Kinney, A Kintono, J Kirk, D Kirkbride, A Kirkby, I Kirker, K Kislingbury, JE Kiss, G Kitsios, L Kittridge, M Knight, K Knowles, D Kobes, K Kolsteren, P Konecny, J Kong, R Koshy, L Koukouflis, R Kovacevic, R Krahn, V Krishnamurthy, P Kruger, R Kruisselbrink, W Krywiak, A Kumar, R Kumar, AK Jha, K Kuntz, D Kutsogiannis, L Kyeremeh, L Kyle, M Laffan, J Laffey, J Lafrenier, S Laha, M Lahaie, B Laing, M Lake, CK Lam, B Lamb, H Lamoureux, R Lanaway, J Lancut, P Landy, E Lang, L Lankester, C Larivee, C Larner, M Larose, W Lason, V Latham, D Latimer, A Laumaea, F Lauzier, C Lawler, M Lawley, J Lawrence, R Lawrence, J Lawson, R Lawton, JM Lazaro, D Leaf, R Lean, C Leaver, S Leaver, J Leblond, M Leclerc, J Lee, LH Lee, M Lee, S Lee, S Lee, W Lee, W Lefresne, D Leguard-White, P Lehto, F Lellouche, I Lenchuk, L Lesage, U Leuschner, C Levett, A Lewin, M Lewin, J Lewis, L Lewis, S Lewis, L Lewis-Prosser, A Li, J Li, A Liao, K Licanio, S Lieber, J Lin, G Lindergard, V Linnett, C Little, T Liu, A Liversidge, P Lizotte, C Lobato, M Lobo-Clarke, S Lock, T Lockett, S Lockyer, T Lofting, M Logan, K Lomme, M Long, ML Martinez, A Lopus, Stuart, L Lordache, K Loregnard, C Lorenzon, S Lother, E Loutraris, H Lovett, D Loveys, B Lowe, C Lowe, M Lowery, E Loxley, R Lucas, K Lucier, T Luk, B Lukasik, H Lund, K Lundy, J Luo, J Lussier, H Luyckx, CH Ly, E Ly, S Lymn, C Lynch, D Lynch, B Lyon, E Lyons, A Macauley, K MacDonald, P MacDonald, S MacDonald, T MacDonald, C MacGuigan, L MacKay, C MacKenzie, D MacKenzie, P Mackey, S MacLennan, S MacLeod, P MacNally, N MacNeil, K Madgwick, H Madiyiko, T Maggs, K Maguire, T Maguire, S Magwood, A Maharajh, J Mailman, C Main, E Makanju, A Makky, A Makowski, S Malakouti, M Male, B Malley, C Maloney, G Maloney, V Manax, Y Mangindaan, K Manguiat, L Mannion, V Manoharan, E Manuel, G Marange, L March, G Marcotte, H Maria-Osborn, N Marin, D Marinakis, N Marinoff, R Markgraff, M Marotti, SM Hernandez, C Marriot, Y Marriott, O Marroquin, BD Marsden, T Marsden, E Marsh, J Marshall, S Marston, N Marten, E Martin, E Martin, J Martin, L Martin, T Martin, A Martinez, M Martins, O Martins, LM Ferreira, R Mary-Genetu, L Mason, B Massar, C Masse, MH Masse, N Massey, M Mataliotakis, C Mathews, M Mathie, W Matimba-Mupaya, R Matsa, J Matthews, P Matthews, S Matthews, G Matthias, G Maxwell, O May, K Mayak, I Mayangao, L Maynard, F Mayr, J Mazerall, M Mbwembwe, CM Goldrick, MM Master, H Mcaleese, S McAllery, J McAuley, E McCallion, M McCalmont, J McCarthy, D McClintock, C McCracken, P McCracken, E McCreary, L McCreery, IJ McCullagh, C McCulloch, J McDonald, R McEldrew, F McGain, K McGarry, M McGarvey, M McGee, C McGhee, H McGivern, D McGlynn, P McGuigan, L McIntyre, M McKee, S McKenna, S McKenna, D Mckeown, C Mckie, S McKilop, L McLintock, DK McMahon, J McMahon, J McManus, A McMillan, C McMillan, H McMillan, L McMorrow, J McMurdo, D McNamara, R McNamara, D McNaughton, MP McNicholl, S McWilliam, S Medic, H Medjahed, R Medva, J Mehew, R Mehta, J Meier, S Mellin, P Mellor, LP Ménard, E Mendoza, M Meredith, S Metherell, G Methven, L Mew, J Meyer, N Mguni, A Michael, V Michael, N Michalak, S Michalowicz, C Michelson, S Middlethorp, M Miedema, S Miezitis, J Mikusek, I Millar, T Millen, J Miller, L Miller, M Milloy, GH Mills, S Mills, R Miln, C Milot, A Minella, SM Garcia, A Minhas, T Minnier, A Minogue, L Miranda, D Mistry, R Mistry, B Misztal, S Mitchard, S Mitchell, G Mmadubuko, D Modi, K Moghbeli, M Mohan, R Moir, A Molloy, L Molson, H Monaghan, J Monaghan, I Moody, C Moore, G Moore, H Moore, L Moore, T Moore, V Moore, L Moorhouse, MA Moreau, N Moreland, JM Cuesta, A Morgan, J Morgan, K Morgan, M Morgan, R Morgan, S Morpeth, H Morris, S Morris, S Morrisey, S Morton, R Mortuza, I Mounitsyn, L Mounsey, D Moyst, S Mtuwa, D Mueller, A Muir, M Muir, D Mukherjee, T Mukwa, J Mulder, S Mulla, B Mullin, J Mullings, M Mullowney, S Mumford, S Munt, N Munu, D Murdoch, A Murphy, E Murphy, F Murphy, J Murphy, P Murphy, S Murphy, L Murray, S Murthy, K Mushtaq, E Music, N Muzengi, E Mwaura, J Nabess, A Naeem, P Naga, P Nair, RN Khade, RN Sekiwala, A Nandani, S Narayan, A Natajaran, V Nayyar, M Naz, S Nazarali, M Neal, M Netea, K Netherton, G Neves, CM Neville, J Newanji, J Newman, R Newman, S Newman, T Newman, C Newsam, C Ng, D Nguyen, A Nicholson, G Nicholson, J Nicholson, S Nijjar, N Nikitas, J Nnadi, H Noble, J Noel, J Nolan, MÈ Nolin, J Nordstrom, J Norgrave, J North, J Northcote, J Nortje, A Nown, T Noyce, A Noyon, GN Agha, K Nwankiti, E Nweje, M Nygren, A OConnor, A OConnor, S OConnor, K OHalloran, S OKane, R OLeary, A ONeill, K OReilly, S Oakley, A Oborska, A O'Brien, S O'Brien, M O'Connell, M O'Connell, T O'Connor, S Oczkowski, R O'Dea, R O'Donnell, V O'Donnell, D Odumeru, B Ogg, K Ogungbenro, C O'Kane, E O'Kell, C Okundaye, C Okyne-Turkson, J Oldham, M Oliveira, A Oliver, N Omer, L Oncea, B O'Neill, RO Prabakaran, C Orchard, J O'Reilly, N Orford, LO de Gordoa, D Ormrod, K Orr, L Orr, R Osagie, A Osborne, D Osborne, R Osmond, AO Stella, KL Oueng, N Outten, D Oza, U Pabasara, T Paddock, J Pade, N Page, VJ Page, ML Pakats, S Palihavadana, K Palmer, C Pambrun, R Pankhurst, A Pantanwala, E Pappa, M Pappa, M Paquet, E Paramasivam, A Parejasanchez, D Parekh, C Parent, É Parent, V Parent, L Park, C Parker, L Parkinson, M Parmar, K Parry-Billings, K Parsons, S Parsons, K Pass, S Patch, A Patel, B Patel, K Patel, M Patel, P Patel, R Patel, A Patterson, L Patterson, P Patterson, T Patzer, D Paul, J Paul, R Paul, B Paunovic, D Pavelich, D Payne, A Peacock, S Peake, H Pearson, K Pearson, S Pegler, B Pelle, A Pemberton, J Pendlebury, S Pendlebury, A Penny, RP Saluzzio, A Pereira, R Pereira, P Perera, J Perez, R Perkins, J Perreault, R Perri, T Perry, C Peters, J Peters, S Peters, S Peters, S Peterson, T Petraszko, T Pettigrew, V Pettilä, S Peyton, G Phalod, JE Philbin, N Philips, B Phillips, D Phillips, K Phillips, M Phillips, P Phillips, C Phillipson, K Philpott, MK Phull, C Pickering, H Pickford, C Piercy, J Piersma, CM Pigeon, S Pillai, N Pilutti, J Pinder, J Pink, J Pinnell, M Pitcher, S Pitts, M Pletz, R Ploeg, T Pogreban, D Pogson, D Poles, P Polgarova, B Pollock, M Polson, F Pomeroy, JS Pooni, I Popescu, E Poppitt, C Porada, R Porteous, D Porter, A Potter, K Potter, P Povoa, C Powel, E Powell, G Powell, G Powter, R Pramanik, M Prasad, S Pratheepkumar, A Prefontaine, J Presneill, J Prévost, A Prihoda, J Pring, L Privatera, L Prokopiuk, T Pronyk-Ward, N Proudfoot, R Prout, R Pugh, L Purandare, C Purcell, D Purohit, S Purvis, D Putensen, Z Puthucheary, K Puxty, X Qiu, R Quayle, M Quinagon, A Quinn, K Quinn, M Quinones-Mateu, A Quirk, H Qureshi, W Rabin, I Rabusseau, E Rademaker, S Rainey, A Raithatha, D Ralphs, M Ramali, A Ramos, L Ramos, H Randall, S Randall, G Randell, R Randhawa, H Ranton, D Rao, RR Baikady, A Rashid, C Rasko, J Ratcliff, V Ratnam, R Rauniyar, S Rawlins, M Ray, K Raymakers, B Rayner, M Reay, R Rebello, A Reddy, H Reddy, C Reed, G Rees, I Rees, B Reeve, F Regan, A Reid, R Reilly, S Reilly, H Reschreiter, L Retzlaff, A Revill, O Rewa, B Reynolds, C Reynolds, J Reynolds, K Reznicek, J Rhodes, E Rich, J Richard, D Richards, S Richards, A Richards-Belle, C Richardson, E Richardson, J Riches, D Ricketts, J Ricks, I Rietveld, S Rigby, L Rikkert, D Rimmer, C Risbridger, M Ritchot, J Ritzema, P Riverin, M Roach, M Robb, É Roberge, E Roberts, L Roberts, T Roberts, D Robertson, D Robertson, A Robinson, K Robinson, M Robinson, S Robinson, C Robson, L Roche, M Roche, B Rochwerg, J Rock, N Rodden, C Rodley, A Rogers, G Rohde, R Rojo, T Romagnuolo, A Roman, C Rook, K Rooney, M Rosario, LP Rosaroso, B Rosborough, D Rose, R Rose, S Rose, V Rose, J Ross, N Ross, A Rostron, J Roth, P Rouleau, C Rounds, K Rowan, S Rowan-Ferry, L Rowe-Leete, M Rowland, M Rowley, A Roy, A Roynon-Reed, A Rudd, W Ruiz, P Ruoso, R Rushworth, L Rusk, K Ryalls, E Ryan, L Ryan, N Rylance, S Sabaretnam, U Sabat, R Sackrowitz, G Sadera, MI Saez-Garcia-Holloway, S Saha, A Salberg, J Sall, A Salmon, K Salmon, N Salmons, Z Sammut, L Samuel, FS Diego, M Sanchez, A Sanderson, C Sanderson, G Sandhu, A Sanil, F Santos, A Saran, S Sathe, P Sathianathan, M Saull, S Sauvageau, R Sawler, M Saxena, J Scanlan, R Scano, I Scheepstra-Beukers, M Schmidhofer, A Schoenling, J Schotsman, R Schroeder, M Schuett, M Schuster-Bruce, R Schutgens, S Schweikert, A Scott, K Scott, Z Scott, D Seals, J Seaman, R Seaman, D Seddon, F Sedigh-Zadeh, F Seidu, M Sekhar, F Selene, J Sell, K Sellers, H Senior, P Senior, I Seppelt, K Serri, C Sevilla, M Shade, F Shah, T Shahid, M Shankar-Hari, S Shanmugaranjan, K Shaughnessy, D Shaw, D Shaw, J Shaw, A Shearer, B Sheath, J Sheffield, L Sheldon, S Shelton, V Shetty, D Shield, R Shiers, C Shin, K Shirley, R Shortland, C Shovelton, M Shyamsundar, Z Sibanda, S Sibin, C Sicat, A Siddiqui, M Siek, C Siewersk, N Sikondari, A Silver, M Silverstone, MA Sim, C Simard, P Simmonds, B Simpson, B Simpson, J Simpson, T Simpson, A Simpson, JA Sinclair, J Singh, R Singh, V Singh, J Singleton, P Sinha, R Sivers, A Sivyer, MJ Skill, D Skinner, T Skinner, A Skorko, A Skrtich, W Slack, H Slade, M Slaughter, W Sligl, J Sloan, C Small, E Small, A Smallwood, J Smee, A Smit, A Smith, C Smith, G Smith, J Smith, J Smith, K Smith, L Smith, M Smith, P Smith, P Smith, R Smith, S Smith, T Smith, T Smith, G Smithson, S Smuts, J Smyrski, K Smyth, N Smyth, N Smyth, L Snouber, M Sokolowski, A Solesbury, A Somerville, T Song, D Sood, M Sosa, SS Arias, D Southern, J Speidel, H Speight, J Spence, S Spencer, H Spicer, R Spicer, B Spires, A Spong, K Spreckley, S Springworth, R Squires, CS Onge-Legault, C Stacey, T Staincliffe, M Stambaugh, K Stammers, SJ Stanworth, J Staves, R Stedman, T Steed, SS Sprinckmoller, M Sterba, G Stevens, G Stevens, E Stevenson, A Stewart, R Stewart, R Stewart, R Stirk, M St-John, S Stone, E Strakosch, E Stratton, L Streeter, T Suber, L Sudlow, A Sukuraman, N Sull, A Summerfield, C Summers, J Summers, AS Raj, R Sundaram, D Sundaran, H Sutherland, SB Sutherland, S Sutherland, J Sutton, M Sutu, J Swabe, L Swan, N Swarbrick, K Sweet, S Sweity, E Sy, T Szakmany, H Tackaberry, MT Saleem, S Taibo, N Talia, P Tamblin-Hopper, J Tan, X Tang, R Tao, E Tarr, D Tasker, M Tate, ML Tate, KC Tatham, MN Altomy, A Taylor, B Taylor, C Taylor, H Taylor, M Taylor, S Tekle, S Teklehaimanot, H Templar, M Templeton, P Tendler, A Tervit, K Tettmar, S Theander, S Thellend, A Thomas, D Thomas, E Thomas, H Thomas, V Thomas, S Thomas-Wright, P Thompson, T Thompson, U Thompson, N Thomson, W Thorne, A Thorpe, J Thrush, S Thurairatnam, C Tierney, EM Timms, M Tokessy, T Tolppa, H Tomlinson, S Tong, K Tony, S Torrance, I Tosi, O Touma, J Towler, M Towns, A Townsend, C Townsend, A Tracy, C Tranter, T Trapani, J Trattles, E Traverse, S Tremblay, T Tremblay, K Treuberg, SC Trevelin, M Trevett, M Trevett, F Trim, T Trimble, K Trimmer, A Trueman, N Truman, S Tryon, K Tsakiridou, HP Tsang, J Tsang, G Tsinaslanidis, V Tuckley, C Tuckwell, RP Tully, R Tung, S Turawa, A Turco, K Turek, S Turki, D Turner, F Turner, K Turner, L Turner, M Turner, R Turner, S Turner, I Turner-Bone, M Turns, S Turville, I Udayanga, R Uddin, A Udy, L Unitt, A Unsworth, J Uppal, J Uprichard, A Uriel, A Ustianowski, J Uttley, T Uyeki, E Valentine, L Vamplew, T van der Poll, CV der Riet, D van Hout, R van Kimmenade, M van Beurden, JL Deursen, WV Hoff, K Vardigans, S Varghese, G Vazquez-Grande, A Veen, T Veenith, M Veillette, T Velcich, D Veniard, B Venkatesh, E Venz, M Verlander, M Vertue, J Verula, C Viau, S Victor, A Viehman, W Vietri, S Villeneuve, S Vimalanathan, R Vincent, S Virdee, L Voutour, A Vuylsteke, A Waite, A Walden, J Walden, G Walker, J Walker, MT Walker, R Walker, S Walker, D Wallbank, F Waller, J Walsh, J Walsham, S Walters, E Ward, G Ward, K Ward, L Ward, R Ward, A Wardle, M Warnock, L Warren, C Washington, O Watchorn, A Waters, S Waterson, C Watkins, N Watkins, I Watpool, A Watts, V Waugh, P Weaver, L Weber, K Webert, T Weerasinghe, A Weissman, C Wells, ID Welters, J Wesson, J Wesson, A West, S Westlake, B Wetherill, A White, I White, K White, S White, T Whitehouse, V Whiteside, K Whitley, M Whynot, B Wibrow, E Wilby, E Wilcox, L Wilcox, H Wild, L Wild, L Wilding, R Wildman, D Wiles, M Wiles, D Wiley, E Wilhelmsen, C Wilkes, D Wilkinson, H Wilkinson, H Wilkinson, F Willams, A Williams, A Williams, A Williams, G Williams, H Williams, JD Williams, J Williams, K Williams, P Williams, S Williams, V Williams, D Williamson, JD Williamson, B Willian, J Willis, J Willson, A Wilson, C Wilson, M Wilson, M Wilson, E Wiltsher, P Windrum, P Winter, M Wise, MK Wisniewski, H Wissett, K Witherell, A Woelke, P Wojcik, M Wolna, C Wong, L Wong, O Wong, YM Wong, CA Wood, H Wood, H Wood, K Wood, T Wood, J Woodford, L Woodford, U Woodford, D Woods, J Woods, L Woods, S Wowchuk, S Woycik, J Wren, J Wren, L Wren, CW Brown, A Wright, C Wright, L Wright, P Wright, R Wright, J Wu, R Wyatt, K Wylie, K Xavier, CX Tai, H Xiao, Y Yang, E Yarad, D Yates, D Yealy, A Yeatman, P Yedynak, I Young, M Young, P Young, T Youngstein, H Yu, H Yusuff, A Zaidi, A Zaki, M Zaman, R Zaman, C Zammit, L Zarb, R Zarychanski, M Zeller, M Zelman, A Zimperi, DB de Pinedo Artaraz, L Zouita, W Zuurbier, S Zyengi, LJ Estcourt, AF Turgeon, ZK McQuilten, BJ McVerry, F Al-Beidh, D Annane, YM Arabi, DM Arnold, A Beane, P Bégin, W van Bentum-Puijk, LR Berry, Z Bhimani, JE Birchall, MJ Bonten, CA Bradbury, FM Brunkhorst, M Buxton, JL Callum, M Chassé, AC Cheng, ME Cove, J Daly, L Derde, MA Detry, MD Jong, A Evans, DA Fergusson, M Fish, M Fitzgerald, C Foley, H Goossens, AC Gordon, IB Gosbell, C Green, R Haniffa, H Harvala, AM Higgins, TE Hills, VC Hoad, C Horvat, DT Huang, CL Hudson, N Ichihara, E Laing, AA Lamikanra, F Lamontagne, PR Lawler, K Linstrum, E Litton, E Lorenzi, S MacLennan, J Marshall, DF McAuley, JF McDyer, A McGlothlin, S McGuinness, G Miflin, S Montgomery, PR Mouncey, S Murthy, A Nichol, R Parke, JC Parker, N Priddee, DF Purcell, LF Reyes, P Richardson, N Robitaille, KM Rowan, J Rynne, H Saito, M Santos, CT Saunders, AS Neto, CW Seymour, JA Silversides, AA Tinmouth, DJ Triulzi, AM Turner, F van de Veerdonk, TS Walsh, EM Wood, S Berry, RJ Lewis, DK Menon, C McArthur, R Zarychanski, DC Angus, SA Webb, DJ Roberts, M Shankar-Hari |
Journal of the American Medical Association | 2021 |
|
Adverse Cardiovascular Effects of Anti-COVID-19 Drugs
D Liu, X Zeng, Z Ding, F Lv, JL Mehta, X Wang |
Frontiers in pharmacology | 2021 |
|
Ubiquitous convalescent plasma: An artificial universal plasma for COVID-19 patients
MS Bardsiri, SM Kouhbananinejad, R Vahidi, S Soleimany, M Moghadari, A Derakhshani, B Kashani, A Farsinejad |
Transfusion and apheresis science : official journal of the World Apheresis Association : official journal of the European Society for Haemapheresis | 2021 |
|
Convalescent plasma therapy in patients with moderate-to-severe COVID-19: A study from Indonesia for clinical research in low- and middle-income countries
MS Rejeki, N Sarnadi, R Wihastuti, V Fazharyasti, WY Samin, FA Yudhaputri, E Johar, N Nurainy, NS Bachtiar, DH Muljono |
2021 | |
|
Convalescent plasma therapy as a conventional trick for treating COVID-19: a systematic review and meta-analysis study
M Keikha, M Karbalaei |
New Microbes and New Infections | 2021 |
|
The interplay between the immune system and SARS-CoV-2 in COVID-19 patients
S Shabbir, MH Raza, M Arshad, MJ Khan |
Archives of Virology | 2021 |
|
Review of COVID-19 Treatment
Somayeh Sadeghi, Mahnaz Momenzadeh, Peiman Nasri, Mina Nickpour |
Journal of Research in Pharmacy Practice | 2021 |
|
Landscape of humoral immune responses against SARS-CoV-2 in patients with COVID-19 disease and the value of antibody testing
S Mahalingam, J Peter, Z Xu, D Bordoloi, M Ho, VS Kalyanaraman, A Srinivasan, K Muthumani |
Heliyon | 2021 |
|
Assessment of the Safety and Therapeutic Benefits of Convalescent Plasma in COVID-19 Treatment: A Systematic Review and Meta-Analysis
DF Barreira, RA Lourenço, R Calisto, D Moreira-Gonçalves, LL Santos, PA Videira |
Frontiers in Medicine | 2021 |
|
Immunotherapies and immunomodulatory approaches in clinical trials - a mini review
MI Yatoo, Z Hamid, I Rather, QU Nazir, RA Bhat, AU Haq, SN Magray, Z Haq, R Sah, R Tiwari, SK Natesan, M Bilal, H Harapan, K Dhama |
Human Vaccines & Immunotherapeutics | 2021 |
|
COVID‐19 convalescent plasma donor characteristics, product disposition, and comparison with standard apheresis donors
B Lasky, EG Meyer, WR Steele, LA Crowder, PP Young |
Transfusion | 2021 |
|
Recent biotechnological advances as potential intervention strategies against COVID-19
N Lobo-Galo, JC Gálvez-Ruíz, AP Balderrama-Carmona, NP Silva-Beltrán, E Ruiz-Bustos |
3 Biotech | 2021 |
|
Severe SARS-CoV-2 disease in the context of a NF-κB2 loss-of-function pathogenic variant
RS Abraham, JM Marshall, HS Kuehn, CM Rueda, A Gibbs, W Guider, C Stewart, SD Rosenzweig, H Wang, S Jean, M Peeples, T King, WG Hunt, JR Honegger, O Ramilo, PJ Mustillo, A Mejias, MI Ardura, M Shimamura |
Journal of Allergy and Clinical Immunology | 2021 |
|
Perspectives for immune plasma treatment of COVID-19
B SAYINALP, OE ÇINAR, İC HAZNEDAROĞLU |
2021 | |
|
Immunotherapy Summary for Cytokine Storm in COVID-19
Y Li, W Zhao, J Liu, Z Chen, Q Lv, Z Zhang |
Frontiers in pharmacology | 2021 |
|
Assessment of anti‐SARS‐CoV‐2 antibodies level in convalescents plasma
A Skorek, A JaźwińskaCuryłło, A Romanowicz, K Kwaśniewski, W Narożny, D Tretiakow |
Journal of Medical Virology | 2021 |
|
Convalescence plasma treatment of COVID-19: results from a prematurely terminated randomized controlled open-label study in Southern Sweden
K Holm, MN Lundgren, J Kjeldsen-Kragh, O Ljungquist, B Böttiger, C Wikén, J Öberg, N Fernström, E Rosendal, AK Överby, JW Byström, M Forsell, M Landin-Olsson, M Rasmussen |
BMC Research Notes | 2021 |
|
Therapeutic Use of Convalescent Plasma in COVID-19 Infected Patients with Concomitant Hematological Disorders:
F Lanza, V Agostini, F Monaco, F Passamonti, J Seghatchian |
2021 | |
|
COVID ‐19 convalescent plasma cohort study: Evaluation of the association between both donor and recipient neutralizing antibody titers and patient outcomes
AP Yokoyama, S Wendel, C BonetBub, RM Fachini, AP Dametto, F Blumm, VF Dutra, GT Candelaria, AM Sakashita, RR Machado, R FontãoWendel, N Hamerschlak, R Achkar, MS Assunção, P Scuracchio, V Nudelman, L Pastore, JR Pinho, MD Ben, RK Filho, AR Marra, MT Amano, EG Kallás, AS Helito, CR Carvalho, DB Araujo, EL Durigon, AA Camargo, LV Rizzo, LF Reis, JM Kutner |
Transfusion | 2021 |
|
Convalescent Plasma Efficacy in Life-Threatening COVID-19 Patients Admitted to the ICU: A Retrospective Cohort Study
M Abuzakouk, K Saleh, M Algora, A Nusair, J Alameri, F Alshehhi, S Alkhaja, M Badr, K Abdallah, BD Oliveira, A Nadeem, Y Varghese, D Munde, S Salam, B Abduljawad, H Elkambergy, A Wahla, A Taha, J Dibu, A Bayrlee, F Hamed, L AbdelWareth, N Rahman, J Guzman, J Mallat |
Journal of Clinical Medicine | 2021 |
|
No Evidence for Human Monocyte-Derived Macrophage Infection and Antibody-Mediated Enhancement of SARS-CoV-2 Infection
O García-Nicolás, P Vkovski, F Zettl, G Zimmer, V Thiel, A Summerfield |
Frontiers in Cellular and Infection Microbiology | 2021 |
|
Convalescent plasma therapy - a silver lining for COVID-19 management?
S Saha, S Kadam |
2021 | |
|
Convalescent plasma therapy in COVID-19 critically ill patients during advanced phases of clinical trials and their preliminary results
FA de Oliveira, MP Nucci, GN de Albuquerque Rego, A da Hora Alves, LC Marti, LP Nucci, JB Mamani, LF Gamarra |
Einstein (São Paulo) | 2021 |
|
Suggested guidelines for convalescent plasma therapy for the treatment of COVID-19
GC Santis, A Mendrone, D Langhi, DT Covas, A Fabron, AJ Cortez, CL Dinardo, EM Ubiali, JF Marques, JO Bordin, MA Rugani |
2021 | |
|
Therapeutic Strategies in the Management of COVID-19
RR Naik, AK Shakya |
Frontiers in Molecular Biosciences | 2021 |
|
Matched Cohort Study of Convalescent COVID-19 Plasma Treatment in Severely or Life Threateningly Ill COVID-19 Patients
M Klapholz, SR Pentakota, JP Zertuche, M McKenna, W Roque, M Forsberg, J Packer, DS Lal, L Dever |
Open Forum Infectious Diseases | 2021 |
|
Early mortality benefit with COVID‐19 convalescent plasma: a matched control study
AG Shenoy, AZ Hettinger, SJ Fernandez, J Blumenthal, V Baez |
British Journal of Haematology | 2021 |
|
Monoclonal antibodies for the treatment of COVID-19 patients: An umbrella to overcome the storm?
SM Pinna, T Lupia, S Scabini, D Vita, ID Benedetto, A Gaviraghi, I Colasanto, A Varese, F Cattel, FG Rosa, S Corcione |
International Immunopharmacology | 2021 |
|
Potential Therapeutic Targets and Vaccine Development for SARS-CoV-2/COVID-19 Pandemic Management: A Review on the Recent Update
U Anand, S Jakhmola, O Indari, HC Jha, ZS Chen, V Tripathi, JM de la Lastra |
Frontiers in immunology | 2021 |
|
Association of Convalescent Plasma Therapy With Survival in Patients With Hematologic Cancers and COVID-19
MA Thompson, JP Henderson, PK Shah, SM Rubinstein, MJ Joyner, TK Choueiri, DB Flora, EA Griffiths, AP Gulati, C Hwang, VS Koshkin, EB Papadopoulos, EV Robilotti, CT Su, EM Wulff-Burchfield, Z Xie, PP Yu, S Mishra, JW Senefeld, DP Shah, JL Warner, B Halmos, A Verma, BA Gartrell, S Goel, N Ohri, RA Sica, A Thakkar, KE Stockerl-Goldstein, O Butt, JL Campian, MA Fiala, R Monahan, AY Zhou, P Bohachek, D Mundt, M Streckfuss, E Tadesse, PE Lammers, SG Revankar, OA Panagiotou, PC Egan, D Farmakiotis, H Khan, AJ Olszewski, A Loaiza-Bonilla, SA Prete, AH Angevine, MH Bar, KM Lo, J Stratton, PL Weinstein, PF Caimi, JS Barnholtz-Sloan, JA Garcia, JM Nakayama, S Gupta, NA Pennell, MS Ahluwalia, SJ Dawsey, A Nizam, CA Lemmon, C Hoppenot, A Li, Z Bakouny, G Bouchard, FJ Busser, JM Conners, CR Curran, GD Demetri, A Giordano, K Kelleher, A Nohria, A Schmidt, G Shaw, EM Allen, PV Nuzzo, W Xu, RL Zon, T Zhang, S Halabi, GH Lyman, JJ Graber, P Grivas, AR Khaki, ET Loggers, RC Lynch, ES Nakasone, MT Schweizer, LM Tachiki, S Vinayak, MJ Wagner, A Yeh, NT Gatson, S Goyal, MP Huynh-Le, LJ Rosenstein, JM Clement, A Daher, ME Dailey, R Elias, E Hsu, AG Menendez, J Rathmann, OK Serrano, A Jayaraj, SM Gadgeel, JE Hawley, DL Hershman, MK Accordino, D Bhutani, GK Schwartz, DY Reuben, S Mushtaq, EH Bernicker, J Deeken, D Shafer, MA Lewis, TD Rhodes, DM Gill, CA Low, S Nagle, B Hayes-Lattin, S McWeeney, ER Nemecek, HA Zaren, SJ Smith, G Nagaraj, M Akhtari, E Lau, ME Reeves, S Berg, D Elms, AK Morgans, FH Wehbe, J Altman, M Gurley, MF Mulcahy, EB Durbin, AA Kulkarni, HH Nelson, S Shah, RP Rosovsky, K Reynolds, A Bardia, G Boland, J Gainor, L Zubiri, TR Halfdanarson, T Bekaii-Saab, A Desai, RA Mesa, M Bonnen, D Mahadevan, AG Ramirez, M Salazar, R Belenkaya, J Philip, GJ Riely, B Faller, RR McKay, A Ajmera, A Cabal, JA Shaya, LB Weissmann, C Jani, JL Chen, ME Gatti-Mays, SR Jhawar, MB Lustberg, JD Palmer, C Pillainayagam, DG Stover, S Wall, NO Williams, V Karivedu, D Addison, M Joshi, H Menon, MA Rovito, A Elshoury, SK Jabbour, MR Shah, B Bashir, SZ Mahmood, C McNair, V Mico, AV Rivera, C Miller, E Cabebe, MJ Glover, A Jha, L Schapira, SA Shah, JT Wu, S Subbiah, BB Logan, G Kloecker, , K Russell, B Stith, M Smits, N Edwin, DD Chism, S Owenby, DB Doroshow, MD Galsky, H Zhu, JC Fu, A Fazio, KG Patel, J Riess, DH Kwon, V Kumar, JY Islam, WA Wood, SA Ahmad, P Grover, S Gulati, J Kharofa, M Marcum, C Park, TM Wise-Draper, DW Bowles, CL Geiger, R Bishnoi, MJ Markham, C Shah, JD Acoba, YS Rho, LE Feldman, KF Hoskins, G Gantt, M Khan, RH Nguyen, MM Pasquinelli, C Schwartz, NK Venepalli, P Vikas, A Kasi, LA Fecher, CR Friese, BH Mavromatis, QU Zaman, R Bijjula, A Cheng, EJ Davis, B French, EA Gillaspie, DJ Hausrath, C Hennessy, CY Hsu, DB Johnson, X Li, SA Reid, BI Rini, Y Shyr, DA Slosky, CC Solorzano, MD Tucker, K Vega-Luna, LL Wang, KT Enriquez, T Sun, TM Carducci, M Puc, SV Loon, KJ Goldsmith, RL Rice, WD Cabalona, C Pilar, BB McCollough, P Peddi, LR Rosen, MA Bilen, D Ravindranathan, N Hafez, RS Herbst, P LoRusso, T Masters, C Stratton |
JAMA Oncology | 2021 |
|
Limited window for donation of convalescent plasma with high live-virus neutralizing antibody titers for COVID-19 immunotherapy
A Gontu, S Srinivasan, E Salazar, MS Nair, RH Nissly, D Greenawalt, IM Bird, CM Herzog, MJ Ferrari, I Poojary, R Katani, SE Lindner, AM Minns, R Rossi, PA Christensen, B Castillo, J Chen, TN Eagar, X Yi, P Zhao, C Leveque, RJ Olsen, DW Bernard, J Gollihar, SV Kuchipudi, JM Musser, V Kapur |
2021 | |
|
Disease Severity, Fever, Age, and Sex Correlate With SARS-CoV-2 Neutralizing Antibody Responses
S Schlickeiser, T Schwarz, S Steiner, K Wittke, NA Besher, O Meyer, U Kalus, A Pruß, F Kurth, T Zoller, M Witzenrath, LE Sander, MA Müller, C Scheibenbogen, HD Volk, C Drosten, VM Corman, LG Hanitsch |
Frontiers in immunology | 2021 |
|
Significantly Decreased Mortality in a Large Cohort of Coronavirus Disease 2019 (COVID-19) Patients Transfused Early with Convalescent Plasma Containing High-Titer Anti–Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Spike Protein IgG
E Salazar, PA Christensen, EA Graviss, DT Nguyen, B Castillo, J Chen, BV Lopez, TN Eagar, X Yi, P Zhao, J Rogers, A Shehabeldin, D Joseph, F Masud, C Leveque, RJ Olsen, DW Bernard, J Gollihar, JM Musser |
The American Journal of Pathology | 2021 |
|
Emergency seed funding for COVID-19 research: lessons from Johns Hopkins University
J Messersmith, C Stoddart-Osumah, M Lennon, D Wirtz |
Journal of Clinical Investigation | 2021 |
|
Engineering luminescent biosensors for point-of-care SARS-CoV-2 antibody detection
SK Elledge, XX Zhou, JR Byrnes, AJ Martinko, I Lui, K Pance, SA Lim, JE Glasgow, AA Glasgow, K Turcios, NS Iyer, L Torres, MJ Peluso, TJ Henrich, TT Wang, CM Tato, KK Leung, B Greenhouse, JA Wells |
Nature Biotechnology | 2021 |
|
Rapid and Flexible Platform To Assess Anti-SARS-CoV-2 Antibody Neutralization and Spike Protein-Specific Antivirals
D Stelitano, SP Weisberg, MP Goldklang, Y Zhu, FT Bovier, GF Kalantarov, G Greco, D Decimo, G Franci, M Cennamo, G Portella, M Galdiero, C Mathieu, B Horvat, IN Trakht, A Moscona, MA Whitt, M Porotto, R Dutch |
mSphere | 2021 |
|
Case Report: Serial Cases: Prolongation of High Immunoglobulin G Level in Repetitive COVID-19 Convalescence Plasma Donor in Saiful Anwar Hospital Malang, Indonesia
N Nurarifah, HP Brahmantyo, SO Wardhani, DH Hermanto, PM Arsana |
Frontiers in immunology | 2021 |
|
Demographic and Clinical Factors Associated with Reactivity of Anti-SARS-CoV-2 Antibodies in Serbian Convalescent Plasma Donors
J Grujić, N Bujandrić, Z Budakov-Obradović, V Dolinaj, D Bogdan, N Savić, A Cabezas-Cruz, D Mijatović, V Simin, N Anđelić, P Banović |
International journal of environmental research and public health | 2021 |
|
Antibody Response against SARS-CoV-2 Infection: Implications for Diagnosis, Treatment and Vaccine Development
A Mallano, A Ascione, M Flego |
International Reviews of Immunology | 2021 |
|
Rapid growth in the COVID-19 era
Y Lee, M Ng, K Daniel, E Wayne |
MRS bulletin / Materials Research Society | 2021 |
|
Characteristics of published/registered clinical trials on COVID-19 treatment: A systematic review
P Asili, M Mirahmad, O Tabatabaei-Malazy, A Manayi, E Haghighat, M Mahdavi, B Larijani |
DARU Journal of Pharmaceutical Sciences | 2021 |
|
Management of COVID patients with convalescent plasma: Do we have the final word?
F Menichetti, M Falcone, G Tiseo |
European Journal of Internal Medicine | 2021 |
|
Passive immune therapies: another tool against COVID-19
L Estcourt |
Hematology / the Education Program of the American Society of Hematology. American Society of Hematology. Education Program | 2021 |
|
A Glimpse into the Diverse Cellular Immunity against SARS-CoV-2.
Chang CW, Liu Y, Jiao C, Liu H, Gong J, Chen X, Chang LJ |
Human vaccines | 2021 |
|
Effectiveness and Controversy of Convalescent Plasma Therapy for Coronavirus Disease 2019 Patients
Shu Z, Wu P, Qian Q, Zhou L, Du D, Ding M, Peng T, Fang K |
2021 | |
|
Serological anti-SARS-CoV-2 neutralizing antibodies association to live virus neutralizing test titers in COVID-19 paucisymptomatic/symptomatic patients and vaccinated subjects
Cristiano A, Nuccetelli M, Pieri M, Sarubbi S, Pelagalli M, Calugi G, Tomassetti F, Bernardini S |
International Immunopharmacology | 2021 |
|
Coronavirus disease 2019 (COVID-19): Biophysical and biochemical aspects of SARS-CoV-2 and general characteristics.
Güler G, Özdemir H, Omar D, Akdoğan G |
Progress in Biophysics and Molecular Biology | 2021 |
|
Early Transfusion of Convalescent Plasma Improves the Clinical Outcome in Severe SARS-CoV2 Infection
Fodor E, Müller V, Iványi Z, Berki T, Kuten Pella O, Hornyák I, Ambrus M, Sárkány Á, Skázel Á, Madár Á, Kardos D, Kemenesi G, Földes F, Nagy S, Matusovits A, János N, Tordai A, Jakab F, Lacza Z |
Infectious Diseases and Therapy | 2021 |
|
Aging, Immunity, and COVID-19: How Age Influences the Host Immune Response to Coronavirus Infections?
Bajaj V, Gadi N, Spihlman AP, Wu SC, Choi CH, Moulton VR |
Frontiers in physiology | 2021 |
|
SARS-CoV-2 Antibody Neutralization Assay Platforms Based on Epitopes Sources: Live Virus, Pseudovirus, and Recombinant S Glycoprotein RBD.
Septisetyani EP, Prasetyaningrum PW, Anam K, Santoso A |
Immune Network | 2021 |
|
Immunization against severe acute respiratory syndrome Coronavirus 2: an overview.
El-Masry EA |
African health sciences | 2021 |
|
Nanobased Platforms for Diagnosis and Treatment of COVID-19: From Benchtop to Bedside.
Bidram E, Esmaeili Y, Amini A, Sartorius R, Tay FR, Shariati L, Makvandi P |
ACS Biomaterials Science & Engineering | 2021 |
|
Covid 19-the 21st Century Pandemic: The Novel Coronavirus Outbreak and the Treatment Strategies.
Joseph S, Kutty Narayanan A |
Advanced pharmaceutical bulletin | 2021 |
|
Site-specific N-glycosylation Characterization of Recombinant SARS-CoV-2 Spike Proteins
Zhang Y, Zhao W, Mao Y, Chen Y, Wang S, Zhong Y, Su T, Gong M, Du D, Lu X, Cheng J, Yang H |
Molecular & cellular proteomics : MCP | 2021 |
|
Hyperimmune immunoglobulin for people with COVID‐19
Kimber C, Valk SJ, Chai KL, Piechotta V, Iannizzi C, Monsef I, Wood EM, Lamikanra AA, Roberts DJ, McQuilten Z, So-Osman C, Estcourt LJ, Skoetz N |
The Cochrane Database of Systematic Reviews | 2021 |
|
COVID-19 convalescent plasma
Tobian AA, Cohn CS, Shaz BH |
Blood | 2021 |
|
Blockade of SARS-CoV-2 spike protein-mediated cell-cell fusion using COVID-19 convalescent plasma.
Wang L, Zhao J, Nguyen LNT, Adkins JL, Schank M, Khanal S, Nguyen LN, Dang X, Cao D, Thakuri BKC, Lu Z, Zhang J, Zhang Y, Wu XY, El Gazzar M, Ning S, Moorman JP, Yao ZQ |
Scientific Reports | 2021 |
|
Generation of glucocorticoid-resistant SARS-CoV-2 T cells for adoptive cell therapy.
Basar R, Uprety N, Ensley E, Daher M, Klein K, Martinez F, Aung F, Shanley M, Hu B, Gokdemir E, Nunez Cortes AK, Mendt M, Reyes Silva F, Acharya S, Laskowski T, Muniz-Feliciano L, Banerjee PP, Li Y, Li S, Melo Garcia L, Lin P, Shaim H, Yates SG, Marin D, Kaur I, Rao S, Mak D, Lin A, Miao Q, Dou J, Chen K, Champlin RE, Shpall EJ, Rezvani K |
Cell Reports | 2021 |
|
Lines of Treatment of COVID-19 Infection
El-Goly AM |
2021 | |
|
Immunogenicity and protective efficacy of an intranasal live-attenuated vaccine against SARS-CoV-2
Park JG, Oladunni FS, Rohaim MA, Whittingham-Dowd J, Tollitt J, Hodges MD, Fathallah N, Assas MB, Alhazmi W, Almilaibary A, Iqbal M, Chang P, Escalona R, Shivanna V, Torrelles JB, Worthington JJ, Jackson-Jones LH, Martinez-Sobrido L, Munir M |
iScience | 2021 |
|
The Progress and Challenges of Convalescent Plasma Therapy for Coronavirus Disease 2019
Shi M, Zhang C, Wang FS |
2021 | |
|
Development and characterization of two equine formulations towards SARS-CoV-2 proteins for the potential treatment of COVID-19
León G, Herrera M, Vargas M, Arguedas M, Sánchez A, Segura Á, Gómez A, Solano G, Corrales-Aguilar E, Risner K, Narayanan A, Bailey C, Villalta M, Hernández A, Sánchez A, Cordero D, Solano D, Durán G, Segura E, Cerdas M, Umaña D, Moscoso E, Estrada R, Gutiérrez J, Méndez M, Castillo AC, Sánchez L, Sánchez R, Gutiérrez JM, Díaz C, Alape A |
Scientific Reports | 2021 |
|
A Multiclass, Multiproduct Covid-19 Convalescent Plasma Donor Equilibrium Model
Nagurney A, Dutta P |
2021 | |
|
The use of observational research to inform clinical practice
N Paneth, M Joyner |
Journal of Clinical Investigation | 2021 |
|
Regenerative Medicine in COVID-19 Treatment: Real Opportunities and Range of Promises.
Basiri A, Pazhouhnia Z, Beheshtizadeh N, Hoseinpour M, Saghazadeh A, Rezaei N |
Stem Cell Reviews and Reports | 2021 |
|
Convalescent Plasma for Patients With Severe Coronavirus Disease 2019 (COVID-19): A Matched Cohort Study.
Rogers R, Shehadeh F, Mylona EK, Rich J, Neill M, Touzard-Romo F, Geffert S, Larkin J, Bailey JA, Lu S, Sweeney J, Mylonakis E |
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America | 2021 |
|
COVID-19: Virology, biology and novel laboratory diagnosis.
Mohamadian M, Chiti H, Shoghli A, Biglari S, Parsamanesh N, Esmaeilzadeh A |
The Journal of Gene Medicine | 2021 |
|
Epitope-resolved profiling of the SARS-CoV-2 antibody response identifies cross-reactivity with endemic human coronaviruses.
Ladner JT, Henson SN, Boyle AS, Engelbrektson AL, Fink ZW, Rahee F, D'ambrozio J, Schaecher KE, Stone M, Dong W, Dadwal S, Yu J, Caligiuri MA, Cieplak P, Bjørås M, Fenstad MH, Nordbø SA, Kainov DE, Muranaka N, Chee MS, Shiryaev SA, Altin JA |
Cell reports. Medicine | 2021 |
|
Convalescent plasma for COVID-19 complicated by ARDS due to TRALI.
Wang KY, Shah P, Pierce M |
BMJ case reports | 2021 |
|
Trajectory of individual immunity and vaccination required for SARS-CoV-2 community immunity: a conceptual investigation.
Saad-Roy CM, Levin SA, Metcalf CJE, Grenfell BT |
Journal of The Royal Society Interface | 2021 |
|
Living in a Hostile World: Inflammation, New Drug Development, and Coronavirus.
Dobson GP, Biros E, Letson HL, Morris JL |
Frontiers in immunology | 2021 |
|
National level adjustments to the challenges of the SARS-CoV2 pandemic on blood banking operations.
Matusovits A, Nagy S, Baróti-Tóth K, Nacsa J, Lázár M, Marton I, Andrikovics H, Vokó Z, Tordai A |
Transfusion | 2021 |
|
Stem cells and COVID-19: are the human amniotic cells a new hope for therapies against the SARS-CoV-2 virus?
Riedel RN, Pérez-Pérez A, Sánchez-Margalet V, Varone CL, Maymó JL |
Stem Cell Research & Therapy | 2021 |
|
Acute transverse myelitis after SARS-CoV-2 infection: a rare complicated case of rapid onset paraplegia.
Shahali H, Ghasemi A, Farahani RH, Nezami Asl A, Hazrati E |
Journal of Neurovirology | 2021 |
|
Sporting Resilience During COVID-19: What Is the Nature of This Adversity and How Are Competitive Elite Athletes Adapting?
Gupta S, McCarthy PJ |
Frontiers in psychology | 2021 |
|
A humanized mouse model of chronic COVID-19 to evaluate disease mechanisms and treatment options.
Sefik E, Israelow B, Zhao J, Qu R, Song E, Mirza H, Kaffe E, Halene S, Meffre E, Kluger Y, Nussenzweig M, Wilen CB, Iwasaki A, Flavell RA |
Research square | 2021 |
|
Influence of obesity on serum levels of SARS-CoV-2-specific antibodies in COVID-19 patients.
Frasca D, Reidy L, Cray C, Diaz A, Romero M, Kahl K, Blomberg BB |
PloS one | 2021 |
|
In silico evaluation of potential inhibitory activity of remdesivir, favipiravir, ribavirin and galidesivir active forms on SARS-CoV-2 RNA polymerase.
Celik I, Erol M, Duzgun Z |
Molecular Diversity | 2021 |
|
State-of-the-Art of Nanodiagnostics and Nanotherapeutics against SARS-CoV-2.
Derakhshan MA, Amani A, Faridi-Majidi R |
ACS Applied Materials & Interfaces | 2021 |
|
Measures to reduce red cell use in patients with sickle cell disease requiring red cell exchange during a blood shortage.
Uter S, An HH, Linder GE, Kadauke S, Sesok-Pizzini D, Kim HC, Friedman DF, Chou ST |
Blood Advances | 2021 |
|
Inside the story about the research and development of COVID-19 vaccines.
Patel SP, Patel GS, Suthar JV |
Clinical and Experimental Vaccine Research | 2021 |
|
Understanding the immunological aspects of SARS-CoV-2 causing COVID-19 pandemic: A therapeutic approach.
Das A, Roy S, Swarnakar S, Chatterjee N |
Clinical Immunology | 2021 |
|
Approaching the Interpretation of Discordances in SARS-CoV-2 Testing.
Wontakal SN, Bortz RH 3rd, Lin WW, Gendlina I, Fox AS, Hod EA, Chandran K, Prystowsky MB, Weiss LM, Spitalnik SL |
Open Forum Infectious Diseases | 2021 |
|
Overt hematochezia : A rare gastrointestinal presentation in patients with corona virus disease 2019.
Darvishi M, Shahali H |
Medical Journal Armed Forces India | 2021 |
|
Rooibos, a supportive role to play during the COVID-19 pandemic?
Sheik Abdul N, Marnewick JL |
Journal of Functional Foods | 2021 |
|
The Rise of SARS-CoV-2 Variants and the Role of Convalescent Plasma Therapy for Management of Infections.
Moubarak M, Kasozi KI, Hetta HF, Shaheen HM, Rauf A, Al-Kuraishy HM, Qusti S, Alshammari EM, Ayikobua ET, Ssempijja F, Afodun AM, Kenganzi R, Usman IM, Ochieng JJ, Osuwat LO, Matama K, Al-Gareeb AI, Kairania E, Musenero M, Welburn SC, Batiha GE |
2021 | |
|
The hidden influence of communities in collaborative funding of clinical science.
Vasan K, West JD |
Royal Society Open Science | 2021 |
|
Why Does the Precautionary Principle Suffice for Blood Regulation?
Seifner A, Fox AW |
Pharmaceutical medicine | 2021 |
|
Guillain-Barré Syndrome Associated with SARS-CoV-2 Infection: A Case Report.
Darvishi M, Shahali H, Farahani AA |
European Journal of Translational Myology | 2021 |
|
Hypothesis: Immunotherapy by Selective Convalescent Blood Engineering to Stifle Diseases like COVID-19.
Mukherjee AP |
International journal of medical sciences | 2021 |
|
Axonal polineuropathy associated with Sars-CoV 2 infection: a case report.
Tramonti C, Vatteroni E, Iacopini F, Carli V, Iardella M |
European Journal of Translational Myology | 2021 |
|
Statin Use and COVID-19 Infectivity and Severity in South Korea: Two Population-Based Nationwide Cohort Studies.
Lee SW, Kim SY, Moon SY, Yoo IK, Yoo EG, Eom GH, Kim JM, Shin JI, Jeong MH, Yang JM, Yon DK |
2021 | |
|
Microfluidic characterisation reveals broad range of SARS-CoV-2 antibody affinity in human plasma.
Schneider MM, Emmenegger M, Xu CK, Condado Morales I, Meisl G, Turelli P, Zografou C, Zimmermann MR, Frey BM, Fiedler S, Denninger V, Jacquat RP, Madrigal L, Ilsley A, Kosmoliaptsis V, Fiegler H, Trono D, Knowles TP, Aguzzi A |
Life science alliance | 2021 |
|
Convalescent Plasma-A Light at the End of the Tunnel: A Systematic Review and Meta-analysis of Randomized Controlled Trials.
Sarkar S, Khanna P, Singh AK |
Indian journal of critical care medicine : peer-reviewed, official publication of Indian Society of Critical Care Medicine | 2021 |
|
SARS-CoV-2 at the human-animal interphase: A review.
Farag EA, Islam MM, Enan K, El-Hussein AM, Bansal D, Haroun M |
Heliyon | 2021 |
|
Development and validation of novel kit for quantification of SARS-CoV-2 antibodies on clinical samples.
Kumari S, Raina A, Chandra D, Gupta N, Dey N, Bhardwaj AK, Anthwal A, Mishra VC, Raina V, Tiwari AK, Setia R, Bhatia AS |
Journal of Virological Methods | 2021 |
|
COVID-19 and gut immunomodulation.
Roy K, Agarwal S, Banerjee R, Paul MK, Purbey PK |
World Journal of Gastroenterology | 2021 |
|
Epidemiological Characteristics of Hospitalized Patients with Moderate versus Severe COVID-19 Infection: A Retrospective Cohort Single Centre Study.
Khamis F, Al Awaidy S, Shaaibi MA, Shukeili MA, Chhetri S, Balushi AA, Sulaimi SA, Balushi AA, Wesonga R |
2021 | |
|
Assessment of automated high-throughput serological assays for prediction of high-titer SARS-CoV-2 neutralizing antibody.
Moscato G, Mazzetti P, Lucenteforte E, Rosellini A, Cara A, Quaranta P, Mainardi V, Villa P, Focosi D, Lanza M, Bianco I, Mazzoni A, Falcone M, Menichetti F, Maggi F, Lai M, Freer G, Pistello M |
2021 | |
|
Nanomaterial-based drug delivery systems as promising carriers for patients with COVID-19.
Abd Elkodous M, Olojede SO, Morsi M, El-Sayyad GS |
RSC Advances | 2021 |
|
IgA and FcαRI: Versatile Players in Homeostasis, Infection, and Autoimmunity.
van Gool MMJ, van Egmond M |
ImmunoTargets and Therapy | 2021 |
|
Five Commercial Immunoassays for SARS-CoV-2 Antibody Determination and Their Comparison and Correlation with the Virus Neutralization Test.
Šimánek V, Pecen L, Krátká Z, Fürst T, Řezáčková H, Topolčan O, Fajfrlík K, Sedláček D, Šín R, Pazdiora P, Zelená H, Slouka D, Kučera R |
2021 | |
|
Clinical Efficacy of Hydroxychloroquine in Patients with COVID-19: Findings from an Observational Comparative Study in Saudi Arabia.
Alghamdi S, Barakat B, Berrou I, Alzahrani A, Haseeb A, Hammad MA, Anwar S, Sindi AAA, Almasmoum HA, Albanghali M |
2021 | |
|
Timing of convalescent plasma therapy-tips from curing a 100-year-old COVID-19 patient using convalescent plasma treatment: A case report.
Liu B, Ren KK, Wang N, Xu XP, Wu J |
World journal of clinical cases | 2021 |
|
Immune-Based Therapy for COVID-19.
Esmaeilzadeh A, Jafari D, Tahmasebi S, Elahi R, Khosh E |
Advances in experimental medicine and biology | 2021 |
|
Immunoglobulin Y for Potential Diagnostic and Therapeutic Applications in Infectious Diseases.
Lee L, Samardzic K, Wallach M, Frumkin LR, Mochly-Rosen D |
Frontiers in immunology | 2021 |
|
Beyond Vaccines: Clinical Status of Prospective COVID-19 Therapeutics.
Kumar S, Çalışkan DM, Janowski J, Faist A, Conrad BCG, Lange J, Ludwig S, Brunotte L |
Frontiers in immunology | 2021 |
|
Convalescent plasma treatment for patients of 80 years and older with COVID-19 pneumonia.
Romon I, Dominguez-Garcia JJ, Arroyo JL, Suberviola B, Cabezón I, Abascal B, Baldeón C, Cuesta A, Portilla R, Casuso E, Ocio E, Briz M |
BMC geriatrics | 2021 |
|
Effects of COVID-19 Home Confinement on Behavior, Perception of Threat, Stress and Training Patterns of Olympic and Paralympic Athletes.
Martínez-Patiño MJ, Blas Lopez FJ, Dubois M, Vilain E, Fuentes-García JP |
International journal of environmental research and public health | 2021 |
|
Molecular and Clinical Aspects of COVID-19 Vaccines and Other Therapeutic Interventions Apropos Emerging Variants of Concern.
Islam KU, A-Elgadir TME, Afaq S, Ahmad T, Iqbal J |
Frontiers in pharmacology | 2021 |
|
Critically Ill COVID-19 Patients Exhibit Anti-SARS-CoV-2 Serological Responses.
Fraser DD, Cepinskas G, Slessarev M, Martin CM, Daley M, Patel MA, Miller MR, Patterson EK, O'Gorman DB, Gill SE, Higgins I, John JPP, Melo C, Nini L, Wang X, Zeidler J, Cruz-Aguado JA |
2021 | |
|
Risks and Benefits of Kidney Transplantation during the COVID-19 Pandemic: Transplant or Not Transplant?
Ajaimy M, Liriano-Ward L, Graham JA, Akalin E |
2021 | |
|
Structural insights into the cross-neutralization of SARS-CoV and SARS-CoV-2 by the human monoclonal antibody 47D11.
Fedry J, Hurdiss DL, Wang C, Li W, Obal G, Drulyte I, Du W, Howes SC, van Kuppeveld FJM, Förster F, Bosch BJ |
Science Advances | 2021 |
|
Features of Pathobiology and Clinical Translation of Approved Treatments for Coronavirus Disease 2019.
Fallah A, Razavi Nikoo H, Abbasi H, Mohammad-Hasani A, Hosseinzadeh Colagar A, Khosravi A |
Intervirology | 2021 |
|
How should we use convalescent plasma therapies for the management of COVID-19?
Wood EM, Estcourt LJ, McQuilten ZK |
Blood | 2021 |
|
A humanized mouse model of chronic COVID-19.
Sefik E, Israelow B, Mirza H, Zhao J, Qu R, Kaffe E, Song E, Halene S, Meffre E, Kluger Y, Nussenzweig M, Wilen CB, Iwasaki A, Flavell RA |
Nature Biotechnology | 2021 |
|
The majority of SARS-CoV-2-specific antibodies in COVID-19 patients with obesity are autoimmune and not neutralizing.
Frasca D, Reidy L, Romero M, Diaz A, Cray C, Kahl K, Blomberg BB |
International Journal of Obesity | 2021 |
|
Efficacy of convalescent plasma therapy in severe COVID-19 patients.
Akay Cizmecioglu H, Goktepe MH, Demircioglu S, Tekinalp A, Cizmecioglu A, Tuna AK, Ozer H |
Transfusion and apheresis science : official journal of the World Apheresis Association : official journal of the European Society for Haemapheresis | 2021 |
|
Mapping the SARS-CoV-2 spike glycoprotein-derived peptidome presented by HLA class II on dendritic cells.
Parker R, Partridge T, Wormald C, Kawahara R, Stalls V, Aggelakopoulou M, Parker J, Powell Doherty R, Ariosa Morejon Y, Lee E, Saunders K, Haynes BF, Acharya P, Thaysen-Andersen M, Borrow P, Ternette N |
Cell Reports | 2021 |
|
Evaluation of convalescent plasma versus standard of care for the treatment of COVID-19 in hospitalized patients: study protocol for a phase 2 randomized, open-label, controlled, multicenter trial.
Diago-Sempere E, Bueno JL, Sancho-López A, Rubio EM, Torres F, de Molina RM, Fernández-Cruz A, de Diego IS, Velasco-Iglesias A, Payares-Herrera C, Flecha IC, Avendaño-Solà C, Palomino RD, Ramos-Martínez A, Ruiz-Antorán B |
Trials | 2021 |
|
No SARS-CoV-2 RNA detected in the convalescent plasma of COVID-19 patients with different disease severity.
Nomoto H, Kutsuna S, Okuma K, Kuramitsu M, Tezuka K, Ikebe E, Saito S, Kinoshita N, Terada M, Endo M, Suzuki T, Miyazato Y, Nakamoto T, Inada M, Hamaguchi I, Ohmagari N |
Journal of Infection and Chemotherapy | 2021 |
|
COVID-19 Antibody Tests and Their Limitations.
Liu G, Rusling JF |
ACS Sensors | 2021 |
|
Multiplex quantitative detection of SARS-CoV-2 specific IgG and IgM antibodies based on DNA-assisted nanopore sensing.
Zhang Z, Wang X, Wei X, Zheng SW, Lenhart BJ, Xu P, Li J, Pan J, Albrecht H, Liu C |
Biosensors & bioelectronics | 2021 |
|
Convalescent Blood: Current Perspective on the Efficacy of a Legacy Approach in COVID-19 Treatment.
Sheervalilou R, Shirvaliloo M, Sargazi S, Bahari S, Saravani R, Shahraki J, Shirvalilou S, Shahraki O, Nazarlou Z, Shams Z, Ghaznavi H |
Blood Purification | 2021 |
|
What convalescent plasma in treating severe acute respiratory infections of viral aetiology can hint for COVID-19? Evidence from a meta-analysis.
Zeng J, Yin S, Du X, Song T, Lin T |
2021 | |
|
Plasma exchange followed by convalescent plasma transfusion in COVID-19 patients.
Roshandel E, Sankanian G, Salimi M, Jalili A, Salari S, Sadeghi A, Hashemian SM, Moshari MR, Pirsalehi A, Hajifathali A |
Transfusion and apheresis science : official journal of the World Apheresis Association : official journal of the European Society for Haemapheresis | 2021 |
|
Convalescent plasma for COVID-19 in the intensive care unit.
Rollas K, Emgin Ö, Çalışkan T, K Güldoğan I, Zincircioğlu Ç, Ersan G, Sahar İ, Sarıtaş A, Uzun U, Senoğlu N |
2021 | |
|
Luciferase-Based Biosensors in the Era of the COVID-19 Pandemic.
Azad T, Janse van Rensburg HJ, Morgan J, Rezaei R, Crupi MJF, Chen R, Ghahremani M, Jamalkhah M, Forbes N, Ilkow C, Bell JC |
2021 | |
|
Functional Antibodies in COVID-19 Convalescent Plasma.
Herman JD, Wang C, Loos C, Yoon H, Rivera J, Dieterle ME, Haslwanter D, Jangra RK, Bortz RH 3rd, Bar KJ, Julg B, Chandran K, Lauffenburger D, Pirofski LA, Alter G |
medRxiv : the preprint server for health sciences | 2021 |
|
Early post-infection treatment of SARS-CoV-2 infected macaques with human convalescent plasma with high neutralizing activity reduces lung inflammation.
Van Rompay KKA, Olstad KJ, Sammak RL, Dutra J, Watanabe JK, Usachenko JL, Immareddy R, Roh JW, Verma A, Shaan Lakshmanappa Y, Schmidt BA, Di Germanio C, Rizvi N, Stone M, Simmons G, Dumont LJ, Allen AM, Lockwood S, Pollard RE, de Assis RR, Yee JL, Nham PB, Ardeshir A, Deere JD, Patterson J, Jain A, Felgner PL, Iyer SS, Hartigan-O'Connor DJ, Busch MP, Reader JR |
bioRxiv : the preprint server for biology | 2021 |
|
Management of Coronavirus Disease 2019 (COVID-19) Pneumonia
Thirkell P, Griffiths M, Waller MD |
Encyclopedia of Respiratory Medicine | 2021 |
|
Design and validation of a scale to measure worry for contagion of the COVID-19 (PRE-COVID-19)
Caycho-Rodríguez T, Ventura-León J, Barboza-Palomino M |
2021 | |
|
Intractable airsickness associated with COVID-19: A case report
Talebi Bezmin Abadi H, Abadi AT, Farahani AA, Darvishi M |
2021 | |
|
SARS-CoV-2 viral load and antibody responses: the case for convalescent plasma therapy
Arturo Casadevall, Michael J. Joyner, Liise-anne Pirofski |
Journal of Clinical Investigation | 2020 |
|
Early Safety Indicators of COVID-19 Convalescent Plasma in 5,000 Patients
Michael J. Joyner, R. Scott Wright, DeLisa Fairweather, Jonathon W. Senefeld, Katelyn A. Bruno, Stephen A. Klassen, Rickey E. Carter, Allan M. Klompas, Chad C. Wiggins, John R.A. Shepherd, Robert F. Rea, Emily R. Whelan, Andrew J. Clayburn, Matthew R. Spiegel, Patrick W. Johnson, Elizabeth R. Lesser, Sarah E. Baker, Kathryn F. Larson, Juan G. Ripoll, Kylie J. Andersen, David O. Hodge, Katie L. Kunze, Matthew R. Buras, Matthew N.P. Vogt, Vitaly Herasevich, Joshua J. Dennis, Riley J. Regimbal, Philippe R. Bauer, Janis E. Blair, Camille M. van Buskirk, Jeffrey L. Winters, James R. Stubbs, Nigel S. Paneth, Nicole C. Verdun, Peter Marks, Arturo Casadevall |
Journal of Clinical Investigation | 2020 |
|
Sex, age, and hospitalization drive antibody responses in a COVID-19 convalescent plasma donor population
Sabra L. Klein, Andrew Pekosz, Han-Sol Park, Rebecca L. Ursin, Janna R. Shapiro, Sarah E. Benner, Kirsten Littlefield, Swetha Kumar, Harnish Mukesh Naik, Michael Betenbaugh, Ruchee Shrestha, Annie A. Wu, Robert M. Hughes, Imani Burgess, Patrizio Caturegli, Oliver Laeyendecker, Thomas C. Quinn, David J. Sullivan, Shmuel Shoham, Andrew D. Redd, Evan M. Bloch, Arturo Casadevall, Aaron A. R. Tobian |
Journal of Clinical Investigation | 2020 |
|
Deployment of convalescent plasma for the prevention and treatment of COVID-19
Evan M. Bloch, Shmuel Shoham, Arturo Casadevall, Bruce S. Sachais, Beth Shaz, Jeffrey L. Winters, Camille van Buskirk, Brenda J. Grossman, Michael J. Joyner, Jeffrey P. Henderson, Andrew Pekosz, Bryan Lau, Amy Wesolowski, Louis Katz, Hua Shan, Paul G. Auwaerter, David Thomas, David J. Sullivan, Nigel Paneth, Eric A Gehrie, Steven L. Spitalnik, Eldad Hod, Lewis Pollack, Wayne T. Nicholson, Liise-anne Pirofski, Jeffrey A. Bailey, Aaron A.R. Tobian |
Journal of Clinical Investigation | 2020 |
|
Quantum leap of monoclonal antibody (mAb) discovery and development in the COVID-19 era
S Pecetta, O Finco, A Seubert |
Seminars in Immunology | 2020 |
|
Obesity and COVID-19: A Fatal Alliance
M Banerjee, S Gupta, P Sharma, J Shekhawat, K Gauba |
Indian Journal of Clinical Biochemistry | 2020 |
|
Current pharmacological treatments for COVID‐19: What's next?
C Scavone, S Brusco, M Bertini, L Sportiello, C Rafaniello, A Zoccoli, L Berrino, G Racagni, F Rossi, A Capuano |
British Journal of Pharmacology | 2020 |
|
Pharmaco-Immunomodulatory Therapy in COVID-19
JG Rizk, K Kalantar-Zadeh, MR Mehra, CJ Lavie, Y Rizk, DN Forthal |
Drugs | 2020 |
|
COVID-19 and the Heart
A Akhmerov, E Marbán |
Circulation research | 2020 |
|
Immunology of COVID‐19: Mechanisms, clinical outcome, diagnostics, and perspectives—A report of the European Academy of Allergy and Clinical Immunology (EAACI)
M Sokolowska, ZM Lukasik, I Agache, CA Akdis, D Akdis, M Akdis, W Barcik, HA Brough, T Eiwegger, A Eljaszewicz, S Eyerich, W Feleszko, C GomezCasado, K HoffmannSommergruber, J Janda, R JiménezSaiz, M Jutel, EF Knol, IK Krohn, A Kothari, J Makowska, M Moniuszko, H Morita, L O'Mahony, K Nadeau, C Ozdemir, I PaliSchöll, O Palomares, F Papaleo, M Prunicki, CB SchmidtWeber, A Sediva, J Schwarze, MH Shamji, GA TramperStranders, W Veen, E Untersmayr |
Allergy | 2020 |
|
Inflammatory Type 2 cDCs Acquire Features of cDC1s and Macrophages to Orchestrate Immunity to Respiratory Virus Infection
C Bosteels, K Neyt, M Vanheerswynghels, MJ van Helden, D Sichien, N Debeuf, SD Prijck, V Bosteels, N Vandamme, L Martens, Y Saeys, E Louagie, M Lesage, DL Williams, SC Tang, JU Mayer, F Ronchese, CL Scott, H Hammad, M Guilliams, BN Lambrecht |
Immunity | 2020 |
|
Understanding the complexities of SARS-CoV2 infection and its immunology: A road to immune-based therapeutics
V Kumar |
International Immunopharmacology | 2020 |
|
Antibody-dependent enhancement and SARS-CoV-2 vaccines and therapies
WS Lee, AK Wheatley, SJ Kent, BJ DeKosky |
Nature Microbiology | 2020 |
|
Emerging Prevention and Treatment Strategies to Control COVID-19
VK Singh, A Mishra, S Singh, P Kumar, M Singh, C Jagannath, A Khan |
Pathogens | 2020 |
|
Special considerations in the management of adult patients with acute leukaemias and myeloid neoplasms in the COVID-19 era: recommendations from a panel of international experts
AM Zeidan, PC Boddu, MM Patnaik, JP Bewersdorf, M Stahl, RK Rampal, R Shallis, DP Steensma, MR Savona, MA Sekeres, GJ Roboz, DJ DeAngelo, AC Schuh, E Padron, JF Zeidner, RB Walter, F Onida, A Fathi, A DeZern, G Hobbs, EM Stein, P Vyas, AH Wei, DT Bowen, P Montesinos, EA Griffiths, AK Verma, A Keyzner, M Bar-Natan, SC Navada, M Kremyanskaya, AD Goldberg, A Al-Kali, ML Heaney, A Nazha, H Salman, S Luger, KW Pratz, H Konig, R Komrokji, M Deininger, BX Cirici, VR Bhatt, LR Silverman, HP Erba, P Fenaux, U Platzbecker, V Santini, ES Wang, MS Tallman, RM Stone, J Mascarenhas |
The Lancet Haematology | 2020 |
|
Promise and challenges in the development of COVID-19 vaccines
W Chen |
Human Vaccines & Immunotherapeutics | 2020 |
|
Serodiagnostics for Severe Acute Respiratory Syndrome–Related Coronavirus 2: A Narrative Review
MP Cheng, CP Yansouni, NE Basta, M Desjardins, S Kanjilal, K Paquette, C Caya, M Semret, C Quach, M Libman, L Mazzola, JA Sacks, S Dittrich, J Papenburg |
Annals of internal medicine | 2020 |
|
Anti-SARS-CoV-2 hyperimmune plasma workflow
P Annamaria, Q Eugenia, S Paolo |
Transfusion and apheresis science : official journal of the World Apheresis Association : official journal of the European Society for Haemapheresis | 2020 |
|
COVID-19: Immunology and treatment options
S Felsenstein, JA Herbert, PS McNamara, CM Hedrich |
Clinical Immunology | 2020 |
|
COVID‐19 and immunological regulations – from basic and translational aspects to clinical implications
MP Schön, C Berking, T Biedermann, T Buhl, L Erpenbeck, K Eyerich, S Eyerich, K Ghoreschi, M Goebeler, RJ Ludwig, K Schäkel, B Schilling, C Schlapbach, G Stary, E Stebut, K Steinbrink |
Journal der Deutschen Dermatologischen Gesellschaft | 2020 |
|
COVID‐19 und Immunregulation – von grundlegenden und translationalen Aspekten zu klinischen Implikationen
MP Schön, C Berking, T Biedermann, T Buhl, L Erpenbeck, K Eyerich, S Eyerich, K Ghoreschi, M Goebeler, RJ Ludwig, K Schäkel, B Schilling, C Schlapbach, G Stary, E Stebut, K Steinbrink |
Journal der Deutschen Dermatologischen Gesellschaft | 2020 |
|
Clinical predictors of donor antibody titre and correlation with recipient antibody response in a COVID‐19 convalescent plasma clinical trial
ML Madariaga, JJ Guthmiller, S Schrantz, MO Jansen, C Christensen, M Kumar, M Prochaska, G Wool, A DurkinCelauro, WH Oh, L Trockman, J Vigneswaran, R Keskey, DG Shaw, H Dugan, NY Zheng, M Cobb, H Utset, J Wang, O Stovicek, C Bethel, S Matushek, M Giurcanu, KG Beavis, D Sabato, D Meltzer, MK Ferguson, JP Kress, K Shanmugarajah, JB Matthews, JF Fung, PC Wilson, JC Alverdy, JS Donington |
Journal of Internal Medicine | 2020 |
|
SARS-CoV-2 Inflammatory Syndrome. Clinical Features and Rationale for Immunological Treatment
M Prete, E Favoino, G Catacchio, V Racanelli, F Perosa |
International journal of molecular sciences | 2020 |
|
Immunological aspects of COVID-19: What do we know?
TV Velikova, SV Kotsev, DS Georgiev, HM Batselova |
World journal of biological chemistry | 2020 |
|
Road Map to Understanding SARS-CoV-2 Clinico-Immunopathology and COVID-19 Disease Severity
D Karmakar, B Lahiri, P Ranjan, J Chatterjee, P Lahiri, S Sengupta |
Pathogens | 2020 |
|
Overview of Immune Response During SARS-CoV-2 Infection: Lessons From the Past
VK Shah, P Firmal, A Alam, D Ganguly, S Chattopadhyay |
Frontiers in immunology | 2020 |
|
COVID-19 in otolaryngologist practice: a review of current knowledge
J Krajewska, W Krajewski, K Zub, T Zatoński |
European Archives of Oto-Rhino-Laryngology | 2020 |
|
Surviving Sepsis Campaign: guidelines on the management of critically ill adults with Coronavirus Disease 2019 (COVID-19)
W Alhazzani, M Møller, Y Arabi, M Loeb, M Gong, E Fan, S Oczkowski, M Levy, L Derde, A Dzierba, B Du, M Aboodi, H Wunsch, M Cecconi, Y Koh, D Chertow, K Maitland, F Alshamsi, E Belley-Cote, M Greco, M Laundy, J Morgan, J Kesecioglu, A McGeer, L Mermel, M Mammen, P Alexander, A Arrington, J Centofanti, G Citerio, B Baw, Z Memish, N Hammond, F Hayden, L Evans, A Rhodes |
Intensive Care Medicine | 2020 |
|
Convalescent plasma in Covid-19: Possible mechanisms of action
M Rojas, Y Rodríguez, DM Monsalve, Y Acosta-Ampudia, B Camacho, JE Gallo, A Rojas-Villarraga, C Ramírez-Santana, JC Díaz-Coronado, R Manrique, RD Mantilla, Y Shoenfeld, JM Anaya |
Autoimmunity Reviews | 2020 |
|
Convalescent Plasma Therapy for Management of COVID-19: Perspectives and Deployment in the Current Global Pandemic N Samad, TE Sodunke, HA Banna, A Sapkota, AN Fatema, K Iskandar, D Jahan, TC Hardcastle, T Nusrat, TS Chowdhury, M Haque |
Risk Management and Healthcare Policy | 2020 |
|
Potential Anti-COVID-19 Therapeutics that Block the Early Stage of the Viral Life Cycle: Structures, Mechanisms, and Clinical Trials
RA Al-Horani, S Kar, KF Aliter |
International journal of molecular sciences | 2020 |
|
Safety Update
MJ Joyner, KA Bruno, SA Klassen, KL Kunze, PW Johnson, ER Lesser, CC Wiggins, JW Senefeld, AM Klompas, DO Hodge, JR Shepherd, RF Rea, ER Whelan, AJ Clayburn, MR Spiegel, SE Baker, KF Larson, JG Ripoll, KJ Andersen, MR Buras, MN Vogt, V Herasevich, JJ Dennis, RJ Regimbal, PR Bauer, JE Blair, CM van Buskirk, JL Winters, JR Stubbs, N van Helmond, BP Butterfield, MA Sexton, JC Soto, NS Paneth, NC Verdun, P Marks, A Casadevall, DL Fairweather, RE Carter, RS Wright |
Mayo Clinic Proceedings | 2020 |
|
Pathogenesis of COVID-19 from the Perspective of the Damage-Response Framework
L Pirofski, A Casadevall, TE Morrison, DA Garsin |
mBio | 2020 |
|
Palestinian strategies, guidelines, and challenges in the treatment and management of coronavirus disease-2019 (COVID-19)
HA Hejaz |
Avicenna Journal of Medicine | 2020 |
|
Mortality reduction in 46 severe Covid-19 patients treated with hyperimmune plasma. A proof of concept single arm multicenter trial
C Perotti, F Baldanti, R Bruno, CD Fante, E Seminari, S Casari, E Percivalle, C Glingani, V Musella, M Belliato, M Garuti, F Meloni, M Frigato, AD Sabatino, C Klersy, GD Donno, M Franchini, C plasma task force |
Haematologica | 2020 |
|
A review of covid 19 in Tamilnadu with regression and correlation co-efficient
S Arunkumar, G Sriram, C Gnanadesikan |
2020 | |
|
Recruitment Strategy for Potential COVID-19 Convalescent Plasma Donors
KJ Andersen, SA Klassen, KF Larson, JG Ripoll, JW Senefeld, AJ Clayburn, JR Shepherd, AS Tseng, CC Wiggins, BM Murphy, SK Ford, CP Johnson, AD Miller, SE Baker, RS Wright, JL Winters, JR Stubbs, MJ Joyner, CM van Buskirk |
Mayo Clinic Proceedings | 2020 |
|
Low serum neutralizing anti-SARS-CoV-2 S antibody levels in mildly affected COVID-19 convalescent patients revealed by two different detection methods
B Bošnjak, SC Stein, S Willenzon, AK Cordes, W Puppe, G Bernhardt, I Ravens, C Ritter, CR Schultze-Florey, N Gödecke, J Martens, H Kleine-Weber, M Hoffmann, A Cossmann, M Yilmaz, I Pink, MM Hoeper, GM Behrens, S Pöhlmann, R Blasczyk, TF Schulz, R Förster |
Cellular and Molecular Immunology | 2020 |
|
Emerging treatment strategies for COVID-19 infection
M Gavriatopoulou, I Ntanasis-Stathopoulos, E Korompoki, D Fotiou, M Migkou, IG Tzanninis, T Psaltopoulou, E Kastritis, E Terpos, MA Dimopoulos |
Clinical and Experimental Medicine | 2020 |
|
Antibody Binding to SARS-CoV-2 S Glycoprotein Correlates with but Does Not Predict Neutralization
S Ding, A Laumaea, M Benlarbi, G Beaudoin-Bussières, R Gasser, H Medjahed, M Pancera, L Stamatatos, A McGuire, R Bazin, A Finzi |
Viruses | 2020 |
|
The dynamic treatment of SARS-CoV-2 disease
U Sandkovsky, P Colley, T Sam, AM Modrykamien, M Berhe |
Proceedings (Baylor University. Medical Center) | 2020 |
|
A single center cohort of 40 severe COVID-19 patients who were treated with convalescent plasma
A GEMİCİ, H BİLGEN, C ERDOĞAN, A KANSU, O OLMUŞÇELİK, HS BEKÖZ, R DİNLEYİCİ, A MERT, ÖG SEVİNDİK |
2020 | |
|
Decline of Humoral Responses against SARS-CoV-2 Spike in Convalescent Individuals
G Beaudoin-Bussières, A Laumaea, SP Anand, J Prévost, R Gasser, G Goyette, H Medjahed, J Perreault, T Tremblay, A Lewin, L Gokool, C Morrisseau, P Bégin, C Tremblay, V Martel-Laferrière, DE Kaufmann, J Richard, R Bazin, A Finzi, DD Ho, SP Goff |
mBio | 2020 |
|
Rapid and quantitative detection of SARS-CoV-2 specific IgG for convalescent serum evaluation
X Tan, M Krel, E Dolgov, S Park, X Li, W Wu, YL Sun, J Zhang, MK Oo, DS Perlin, X Fan |
Biosensors & bioelectronics | 2020 |
|
Positive aspects, negative aspects and limitations of plasma therapy with special reference to COVID-19
B Nagoba, A Gavkare, N Jamadar, S Mumbre, S Selkar |
Journal of Infection and Public Health | 2020 |
|
Convalescent plasma therapy: a promising coronavirus disease 2019 treatment strategy
R Piyush, K Rajarshi, R Khan, S Ray |
Open Biology | 2020 |
|
Persistence of SARS‐CoV ‐2 nasopharyngeal swab PCR positivity in COVID ‐19 convalescent plasma donors
S Ikegami, R Benirschke, T Flanagan, N Tanna, T Klein, R Elue, P Debosz, J Mallek, G Wright, P Guariglia, J Kang, TJ Gniadek |
Transfusion | 2020 |
|
Treatment of COVID-19 with convalescent plasma: lessons from past coronavirus outbreaks
DJ Wooding, H Bach |
Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases | 2020 |
|
Convalescent serum therapy for COVID-19: A 19th century remedy for a 21st century disease
D Montelongo-Jauregui, T Vila, AS Sultan, MA Jabra-Rizk, RE Dutch |
PLoS pathogens | 2020 |
|
Natural history of COVID-19 and current knowledge on treatment therapeutic options
WG dos Santos |
Biomedicine & pharmacotherapy = Biomédecine & pharmacothérapie | 2020 |
|
A Perspective on Emerging Therapeutic Interventions for COVID-19
MT Islam, Nasiruddin, IN Khan, SK Mishra, KE, TA Riaz, ES Ali, MS Rahman, MS Mubarak, M Martorell, WC Cho, D Calina, AO Docea, J Sharifi-Rad |
Frontiers in public health | 2020 |
|
Clinical efficacy of convalescent plasma for treatment of COVID-19 infections: Results of a multicenter clinical study
H Abolghasemi, P Eshghi, AM Cheraghali, AA Fooladi, FB Moghaddam, S Imanizadeh, MM Maleki, M Ranjkesh, M Rezapour, A Bahramifar, B Einollahi, MJ Hosseini, NJ Jafari, M Nikpouraghdam, N Sadri, M Tazik, S Sali, S Okati, E Askari, P Tabarsi, J Aslani, E Sharifipour, MH Jarahzadeh, N Khodakarim, M Salesi, R Jafari, S Shahverdi |
Transfusion and apheresis science : official journal of the World Apheresis Association : official journal of the European Society for Haemapheresis | 2020 |
|
Convalescent plasma or hyperimmune immunoglobulin for people with COVID-19: a living systematic review
V Piechotta, KL Chai, SJ Valk, C Doree, I Monsef, EM Wood, A Lamikanra, C Kimber, Z McQuilten, C So-Osman, LJ Estcourt, N Skoetz |
Cochrane Database of Systematic Reviews | 2020 |
|
The Emerging Role of Convalescent Plasma in the Treatment of COVID-19
T Psaltopoulou, TN Sergentanis, V Pappa, M Politou, E Terpos, S Tsiodras, GN Pavlakis, MA Dimopoulos |
HemaSphere | 2020 |
|
SARS-CoV-2: Repurposed Drugs and Novel Therapeutic Approaches—Insights into Chemical Structure—Biological Activity and Toxicological Screening
CA Dehelean, V Lazureanu, D Coricovac, M Mioc, R Oancea, I Marcovici, I Pinzaru, C Soica, AM Tsatsakis, O Cretu |
Journal of Clinical Medicine | 2020 |
|
Improved clinical symptoms and mortality among patients with severe or critical COVID-19 after convalescent plasma transfusion
X Xia, K Li, L Wu, Z Wang, M Zhu, B Huang, J Li, Z Wang, W Wu, M Wu, W Li, L Li, Y Cai, B Bosco, A Zhong, X Liu, T Lv, Z Gan, G Chen, Y Pan, C Liu, K Zhang, X Xu, C Wang, Q Wang |
Blood | 2020 |
|
Clinical use of Convalescent Plasma in the COVID‐19 pandemic: a transfusion‐focussed gap analysis with recommendations for future research priorities
AZ AlRiyami, R Schäfer, K Berg, EM Bloch, LJ Estcourt, R Goel, S Hindawi, CD Josephson, K Land, ZK McQuilten, SL Spitalnik, EM Wood, DV Devine, C SoOsman |
Vox Sanguinis | 2020 |
|
COVID ‐19 convalescent plasma donor recruitment: beware the Faustian bargains
TJ Gniadek, D Donnersberger |
Transfusion | 2020 |
|
Convalescent plasma or hyperimmune immunoglobulin for people with COVID-19: a rapid review
SJ Valk, V Piechotta, KL Chai, C Doree, I Monsef, EM Wood, A Lamikanra, C Kimber, Z McQuilten, C So-Osman, LJ Estcourt, N Skoetz |
Cochrane Database of Systematic Reviews | 2020 |
|
Convalescent Plasma: Therapeutic Hope or Hopeless Strategy in the SARS-CoV-2 Pandemic
HC Sullivan, JD Roback |
Transfusion Medicine Reviews | 2020 |
|
The Role of Antibody Testing for SARS-CoV-2: Is There One?
ES Theel, P Slev, S Wheeler, MR Couturier, SJ Wong, K Kadkhoda, AJ McAdam |
Journal of clinical microbiology | 2020 |
|
The Assessment of Convalescent Plasma Efficacy against COVID-19
A Casadevall, BJ Grossman, JP Henderson, MJ Joyner, S Shoham, L Pirofski, N Paneth |
The American Journal of Medicine | 2020 |
|
COVID-19 Therapeutic Options Under Investigation
M Kaddoura, M AlIbrahim, G Hijazi, N Soudani, A Audi, H Alkalamouni, S Haddad, A Eid, H Zaraket |
Frontiers in pharmacology | 2020 |
|
Convalescent Plasma Therapy for COVID-19: State of the Art
D Focosi, AO Anderson, JW Tang, M Tuccori |
Clinical microbiology reviews | 2020 |
|
Convalescent Plasma Therapy for Coronavirus Disease 2019
JY Choi |
Infection & Chemotherapy | 2020 |
|
Screening for SARS‐CoV ‐2 antibodies in convalescent plasma in Brazil: Preliminary lessons from a voluntary convalescent donor program
S Wendel, JM Kutner, R Machado, R FontãoWendel, C Bub, R Fachini, A Yokoyama, G Candelaria, A Sakashita, R Achkar, N Hamerschlak, P Scuracchio, M Amaral, MD Ben, D Araujo, C Soares, A Camargo, E Kallás, E Durigon, LF Reis, LV Rizzo |
Transfusion | 2020 |
|
Convalescent plasma as a treatment modality for coronavirus disease 2019 in Sudan
MO Hassan, AA Osman, HE Elbasit, HE Hassan, H Rufai, MM Satti, M Elnegoumi, R Idris, A Musa, AH Ali, SA Zroog, AD Altayb, A Khairy, M Allam, AT Abdelhalim |
Transfusion and apheresis science : official journal of the World Apheresis Association : official journal of the European Society for Haemapheresis | 2020 |
|
Treatment of Coronavirus Disease 2019 Patients with Convalescent Plasma Reveals a Signal of Significantly Decreased Mortality
E Salazar, PA Christensen, EA Graviss, DT Nguyen, B Castillo, J Chen, BV Lopez, TN Eagar, X Yi, P Zhao, J Rogers, A Shehabeldin, D Joseph, C Leveque, RJ Olsen, DW Bernard, J Gollihar, JM Musser |
The American Journal of Pathology | 2020 |
|
Hospitalized COVID-19 Patients Treated With Convalescent Plasma in a Mid-size City in The Mid West
William R Hartman, Aaron S Hess, Joseph P Connor |
Research square | 2020 |
|
Hospitalized COVID-19 Patients treated with Convalescent Plasma in a Mid-size City in the Midwest
William R Hartman, Aaron S Hess, Joseph P Connor |
Research square | 2020 |
|
Passive immunotherapy with convalescent plasma against COVID-19? What about the evidence base and clinical trials?
O Garraud |
Transfusion and apheresis science : official journal of the World Apheresis Association : official journal of the European Society for Haemapheresis | 2020 |
|
Immunity, endothelial injury and complement-induced coagulopathy in COVID-19
L Perico, A Benigni, F Casiraghi, LF Ng, L Renia, G Remuzzi |
Nature Reviews Nephrology | 2020 |
|
Virus‐Free and Live‐Cell Visualizing SARS‐CoV‐2 Cell Entry for Studies of Neutralizing Antibodies and Compound Inhibitors
Y Zhang, S Wang, Y Wu, W Hou, L Yuan, C Shen, J Wang, J Ye, Q Zheng, J Ma, J Xu, M Wei, Z Li, S Nian, H Xiong, L Zhang, Y Shi, B Fu, J Cao, C Yang, Z Li, T Yang, L Liu, H Yu, J Hu, S Ge, Y Chen, T Zhang, J Zhang, T Cheng, Q Yuan, N Xia |
Small Methods | 2020 |
|
Can data from paediatric cohorts solve the COVID-19 puzzle?
Do LAH, Anderson J, Mulholland EK, Licciardi PV |
PLoS pathogens | 2020 |
|
Antibody-Based Immunotherapeutic Strategies for COVID-19.
Hussen J, Kandeel M, Hemida MG, Al-Mubarak AIA |
2020 | |
|
Defining the features and duration of antibody responses to SARS-CoV-2 infection associated with disease severity and outcome
Röltgen K, Powell AE, Wirz OF, Stevens BA, Hogan CA, Najeeb J, Hunter M, Wang H, Sahoo MK, Huang C, Yamamoto F, Manohar M, Manalac J, Otrelo-Cardoso AR, Pham TD, Rustagi A, Rogers AJ, Shah NH, Blish CA, Cochran JR, Jardetzky TS, Zehnder JL, Wang TT, Narasimhan B, Gombar S, Tibshirani R, Nadeau KC, Kim PS, Pinsky BA, Boyd SD |
Science Immunology | 2020 |
|
Antibody seroconversion in asymptomatic and symptomatic patients infected with severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2)
Jiang C, Wang Y, Hu M, Wen L, Wen C, Wang Y, Zhu W, Tai S, Jiang Z, Xiao K, Faria NR, De Clercq E, Xu J, Li G |
IBMS BoneKEy | 2020 |
|
Nanoparticles‐assisted delivery of antiviral‐siRNA as inhalable treatment for human respiratory viruses: A candidate approach against SARS‐COV‐2
Ullah A, Qazi J, Rahman L, Kanaras AG, Khan WS, Hussain I, Rehman A |
2020 | |
|
Cancer and COVID-19: Unmasking their ties.
Addeo A, Friedlaender A |
Cancer Treatment Reviews | 2020 |
|
Immune Response, Inflammation, and the Clinical Spectrum of COVID-19.
García LF |
Frontiers in immunology | 2020 |
|
COVID-19: The Immune Responses and Clinical Therapy Candidates.
Zhand S, Saghaeian Jazi M, Mohammadi S, Tarighati Rasekhi R, Rostamian G, Kalani MR, Rostamian A, George J, Douglas MW |
International journal of molecular sciences | 2020 |
|
Can Zn Be a Critical Element in COVID-19 Treatment?
Rahman MT, Idid SZ |
Biological Trace Element Research | 2020 |
|
Revisiting potential druggable targets against SARS-CoV-2 and repurposing therapeutics under preclinical study and clinical trials: A comprehensive review.
Sohag AAM, Hannan MA, Rahman S, Hossain M, Hasan M, Khan MK, Khatun A, Dash R, Uddin MJ |
Drug Development Research | 2020 |
|
Fruitful Neutralizing Antibody Pipeline Brings Hope To Defeat SARS-Cov-2.
Renn A, Fu Y, Hu X, Hall MD, Simeonov A |
Trends in Pharmacological Sciences | 2020 |
|
Actualización de la Declaración de consenso en medicina critica para la atención multidisciplinaria del paciente con sospecha o confirmación diagnóstica de COVID-19
Accini Mendoza JL, Nieto Estrada VH, Beltrán López N, Ramos Bolaños E, Molano Franco D, Dueñas Castell C, Valencia Moreno AA, Alarcón Amaya IC, Serna Flórez J, Gil Valencia BA, Pizarro C, Zabaleta Polo YM, Chica Meza CL |
Acta Colombiana de Cuidado Intensivo | 2020 |
|
Recent Understandings Toward Coronavirus Disease 2019 (COVID-19): From Bench to Bedside
Yu J, Chai P, Ge S, Fan X |
Frontiers in Cell and Developmental Biology | 2020 |
|
COVID-19 - Recent advancements in identifying novel vaccine candidates and current status of upcoming SARS-CoV-2 vaccines
Iqbal Yatoo M, Hamid Z, Parray OR, Wani AH, Ul Haq A, Saxena A, Patel SK, Pathak M, Tiwari R, Malik YS, Sah R, Rabaan AA, Rodriguez Morales AJ, Dhama K |
Human Vaccines & Immunotherapeutics | 2020 |
|
Therapeutic opportunities to manage COVID-19/SARS-CoV-2 infection: Present and future.
Shetty R, Ghosh A, Honavar SG, Khamar P, Sethu S |
Indian journal of ophthalmology | 2020 |
|
Monoclonal antibody as a potential anti-COVID-19.
Jahanshahlu L, Rezaei N |
Biomedicine & Pharmacotherapy | 2020 |
|
Immune response to SARS‐CoV‐2 and mechanisms of immunopathological changes in COVID‐19
Azkur AK, Akdis M, Azkur D, Sokolowska M, van de Veen W, Brüggen M, O\u2019Mahony L, Gao Y, Nadeau K, Akdis CA |
Allergy | 2020 |
|
Guidance for the procurement of COVID‐19 convalescent plasma: differences between high‐ and low‐middle‐income countries
Bloch EM, Goel R, Wendel S, Burnouf T, Al\u2010Riyami AZ, Ang AL, DeAngelis V, Dumont LJ, Land K, Lee C, Oreh A, Patidar G, Spitalnik SL, Vermeulen M, Hindawi S, Van den Berg K, Tiberghien P, Vrielink H, Young P, Devine D, So \u2013 Osman C |
Vox Sanguinis | 2020 |
|
Convalescent plasma is a clutch at straws in COVID‐19 management! A systematic review and meta‐analysis
Sarkar S, Soni KD, Khanna P |
Journal of Medical Virology | 2020 |
|
Supply and demand for plasma‐derived medicinal products ‐ A critical reassessment amid the COVID‐19 pandemic
Hartmann J, Klein HG |
Transfusion | 2020 |
|
Clinical, molecular, and epidemiological characterization of the SARS-CoV-2 virus and the Coronavirus Disease 2019 (COVID-19), a comprehensive literature review
Ortiz-Prado E, Simbaña-Rivera K, Gómez- Barreno L, Rubio-Neira M, Guaman LP, Kyriakidis NC, Muslin C, Jaramillo AM, Barba-Ostria C, Cevallos-Robalino D, Sanches-SanMiguel H, Unigarro L, Zalakeviciute R, Gadian N, López-Cortés A |
Diagnostic Microbiology and Infectious Disease | 2020 |
|
The first, holistic immunological model of COVID‐19: Implications for prevention, diagnosis, and public health measures
Matricardi PM, Dal Negro RW, Nisini R |
Pediatric Allergy and Immunology | 2020 |
|
Convalescent Plasma Therapy in Coronavirus Disease 2019: a Case Report and Suggestions to Overcome Obstacles
JH Im, CH Nahm, JH Baek, HY Kwon, JS Lee |
Journal of Korean Medical Science | 2020 |
|
Better preventing and mitigating the effects of Covid-19
G Maguire |
Future Science OA | 2020 |
|
COVID-19 therapy: What weapons do we bring into battle?
SM de Almeida, JC Soares, KL dos Santos, JE Alves, AG Ribeiro, ÍT Jacob, CJ da Silva Ferreira, JC dos Santos, JF de Oliveira, LB de Carvalho Junior, M do Carmo Alves de Lima |
Bioorganic & Medicinal Chemistry | 2020 |
|
Pivotal role of convalescent plasma in managing emerging infectious diseases.
Wong HK, Lee CK |
Vox Sanguinis | 2020 |
|
COVID-19: The Need for Immunoprevention at Industrial Scale.
Halstead SB |
The American journal of tropical medicine and hygiene | 2020 |
|
An Urgent Need for "Common Cold Units" to Study COVID-19.
Halstead SB |
The American journal of tropical medicine and hygiene | 2020 |
|
The serostatus approach to fighting COVID-19.
Kenyon C |
International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases | 2020 |
|
Individual risk management strategy and potential therapeutic options for the COVID-19 pandemic.
Gasmi A, Noor S, Tippairote T, Dadar M, Menzel A, Bjørklund G |
Clinical Immunology | 2020 |
|
COVID-19: Is a paradigm change to be expected in health care and transfusion medicine?
Garraud O |
2020 | |
|
Brief Summary of Potential SARS-CoV-2 Prophylactic and Treatment Drugs in the Emergency Department.
Brown C, Noble J, Coralic Z |
The western journal of emergency medicine | 2020 |
|
A short review on antibody therapy for COVID-19.
Venkat Kumar G, Jeyanthi V, Ramakrishnan S |
New Microbes and New Infections | 2020 |
|
COVID-19 convalescent plasma transfusion.
Langhi DM Junior, Santis GC, Bordin JO |
2020 | |
|
Convalescent plasma transfusion for the treatment of COVID-19: Systematic review.
Rajendran K, Krishnasamy N, Rangarajan J, Rathinam J, Natarajan M, Ramachandran A |
Journal of Medical Virology | 2020 |
|
Interdisciplinary Perspectives on Health Literacy Research Around the World: More Important Than Ever in a Time of COVID-19.
Sentell T, Vamos S, Okan O |
International journal of environmental research and public health | 2020 |
|
Balancing evidence and frontline experience in the early phases of the COVID-19 pandemic: current position of the Italian Society of Anti-infective Therapy (SITA) and the Italian Society of Pulmonology (SIP).
Bassetti M, Giacobbe DR, Aliberti S, Barisione E, Centanni S, De Rosa FG, Di Marco F, Gori A, Granata G, Mikulska M, Petrosillo N, Richeldi L, Santus P, Tascini C, Vena A, Viale P, Blasi F |
Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases | 2020 |
|
COVID-19: Timing is Important.
de Simone G, Mancusi C |
European Journal of Internal Medicine | 2020 |
|
Perspectives of Immune Therapy in Coronavirus Disease 2019.
Gasparyan AY, Misra DP, Yessirkepov M, Zimba O |
Journal of Korean Medical Science | 2020 |
|
A Precision Medicine Approach to SARS-CoV-2 Pandemic Management.
Crisci CD, Ardusso LRF, Mossuz A, Müller L |
Current Treatment Options in Allergy | 2020 |
|
Dynamics of Population Immunity Due to the Herd Effect in the COVID-19 Pandemic.
Clemente-Suárez VJ, Hormeño-Holgado A, Jiménez M, Benitez-Agudelo JC, Navarro-Jiménez E, Perez-Palencia N, Maestre-Serrano R, Laborde-Cárdenas CC, Tornero-Aguilera JF |
Human vaccines | 2020 |
|
Harnessing the power of novel animal-free test methods for the development of COVID-19 drugs and vaccines.
Busquet F, Hartung T, Pallocca G, Rovida C, Leist M |
Archives of Toxicology | 2020 |
|
Convalescent plasma, an apheresis research project targeting and motivating the fully recovered COVID 19 patients: A rousing message of clinical benefit to both donors and recipients alike.
Seghatchian J, Lanza F |
Transfusion and apheresis science : official journal of the World Apheresis Association : official journal of the European Society for Haemapheresis | 2020 |
|
The outlook for diagnostic purposes of the 2019-novel coronavirus disease.
Tahmasebi S, Khosh E, Esmaeilzadeh A |
Journal of Cellular Physiology | 2020 |
|
COVID-19 under spotlight: A close look at the origin, transmission, diagnosis, and treatment of the 2019-nCoV disease.
Sheervalilou R, Shirvaliloo M, Dadashzadeh N, Shirvalilou S, Shahraki O, Pilehvar-Soltanahmadi Y, Ghaznavi H, Khoei S, Nazarlou Z |
Journal of Cellular Physiology | 2020 |
|
Position paper on the preparation of immune plasma to be used in the treatment of patients with COVID-19.
Accorsi P, Berti P, de Angelis V, De Silvestro G, Mascaretti L, Ostuni A |
Blood transfusion = Trasfusione del sangue | 2020 |
|
Ease restrictions on U.S. blood donations.
Vasavda C, Ho BK, Snyder SH |
Science (New York, N.Y.) | 2020 |
|
An update on SARS-CoV-2/COVID-19 with particular reference to its clinical pathology, pathogenesis, immunopathology and mitigation strategies.
Dhama K, Patel SK, Pathak M, Yatoo MI, Tiwari R, Malik YS, Singh R, Sah R, Rabaan AA, Bonilla-Aldana DK, Rodriguez-Morales AJ |
Travel Medicine and Infectious Disease | 2020 |
|
Harnessing HLA-E-restricted CD8 T lymphocytes for adoptive cell therapy of patients with severe COVID-19.
Caccamo N, Sullivan LC, Brooks AG, Dieli F |
British Journal of Haematology | 2020 |
|
Vaccines and Drug Therapeutics to Lock Down Novel Coronavirus Disease 2019 (COVID-19): A Systematic Review of Clinical Trials.
Bhagavathula AS, Aldhaleei WA, Rovetta A, Rahmani J |
Cureus | 2020 |
|
Novel therapeutic approaches for treatment of COVID-19.
Hossein-Khannazer N, Shokoohian B, Shpichka A, Aghdaei HA, Timashev P, Vosough M |
Journal of Molecular Medicine | 2020 |
|
Immunologic aspects of characteristics, diagnosis, and treatment of coronavirus disease 2019 (COVID-19).
Chang FY, Chen HC, Chen PJ, Ho MS, Hsieh SL, Lin JC, Liu FT, Sytwu HK |
Journal of biomedical science | 2020 |
|
Management of critically ill patients with COVID-19 in ICU: statement from front-line intensive care experts in Wuhan, China.
Shang Y, Pan C, Yang X, Zhong M, Shang X, Wu Z, Yu Z, Zhang W, Zhong Q, Zheng X, Sang L, Jiang L, Zhang J, Xiong W, Liu J, Chen D |
Annals of Intensive Care | 2020 |
|
COVID-19 and the ABO blood group connection.
Zaidi FZ, Zaidi ARZ, Abdullah SM, Zaidi SZA |
Transfusion and apheresis science : official journal of the World Apheresis Association : official journal of the European Society for Haemapheresis | 2020 |
|
SARS-CoV-2 COVID-19 susceptibility and lung inflammatory storm by smoking and vaping.
Kaur G, Lungarella G, Rahman I |
Journal of inflammation (London, England) | 2020 |
|
Position paper on the preparation of immune plasma to be used in the treatment of patients with COVID-19.
Accorsi P, Berti P, de Angelis V, De Silvestro G, Mascaretti L, Ostuni A |
Transfusion and apheresis science : official journal of the World Apheresis Association : official journal of the European Society for Haemapheresis | 2020 |
|
COVID-19: molecular diagnostics overview.
Touma M |
Journal of Molecular Medicine | 2020 |
|
Potential Antiviral Options against SARS-CoV-2 Infection.
Ianevski A, Yao R, Fenstad MH, Biza S, Zusinaite E, Reisberg T, Lysvand H, Løseth K, Landsem VM, Malmring JF, Oksenych V, Erlandsen SE, Aas PA, Hagen L, Pettersen CH, Tenson T, Afset JE, Nordbø SA, Bjørås M, Kainov DE |
Viruses | 2020 |
|
Pathological Findings and Management of COVID-19 Patients: A Brief Overview of Modern-day Pandemic.
Mian MS, Razaq L, Khan S, Hussain N, Razaq M |
Cureus | 2020 |
|
Balancing Supply and Demand for Blood during the COVID-19 Pandemic.
Gehrie EA, Frank SM, Goobie SM |
Anesthesiology | 2020 |
|
Vaccines and Therapies in Development for SARS-CoV-2 Infections.
Wu D, Koganti R, Lambe UP, Yadavalli T, Nandi SS, Shukla D |
Journal of Clinical Medicine | 2020 |
|
COVID-19 and SARS Coronavirus 2: Antibodies for the Immediate Rescue and Recovery Phase.
Halstead SB, Akkina R |
Frontiers in immunology | 2020 |
|
Clinical and Analytical Performance of an Automated Serological Test That Identifies S1/S2-Neutralizing IgG in COVID-19 Patients Semiquantitatively.
Bonelli F, Sarasini A, Zierold C, Calleri M, Bonetti A, Vismara C, Blocki FA, Pallavicini L, Chinali A, Campisi D, Percivalle E, DiNapoli AP, Perno CF, Baldanti F |
Journal of clinical microbiology | 2020 |
|
Antibody Dependent Enhancement Due to Original Antigenic Sin and the Development of SARS.
Fierz W, Walz B |
Frontiers in immunology | 2020 |
|
[Seroprevalence and SARS-CoV-2 testing in healthcare occupations].
Ziemssen F, Bayyoud T, Bartz-Schmidt KU, Peter A, Ueffing M |
2020 | |
|
Helping doctors hasten COVID-19 treatment: Towards a rescue framework for the transfusion of best convalescent plasma to the most critical patients based on biological requirements via ml and novel MCDM methods.
Albahri OS, Al-Obaidi JR, Zaidan AA, Albahri AS, Zaidan BB, Salih MM, Qays A, Dawood KA, Mohammed RT, Abdulkareem KH, Aleesa AM, Alamoodi AH, Chyad MA, Zulkifli CZ |
Computer Methods and Programs in Biomedicine | 2020 |
|
SARS-CoV-2 neutralizing antibody development strategies.
BalcioĞlu BK, Denİzcİ ÖncÜ M, ÖztÜrk HÜ, YÜcel F, Kaya F, Serhatli M, ÜlbeĞİ Polat H, Tekİn Ş, Özdemİr Bahadir A |
2020 | |
|
Combating the Coronavirus Pandemic: Early Detection, Medical Treatment, and a Concerted Effort by the Global Community.
Luo Z, Ang MJY, Chan SY, Yi Z, Goh YY, Yan S, Tao J, Liu K, Li X, Zhang H, Huang W, Liu X |
2020 | |
|
Review of Burden, Clinical Definitions, and Management of COVID-19 Cases.
McArthur L, Sakthivel D, Ataide R, Chan F, Richards JS, Narh CA |
The American journal of tropical medicine and hygiene | 2020 |
|
Life-saving effect of convalescent plasma treatment in covid-19 disease: Clinical trial from eastern Anatolia.
Erkurt MA, Sarici A, Berber İ, Kuku İ, Kaya E, Özgül M |
Transfusion and apheresis science : official journal of the World Apheresis Association : official journal of the European Society for Haemapheresis | 2020 |
|
Going back in time for an antibody to fight COVID-19.
Whittaker GR, Daniel S |
Nature | 2020 |
|
Immunopathology and immunotherapeutic strategies in severe acute respiratory syndrome coronavirus 2 infection.
Keam S, Megawati D, Patel SK, Tiwari R, Dhama K, Harapan H |
Reviews in Medical Virology | 2020 |
|
Coronavirus disease 2019 (COVID-19): latest developments in potential treatments.
Hon KL, Leung KKY, Leung AK, Qian SY, Chan VP, Ip P, Wong IC |
Drugs in Context | 2020 |
|
Current laboratory diagnosis of coronavirus disease 2019.
Lim J, Lee J |
The Korean Journal of Internal Medicine | 2020 |
|
Current perspective on pandemic of COVID-19 in the United States.
Sahu KK, Kumar R |
Journal of Family Medicine and Primary Care | 2020 |
|
Pandemic COVID-19: Current status and challenges of antiviral therapies.
Chan W, He B, Wang X, He ML |
Genes & Diseases | 2020 |
|
Efficacy of Plasmapheresis and Immunoglobulin Replacement Therapy (IVIG) on Patients with COVID-19.
Pourahmad R, Moazzami B, Rezaei N |
2020 | |
|
Artificial Intelligence-Based Clinical Decision Support for COVID-19-Where Art Thou?
Unberath M, Ghobadi K, Levin S, Hinson J, Hager GD |
2020 | |
|
Modulators of the Personal and Professional Threat Perception of Olympic Athletes in the Actual COVID-19 Crisis.
Clemente-Suárez VJ, Fuentes-García JP, de la Vega Marcos R, Martínez Patiño MJ |
Frontiers in psychology | 2020 |
|
Interaction of SARS-CoV-2 and Other Coronavirus With ACE (Angiotensin-Converting Enzyme)-2 as Their Main Receptor: Therapeutic Implications.
Davidson AM, Wysocki J, Batlle D |
2020 | |
|
Effect of Low-Pathogenic Human Coronavirus-Specific Antibodies on SARS-CoV-2.
Jiang S, Du L |
Trends in Immunology | 2020 |
|
SARS-CoV-2/COVID-19 and advances in developing potential therapeutics and vaccines to counter this emerging pandemic.
Rabaan AA, Al-Ahmed SH, Sah R, Tiwari R, Yatoo MI, Patel SK, Pathak M, Malik YS, Dhama K, Singh KP, Bonilla-Aldana DK, Haque S, Martinez-Pulgarin DF, Rodriguez-Morales AJ, Leblebicioglu H |
Annals of clinical microbiology and antimicrobials | 2020 |
|
Current Clinical Dental Practice Guidelines and the Financial Impact of COVID-19 on Dental Care Providers.
Ali S, Farooq I, Abdelsalam M, AlHumaid J |
European journal of dentistry | 2020 |
|
SARS-CoV-2 serology and virology trends in donors and recipients of convalescent plasma.
Dulipsingh L, Ibrahim D, Schaefer EJ, Crowell R, Diffenderfer MR, Williams K, Lima C, McKenzie J, Cook L, Puff J, Onoroski M, Wakefield DB, Eadie RJ, Kleiboeker SB, Nabors P, Hussain SA |
Transfusion and apheresis science : official journal of the World Apheresis Association : official journal of the European Society for Haemapheresis | 2020 |
|
Radiological and clinical improvement in a patient with COVID-19 pneumonia postconvalescent plasma transfusion: A case report.
Al Helali AA, Saeed GA, Elholiby TI, Kukkady MA, Mazrouei SSA |
Radiology Case Reports | 2020 |
|
Safety and Efficacy of Convalescent Plasma to Treat Severe COVID-19: Protocol for the Saudi Collaborative Multicenter Phase II Study.
Albalawi M, Zaidi SZA, AlShehry N, AlAskar A, Zaidi ARZ, Abdallah RNM, Salam A, AlSagheir A, AlMozain N, Elgohary G, Batarfi K, Alfaraedi A, Khojah O, Al-Ansari R, Alfaraj M, Dayel A, Al Bahrani A, Abdelhameed AN, Alhumaidan H, Al-Otaibi JM, Radwi G, Raizah A, Shatry H, Alsaleh S, AlZahrani H, Al-Hashmi H |
JMIR Research Protocols | 2020 |
|
Convalescent Plasma: A Potential Life-Saving Therapy for Coronavirus Disease 2019 (COVID-19).
Alghamdi AN, Abdel-Moneim AS |
Frontiers in public health | 2020 |
|
Immune response in COVID-19: What do we currently know?
Oliveira DS, Medeiros NI, Gomes JAS |
Microbial Pathogenesis | 2020 |
|
A consideration of convalescent plasma and plasma derivatives in the care of Severely-ill patients with COVID-19.
Lung T, Kazatchkine MD, Risch L, Risch M, Nydegger UE |
Transfusion and apheresis science : official journal of the World Apheresis Association : official journal of the European Society for Haemapheresis | 2020 |
|
The emergence of COVID-19 as a global pandemic: Understanding the epidemiology, immune response and potential therapeutic targets of SARS-CoV-2.
Muralidar S, Ambi SV, Sekaran S, Krishnan UM |
Biochimie | 2020 |
|
SARS-COV-2 (COVID-19): Cellular and biochemical properties and pharmacological insights into new therapeutic developments.
Parlakpinar H, Gunata M |
Cell Biochemistry and Function | 2020 |
|
Anti-corona Drugs: Current Scenario.
Fernando E, Gang S, Prasad N, Chaudhary AR, Agarwal SK |
Indian journal of nephrology | 2020 |
|
Viral Emerging Diseases: Challenges in Developing Vaccination Strategies.
Trovato M, Sartorius R, D'Apice L, Manco R, De Berardinis P |
Frontiers in immunology | 2020 |
|
Awareness and Preparedness of COVID-19 Outbreak Among Healthcare Workers and Other Residents of South-West Saudi Arabia: A Cross-Sectional Survey.
Tripathi R, Alqahtani SS, Albarraq AA, Meraya AM, Tripathi P, Banji D, Alshahrani S, Ahsan W, Alnakhli FM |
Frontiers in public health | 2020 |
|
Clinical trial protocols of repurposed prophylaxis for COVID-19: A review.
Sallard E, Belhadi D, Lescure FX, Yazdanpanah Y, Peiffer-Smadja N |
2020 | |
|
Convalescent Plasma: A Challenging Tool to Treat COVID-19 Patients-A Lesson from the Past and New Perspectives.
Selvi V |
BioMed Research International | 2020 |
|
COVID-19 effect on clinical research: Single-site risk management experience.
Ebeid FSE |
Perspectives in Clinical Research | 2020 |
|
Perspective on the Role of Antibodies and Potential Therapeutic Drugs to Combat COVID-19.
Tandon S, Aggarwal A, Jain S, Shukla S, Chaudhary S |
The Protein Journal | 2020 |
|
Preparedness needs research: How fundamental science and international collaboration accelerated the response to COVID-19.
Kinsella CM, Santos PD, Postigo-Hidalgo I, Folgueiras-González A, Passchier TC, Szillat KP, Akello JO, Álvarez-Rodríguez B, Martí-Carreras J |
PLoS pathogens | 2020 |
|
The Current Recommended Drugs and Strategies for the Treatment of Coronavirus Disease (COVID-19).
Sheikhpour M |
Therapeutics and Clinical Risk Management | 2020 |
|
Flattening the Risk: Pre-Exposure Prophylaxis for COVID-19.
Stricker RB, Fesler MC |
Infection and drug resistance | 2020 |
|
The Economic and Public Health Imperatives Around Making Potential Coronavirus Disease-2019 Treatments Available and Affordable.
Forsythe S, Cohen J, Neumann P, Bertozzi SM, Kinghorn A |
2020 | |
|
Generation of Chicken IgY against SARS-COV-2 Spike Protein and Epitope Mapping.
Lu Y, Wang Y, Zhang Z, Huang J, Yao M, Huang G, Ge Y, Zhang P, Huang H, Wang Y, Li H, Wang W |
Journal of Immunology Research | 2020 |
|
Insights of Novel Coronavirus (SARS-CoV-2) disease outbreak, management and treatment.
Kumar D, Batra L, Malik MT |
AIMS Microbiology | 2020 |
|
Recent advances in vaccine and immunotherapy for COVID-19.
Rabaan AA, Al-Ahmed SH, Sah R, Al-Tawfiq JA, Al-Qaaneh AM, Al-Jamea LH, Woodman A, Al-Qahtani M, Haque S, Harapan H, Bonilla-Aldana DK, Kumar P, Dhama K, Rodriguez-Morales AJ |
Human Vaccines & Immunotherapeutics | 2020 |
|
Differences of SARS-CoV-2 serological test performance between hospitalized and outpatient COVID-19 cases.
Wolf J, Kaiser T, Pehnke S, Nickel O, Lübbert C, Kalbitz S, Arnold B, Ermisch J, Berger L, Schroth S, Isermann B, Borte S, Biemann R |
Clinica chimica acta; international journal of clinical chemistry | 2020 |
|
SARS-CoV-2 Infection in Cancer Patients: Effects on Disease Outcomes and Patient Prognosis.
Seth G, Sethi S, Bhattarai S, Saini G, Singh CB, Aneja R |
Cancers | 2020 |
|
Repurposed Drugs, Molecular Vaccines, Immune-Modulators, and Nanotherapeutics to Treat and Prevent COVID-19 Associated with SARS-CoV-2, a Deadly Nanovector.
Dube T, Ghosh A, Mishra J, Kompella UB, Panda JJ |
2020 | |
|
Current Prevention of COVID-19: Natural Products and Herbal Medicine.
Huang J, Tao G, Liu J, Cai J, Huang Z, Chen JX |
Frontiers in pharmacology | 2020 |
|
Amotosalen and ultraviolet A light treatment efficiently inactivates severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in human plasma.
Azhar EI, Hindawi SI, El-Kafrawy SA, Hassan AM, Tolah AM, Alandijany TA, Bajrai LH, Damanhouri GA |
Vox Sanguinis | 2020 |
|
Guidelines for Preoperative Testing for Neurosurgery in Coronavirus Disease 2019 (COVID-19) Era: Indian Viewpoint Amidst Global Practice.
Agarwal N, Raheja A, Suri A |
World Neurosurgery | 2020 |
|
SARS-CoV-2 receptor ACE2 is co-expressed with genes related to transmembrane serine proteases, viral entry, immunity and cellular stress.
Wruck W, Adjaye J |
Scientific Reports | 2020 |
|
Therapeutic and Vaccine Options for COVID-19: Status after Six Months of the Disease Outbreak.
Maciorowski D, Ogaugwu C, Durvasula SR, Durvasula R, Kunamneni A |
2020 | |
|
Clinical characteristics and infectivity of asymptomatic carriers of SARS-CoV-2 (Review).
Zhang W, Wu X, Zhou H, Xu F |
Experimental and therapeutic medicine | 2020 |
|
How Useful is COVID-19 Antibody Testing - A Current Assessment for Oncologists.
Maple PAC, Sikora K |
Clinical Oncology | 2020 |
|
Convalescent plasma therapy in COVID 19: Every dark cloud has a silver lining.
Deokar K, Chawla G, Shadrach BJ, Dutt N |
Journal of Anaesthesiology, Clinical Pharmacology | 2020 |
|
Biomarkers of COVID-19 and technologies to combat SARS-CoV-2.
Zhang L, Guo H |
2020 | |
|
Antivirals for COVID-19: A critical review.
Frediansyah A, Tiwari R, Sharun K, Dhama K, Harapan H |
Clinical Epidemiology and Global Health | 2020 |
|
Convalescent plasma-mediated resolution of COVID-19 in a patient with humoral immunodeficiency.
Honjo K, Russell RM, Li R, Liu W, Stoltz R, Tabengwa EM, Hua Y, Prichard L, Kornbrust AN, Sterrett S, Marques MB, Lima JL, Lough CM, McCarty TP, Ketas TJ, Hatziioannou T, Bieniasz PD, Redden DT, Moore JP, Goepfert PA, Heath SL, Hahn BH, Davis RS |
Cell reports. Medicine | 2020 |
|
Ensuring a safe and adequate blood supply during the COVID-19 pandemic: the Moroccan National Blood Center experience.
Bouhou S, Benajiba M |
The Pan African medical journal | 2020 |
|
An overview of key potential therapeutic strategies for combat in the COVID-19 battle.
Das G, Ghosh S, Garg S, Ghosh S, Jana A, Samat R, Mukherjee N, Roy R, Ghosh S |
RSC Advances | 2020 |
|
Surviving Sepsis Campaign: Guidelines on the Management of Critically Ill Adults with Coronavirus Disease 2019 (COVID-19).
Alhazzani W, Møller MH, Arabi YM, Loeb M, Gong MN, Fan E, Oczkowski S, Levy MM, Derde L, Dzierba A, Du B, Aboodi M, Wunsch H, Cecconi M, Koh Y, Chertow DS, Maitland K, Alshamsi F, Belley-Cote E, Greco M, Laundy M, Morgan JS, Kesecioglu J, McGeer A, Mermel L, Mammen MJ, Alexander PE, Arrington A, Centofanti JE, Citerio G, Baw B, Memish ZA, Hammond N, Hayden FG, Evans L, Rhodes A |
Critical Care Medicine | 2020 |
|
Developing guidelines for COVID-19 management: A moving target. An invited commentary on "Evidence based management guideline for the COVID-19 pandemic - Review article".
Gallaher J, Charles A |
International journal of surgery (London, England) | 2020 |
|
Addressing the Impact of the Coronavirus Disease 2019 (COVID-19) Pandemic on Hematopoietic Cell Transplantation: Learning Networks as a Means for Sharing Best Practices.
Ardura M, Hartley D, Dandoy C, Lehmann L, Jaglowski S, Auletta JJ |
Biology of Blood and Marrow Transplantation | 2020 |
|
The ACE-2 in COVID-19: Foe or Friend?
Dalan R, Bornstein SR, El-Armouche A, Rodionov RN, Markov A, Wielockx B, Beuschlein F, Boehm BO |
2020 | |
|
Treatment for emerging viruses: Convalescent plasma and COVID-19.
Brown BL, McCullough J |
Transfusion and apheresis science : official journal of the World Apheresis Association : official journal of the European Society for Haemapheresis | 2020 |
|
B Cells, Viruses, and the SARS-CoV-2/COVID-19 Pandemic of 2020.
Hurwitz JL |
Viral Immunology | 2020 |
|
Guillain-Barré syndrome related to COVID-19 infection.
Alberti P, Beretta S, Piatti M, Karantzoulis A, Piatti ML, Santoro P, Viganò M, Giovannelli G, Pirro F, Montisano DA, Appollonio I, Ferrarese C |
Neurology: Neuroimmunology & Neuroinflammation | 2020 |
|
On Facing the SARS-CoV-2 (COVID-19) with Combination of Nanomaterials and Medicine: Possible Strategies and First Challenges.
Sivasankarapillai VS, Pillai AM, Rahdar A, Sobha AP, Das SS, Mitropoulos AC, Mokarrar MH, Kyzas GZ |
2020 | |
|
The 2019-2020 coronavirus pandemic in Italy: immunologic and cultural hurdles on the road to a cure.
Virgilio E |
The Brazilian journal of infectious diseases : an official publication of the Brazilian Society of Infectious Diseases | 2020 |
|
COVID-19: Learning from Lessons To Guide Treatment and Prevention Interventions.
Triggle CR, Bansal D, Farag EABA, Ding H, Sultan AA |
mSphere | 2020 |
|
Reflection on passive immunotherapy in those who need most: some novel strategic arguments for obtaining safer therapeutic plasma or autologous antibodies from recovered COVID-19 infected patients.
Lanza F, Seghatchian J |
British Journal of Haematology | 2020 |
|
Convalescent plasma therapy: A passive therapy for an aggressive COVID-19.
Sahu KK, Jindal V, Siddiqui AD, Cerny J, Gerber JM |
Journal of Medical Virology | 2020 |
|
The Effects of ARBs, ACEis, and Statins on Clinical Outcomes of COVID-19 Infection Among Nursing Home Residents.
De Spiegeleer A, Bronselaer A, Teo JT, Byttebier G, De Tré G, Belmans L, Dobson R, Wynendaele E, Van De Wiele C, Vandaele F, Van Dijck D, Bean D, Fedson D, De Spiegeleer B |
Journal of the American Medical Directors Association | 2020 |
|
COVID-19 and the Gut Microbiome: More than a Gut Feeling.
van der Lelie D, Taghavi S |
mSystems | 2020 |
|
Review of Viral Testing (Polymerase Chain Reaction) and Antibody/Serology Testing for Severe Acute Respiratory Syndrome-Coronavirus-2 for the Intensivist.
Motley MP, Bennett-Guerrero E, Fries BC, Spitzer ED |
2020 | |
|
Point-of-Use Rapid Detection of SARS-CoV-2: Nanotechnology-Enabled Solutions for the COVID-19 Pandemic.
Rabiee N, Bagherzadeh M, Ghasemi A, Zare H, Ahmadi S, Fatahi Y, Dinarvand R, Rabiee M, Ramakrishna S, Shokouhimehr M, Varma RS |
International journal of molecular sciences | 2020 |
|
Structural basis for neutralization of SARS-CoV-2 and SARS-CoV by a potent therapeutic antibody.
Lv Z, Deng YQ, Ye Q, Cao L, Sun CY, Fan C, Huang W, Sun S, Sun Y, Zhu L, Chen Q, Wang N, Nie J, Cui Z, Zhu D, Shaw N, Li XF, Li Q, Xie L, Wang Y, Rao Z, Qin CF, Wang X |
Science (New York, N.Y.) | 2020 |
|
Evaluation of Current Therapies for COVID-19 Treatment.
Sethi A, Bach H |
Microorganisms | 2020 |
|
Drug Discovery Strategies for SARS-CoV-2.
Shyr ZA, Gorshkov K, Chen CZ, Zheng W |
The Journal of pharmacology and experimental therapeutics | 2020 |
|
Identification of an anti-SARS-CoV-2 receptor-binding domain-directed human monoclonal antibody from a naïve semisynthetic library.
Parray HA, Chiranjivi AK, Asthana S, Yadav N, Shrivastava T, Mani S, Sharma C, Vishwakarma P, Das S, Pindari K, Sinha S, Samal S, Ahmed S, Kumar R |
The Journal of biological chemistry | 2020 |
|
Diagnostics for SARS-CoV-2 detection: A comprehensive review of the FDA-EUA COVID-19 testing landscape.
Ravi N, Cortade DL, Ng E, Wang SX |
Biosensors & bioelectronics | 2020 |
|
The Anatomy of the SARS-CoV-2 Biomedical Literature: Introducing the CovidX Network Algorithm for Drug Repurposing Recommendation.
Gates LE, Hamed AA |
Journal of Medical Internet Research | 2020 |
|
A Replication-Competent Vesicular Stomatitis Virus for Studies of SARS-CoV-2 Spike-Mediated Cell Entry and Its Inhibition.
Dieterle ME, Haslwanter D, Bortz RH 3rd, Wirchnianski AS, Lasso G, Vergnolle O, Abbasi SA, Fels JM, Laudermilch E, Florez C, Mengotto A, Kimmel D, Malonis RJ, Georgiev G, Quiroz J, Barnhill J, Pirofski LA, Daily JP, Dye JM, Lai JR, Herbert AS, Chandran K, Jangra RK |
Cell Host & Microbe | 2020 |
|
Coronavirus-Related Health Literacy: A Cross-Sectional Study in Adults during the COVID-19 Infodemic in Germany.
Okan O, Bollweg TM, Berens EM, Hurrelmann K, Bauer U, Schaeffer D |
International journal of environmental research and public health | 2020 |
|
Coronavirus disease 2019-Historical context, virology, pathogenesis, immunotherapy, and vaccine development.
Ezzikouri S, Nourlil J, Benjelloun S, Kohara M, Tsukiyama-Kohara K |
Human Vaccines & Immunotherapeutics | 2020 |
|
Outbreak of COVID-19: An emerging global pandemic threat.
Peng M |
Biomedicine & Pharmacotherapy | 2020 |
|
"Tomorrow Never Dies": Recent Advances in Diagnosis, Treatment, and Prevention Modalities against Coronavirus (COVID-19) amid Controversies.
Laskar P, Yallapu MM, Chauhan SC |
2020 | |
|
Crippling life support for SARS-CoV-2 and other viruses through synthetic lethality.
Mast FD, Navare AT, van der Sloot AM, Coulombe-Huntington J, Rout MP, Baliga NS, Kaushansky A, Chait BT, Aderem A, Rice CM, Sali A, Tyers M, Aitchison JD |
The Journal of Cell Biology | 2020 |
|
Coronavirus disease 2019 (COVID-19): Immunological approaches and emerging pharmacologic treatments.
Goodarzi P, Mahdavi F, Mirzaei R, Hasanvand H, Sholeh M, Zamani F, Sohrabi M, Tabibzadeh A, Jeda AS, Niya MHK, Keyvani H, Karampoor S |
International Immunopharmacology | 2020 |
|
Evaluating the Association of Clinical Characteristics With Neutralizing Antibody Levels in Patients Who Have Recovered From Mild COVID-19 in Shanghai, China.
Wu F, Liu M, Wang A, Lu L, Wang Q, Gu C, Chen J, Wu Y, Xia S, Ling Y, Zhang Y, Xun J, Zhang R, Xie Y, Jiang S, Zhu T, Lu H, Wen Y, Huang J |
JAMA internal medicine | 2020 |
|
Genome-wide analysis of SARS-CoV-2 virus strains circulating worldwide implicates heterogeneity.
Islam MR, Hoque MN, Rahman MS, Alam ASMRU, Akther M, Puspo JA, Akter S, Sultana M, Crandall KA, Hossain MA |
Scientific Reports | 2020 |
|
Changes in Intravenous Immunoglobulin Usage for Hypogammaglobulinemia After Implementation of a Stewardship Program.
Derman BA, Schlei Z, Parsad S, Mullane K, Knoebel RW |
2020 | |
|
Coronavirus Disease of 2019 (COVID-19) Facts and Figures: What Every Dermatologist Should Know at this Hour of Need.
Manchanda Y, Das S, De A |
Indian journal of dermatology | 2020 |
|
Potential benefits of combination of Nigella sativa and Zn supplements to treat COVID-19.
Rahman MT |
Journal of Herbal Medicine | 2020 |
|
The role of the urologist, BCG vaccine administration, and SARS-CoV-2: An overview.
Brooks NA, Narayan V, Hegarty PK, Zafirakis H, Han XY, Kamat AM |
2020 | |
|
Cancer Care Management During the COVID-19 Pandemic.
Jafari A, Rezaei-Tavirani M, Karami S, Yazdani M, Zali H, Jafari Z |
Risk Management and Healthcare Policy | 2020 |
|
Primed for global coronavirus pandemic: Emerging research and clinical outcome.
Ahamad S, Branch S, Harrelson S, Hussain MK, Saquib M, Khan S |
European Journal of Medicinal Chemistry | 2020 |
|
The Covid-19, Epidemiology, Clinic and Prevention.
Antonelli A, Elia G, Ferrari SM, Foddis R, De Marco S, Cristaudo A, Fallahi P |
Current genomics | 2020 |
|
Hospitalized COVID-19 patients treated with convalescent plasma in a mid-size city in the Midwest.
Hartman WR, Hess AS, Connor JP |
Translational Medicine Communications | 2020 |
|
Dynamic changes in anti-SARS-CoV-2 antibodies during SARS-CoV-2 infection and recovery from COVID-19.
Li K, Huang B, Wu M, Zhong A, Li L, Cai Y, Wang Z, Wu L, Zhu M, Li J, Wang Z, Wu W, Li W, Bosco B, Gan Z, Qiao Q, Wu J, Wang Q, Wang S, Xia X |
Nature Communications | 2020 |
|
COVID-19 pandemic: Mechanistic approaches and gender vulnerabilities.
Khan L, Khaliq NU, Ullah A, Rafiq N, Ullah M |
2020 | |
|
Exploring the magic bullets to identify Achilles' heel in SARS-CoV-2: Delving deeper into the sea of possible therapeutic options in Covid-19 disease: An update.
Thakur S, Mayank, Sarkar B, Ansari AJ, Khandelwal A, Arya A, Poduri R, Joshi G |
Food and Chemical Toxicology | 2020 |
|
Differences in the Clinical and Hematological Characteristics of COVID-19 Patients with and without Type 2 Diabetes.
Sun Y, Zhao R, Hu Z, Wang W, Wang S, Gao L, Fei J, Jian X, Li Y, Zheng H, Hou X, Chen L |
Journal of Diabetes Research | 2020 |
|
Lead SARS-CoV-2 Candidate Vaccines: Expectations from Phase III Trials and Recommendations Post-Vaccine Approval.
Tumban E |
Viruses | 2020 |
|
Characterization of the SARS-CoV-2 S Protein: Biophysical, Biochemical, Structural, and Antigenic Analysis.
Herrera NG, Morano NC, Celikgil A, Georgiev GI, Malonis RJ, Lee JH, Tong K, Vergnolle O, Massimi AB, Yen LY, Noble AJ, Kopylov M, Bonanno JB, Garrett-Thomson SC, Hayes DB, Bortz RH 3rd, Wirchnianski AS, Florez C, Laudermilch E, Haslwanter D, Fels JM, Dieterle ME, Jangra RK, Barnhill J, Mengotto A, Kimmel D, Daily JP, Pirofski LA, Chandran K, Brenowitz M, Garforth SJ, Eng ET, Lai JR, Almo SC |
ACS Omega | 2020 |
|
Convalescent plasma transfusion a promising therapy for coronavirus diseases 2019 (COVID-19): current updates.
Verma HK, Farran B, Bhaskar LVKS |
2020 | |
|
Innate immune-mediated antiviral response to SARS-CoV-2 and convalescent sera a potential prophylactic and therapeutic agent to tackle COVID-19.
Abdullah, Faisal S, Aman K, Rahman AU |
2020 | |
|
Analysis of the SARS-CoV-2 spike protein glycan shield reveals implications for immune recognition.
Grant OC, Montgomery D, Ito K, Woods RJ |
Scientific Reports | 2020 |
|
A systematic review of antibody mediated immunity to coronaviruses: kinetics, correlates of protection, and association with severity.
Huang AT, Garcia-Carreras B, Hitchings MDT, Yang B, Katzelnick LC, Rattigan SM, Borgert BA, Moreno CA, Solomon BD, Trimmer-Smith L, Etienne V, Rodriguez-Barraquer I, Lessler J, Salje H, Burke DS, Wesolowski A, Cummings DAT |
Nature Communications | 2020 |
|
A review of medications used to control and improve the signs and symptoms of COVID-19 patients.
Hushmandi K, Bokaie S, Hashemi M, Moghadam ER, Raei M, Hashemi F, Bagheri M, Habtemariam S, Nabavi SM |
European Journal of Pharmacology | 2020 |
|
Convalescent plasma for the treatment of patients with severe coronavirus disease 2019: A preliminary report.
Omrani AS, Zaqout A, Baiou A, Daghfal J, Elkum N, Alattar RA, Bakdach D, Abusriwil H, Mostafa AM, Alhariri B, Ambra N, Khatib M, Eldeeb AM, Merenkov Z, Fawzi Z, Hmissi SM, Hssain AA, Coyle PV, Alsoub H, Almaslamani MA, Alkhal A |
Journal of Medical Virology | 2020 |
|
Newcastle disease virus (NDV) expressing the spike protein of SARS-CoV-2 as a live virus vaccine candidate.
Sun W, Leist SR, McCroskery S, Liu Y, Slamanig S, Oliva J, Amanat F, Schäfer A, Dinnon KH 3rd, García-Sastre A, Krammer F, Baric RS, Palese P |
EBioMedicine | 2020 |
|
COVID-19 Pandemic: Oral Health Challenges and Recommendations.
Farook FF, Mohamed Nuzaim MN, Taha Ababneh K, Alshammari A, Alkadi L |
European journal of dentistry | 2020 |
|
COVID-19: A review of therapeutics under investigation.
Crosby JC, Heimann MA, Burleson SL, Anzalone BC, Swanson JF, Wallace DW, Greene CJ |
2020 | |
|
High Potency of a Bivalent Human VH Domain in SARS-CoV-2 Animal Models.
Li W, Schäfer A, Kulkarni SS, Liu X, Martinez DR, Chen C, Sun Z, Leist SR, Drelich A, Zhang L, Ura ML, Berezuk A, Chittori S, Leopold K, Mannar D, Srivastava SS, Zhu X, Peterson EC, Tseng CT, Mellors JW, Falzarano D, Subramaniam S, Baric RS, Dimitrov DS |
Cell | 2020 |
|
Harnessing immunotherapy to combat COVID-19: A modern snake oil or silver bullet?
Gunjegaonkar SM, Shanmugarajan TS, Arunsundar M, Arjun UVNV, Devi K, Wankhede SB, Ravichandiran V |
2020 | |
|
Intractable airsickness associated with COVID-19: A case report.
Talebi Bezmin Abadi H, Abadi ATB, Farahani AA, Darvishi M |
Vacunas | 2020 |
|
Emergence of ancient convalescent plasma (CP) therapy: To manage COVID-19 pandemic.
Dassarma B, Tripathy S, Matsabisa M |
2020 | |
|
Validation of dried blood spot sample modifications to two commercially available COVID-19 IgG antibody immunoassays.
Zava TT, Zava DT |
Bioanalysis | 2020 |
|
Design and validation of a scale to measure worry for contagion of the COVID-19 (PRE-COVID-19).
Caycho-Rodríguez T, Ventura-León J, Barboza-Palomino M |
2020 | |
|
Neutralizing monoclonal antibodies for COVID-19 treatment and prevention.
Jaworski JP |
Biomedical journal | 2020 |
|
COVID-19 outbreak and its monetary implications for dental practices, hospitals and healthcare workers.
Farooq I, Ali S |
Postgraduate medical journal | 2020 |
|
Treatment of Severe COVID-19 with Convalescent Plasma in the Bronx, NYC.
Yoon HA, Bartash R, Gendlina I, Rivera J, Nakouzi A, Bortz RH 3rd, Wirchnianski AS, Paroder M, Fehn K, Serrano-Rahman L, Babb R, Sarwar UN, Haslwanter D, Laudermilch E, Florez C, Dieterle ME, Jangra RK, Fels JM, Tong K, Mariano MC, Vergnolle O, Georgiev GI, Herrera NG, Malonis RJ, Quiroz JA, Morano NC, Krause GJ, Sweeney JM, Cowman K, Allen S, Annam J, Applebaum A, Barboto D, Khokhar A, Lally BJ, Lee A, Lee M, Malaviya A, Sample R, Yang XA, Li Y, Ruiz R, Thota R, Barnhill J, Goldstein DY, Uehlinger J, Garforth SJ, Almo SC, Lai JR, Gil MR, Fox AS, Chandran K, Wang T, Daily JP, Pirofski LA |
medRxiv : the preprint server for health sciences | 2020 |
|
A replication-competent vesicular stomatitis virus for studies of SARS-CoV-2 spike-mediated cell entry and its inhibition.
Dieterle ME, Haslwanter D, Bortz RH 3rd, Wirchnianski AS, Lasso G, Vergnolle O, Abbasi SA, Fels JM, Laudermilch E, Florez C, Mengotto A, Kimmel D, Malonis RJ, Georgiev G, Quiroz J, Barnhill J, Pirofski LA, Daily JP, Dye JM, Lai JR, Herbert AS, Chandran K, Jangra RK |
bioRxiv : the preprint server for biology | 2020 |
|
A systematic review of antibody mediated immunity to coronaviruses: antibody kinetics, correlates of protection, and association of antibody responses with severity of disease.
Huang AT, Garcia-Carreras B, Hitchings MDT, Yang B, Katzelnick LC, Rattigan SM, Borgert BA, Moreno CA, Solomon BD, Rodriguez-Barraquer I, Lessler J, Salje H, Burke D, Wesolowski A, Cummings DAT |
medRxiv : the preprint server for health sciences | 2020 |
|
Detection of SARS-CoV-2 neutralizing antibodies with a cell-free PCR assay.
Danh K, Karp DG, Robinson PV, Seftel D, Stone M, Simmons G, Bagri A, Schreiber M, Buser A, Holbro A, Battegay M, Corash LM, Hanson C, Tsai CT |
medRxiv : the preprint server for health sciences | 2020 |
|
SARS-CoV-2 Antibody Responses Correlate with Resolution of RNAemia But Are Short-Lived in Patients with Mild Illness.
Röltgen K, Wirz OF, Stevens BA, Powell AE, Hogan CA, Najeeb J, Hunter M, Sahoo MK, Huang C, Yamamoto F, Manalac J, Otrelo-Cardoso AR, Pham TD, Rustagi A, Rogers AJ, Shah NH, Blish CA, Cochran JR, Nadeau KC, Jardetzky TS, Zehnder JL, Wang TT, Kim PS, Gombar S, Tibshirani R, Pinsky BA, Boyd SD |
medRxiv : the preprint server for health sciences | 2020 |
|
Engineering luminescent biosensors for point-of-care SARS-CoV-2 antibody detection.
Elledge SK, Zhou XX, Byrnes JR, Martinko AJ, Lui I, Pance K, Lim SA, Glasgow JE, Glasgow AA, Turcios K, Iyer N, Torres L, Peluso MJ, Henrich TJ, Wang TT, Tato CM, Leung KK, Greenhouse B, Wells JA |
medRxiv : the preprint server for health sciences | 2020 |
|
Natural and Synthetic Drugs as Potential Treatment for Coronavirus Disease 2019 (COVID-2019)
Farooq S, Ngaini Z |
2020 | |
|
Lesión renal aguda en COVID-19: puesta al día y revisión de la literatura
Vargas JG, Avila N, Hurtado D, Cárdenas-Roldán J, Peña D, Ortiz G |
Acta Colombiana de Cuidado Intensivo | 2020 |
|
Epitope-resolved profiling of the SARS-CoV-2 antibody response identifies cross-reactivity with an endemic human CoV
Ladner JT, Henson SN, Boyle AS, Engelbrektson AL, Fink ZW, Rahee F, D\u2019ambrozio J, Schaecher KE, Stone M, Dong W, Dadwal S, Yu J, Caligiuri MA, Cieplak P, Bjørås M, Fenstad MH, Nordbø SA, Kainov DE, Muranaka N, Chee MS, Shiryaev SA, Altin JA |
2020 | |
|
Characterization of the SARS-CoV-2 S Protein: Biophysical, Biochemical, Structural, and Antigenic Analysis
Herrera NG, Morano NC, Celikgil A, Georgiev GI, Malonis RJ, Lee JH, Tong K, Vergnolle O, Massimi AB, Yen LY, Noble AJ, Kopylov M, Bonanno JB, Garrett-Thomson SC, Hayes DB, Bortz RH III, Wirchnianski AS, Florez C, Laudermilch E, Haslwanter D, Fels JM, Dieterle ME, Jangra RK, Barnhill J, Mengotto A, Kimmel D, Daily JP, Pirofski LA, Chandran K, Brenowitz M, Garforth SJ, Eng ET, Lai JR, Almo SC |
2020 | |
|
Novel Coronavirus Disease (COVID-19)
Sharma AK |
Resonance | 2020 |
|
The potential for antibody-dependent enhancement of SARS-CoV-2 infection: Translational implications for vaccine development
Wang J, Zand MS |
Journal of Clinical and Translational Science | 2020 |
|
National common metrics for the NIH Clinical and Translational Science Award Institutions: A signal of the transformation of the American biomedical research enterprise.
Selker HP |
Journal of Clinical and Translational Science | 2019 |
|
Pulmonary surfactant: an immunological perspective
ZC Chroneos, Z Sever-Chroneos, VL Shepherd |
Cellular physiology and biochemistry : international journal of experimental cellular physiology, biochemistry, and pharmacology | 2009 |
Copyright © 2025 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)